Vascular & Endovascular
Challenges Update 15–18 APRIL 2019 MONDAY–THURSDAY OLYMPIA GRAND • LONDON • UNITED KINGDOM
Aortic Challenges
Peripheral Arterial Challenges
Venous & Lymphatic Challenges
Acute Stroke Challenges
Vascular Access Challenges
and introducing
Programme
EDUCATION
INNOVATION EVIDENCE
www.cxsymposium.com
Vascular & Endovascular Challenges Update
CX Pick Up Point Delegate bags
Book & Bag Stand
CX Book pick up point Book & Bag Stand
Pavilion Sponsors
CX Programme – Slim Jim Book & Bag Stand
Cook Medical
140
Gore
Endologix
155
Medtronic
450
Getinge
170
Terumo Aortic
240
BD
428
Merit Medical
470
Bentley
419
Philips
444
Boston Scientific
228
RD GLOBAL
238
Cydar Medical
229
Siemens Healthineers
150
JOTEC - CryoLife
440
Straub Medical
418
Lombard Medical
432
Major Sponsors
Exhibitors
250/260
3D Systems Simbionix
315
BTG
212
Abbott Vascular
232
C3 interventional Academy
501
Advanced Oxygen Therapy Inc
138
CACVS / i-MEET /DIVINE ID
118
ALN Implants Chirurgicaux
122
Cardionovum
716
AndraTec
712
CIRSE
644
Aortic Association
710
Clinlogix
736
Avenu Medical
734
Concept Medical
401
BALTON SP. Z.O.O.
304
Corindus
400
BIBA Medtech Insights
110
Edinburgh Surgery Online
135
Biotronik
402
Edizioni Minerva Medica
646
Upper Main Auditorium Accessable via Staircase
CX Poster Gallery
CX Vascular Access Workshop
648
470
450
646
444
644
An Introduction to Vascular Surgery
440
428
533
538
432
438
Entrance to Lower Main
CX Aortic Workshop
523
424
Stairs to Gallery and
Auditorium
Upper Main Auditorium
250
260
240 Catering
Stairs to Gallery and Upper Main Auditorium
155
150
140
238
229
232
170 124 137
Entrance to
138
135 136
132
134
Lower Main Auditorium
10 2019
Ground Floor
131
9
Edwards Lifesciences
137
optimed
404
ESVS
114
Orbus Neich
505
Evarplanning
132
Penumbra
412
EVC
213
Pie Medical Imaging
538
EVF
117
Piur Imaging
215
EVT
119
R&D Surgical
720
F Care Systems
116
Ra Medical Systems
509
Firstkind
131
Regen Medical
124
Fist Assist Devices
718
Scanlan International
211
GE Healthcare
311
Shockwave Medical
424
H&R Healthcare
308
SITE
501
Huntleigh
209
Therenva
533
Intact Vascular
408
Vascular News
110
Laminate Medical
409
Legs Matter
136
Vascular Society and Circulation Foundation 207
Lifetech Scientific
523
LimFlow
714
LINC
648
LSO Medical
220
Medi
217
Micro Medical solutions
738
Mรถlnlycke
134
Nanjing ECO Microwave
208
Venclose
112
Venous News
110
VentureMed
732
Veryan Medical
438
Vivasure Medical
317
Walk Vascular
113
Wisepress Medical Bookshop
725
Ziehm Imaging
223
Stairs to Gallery Suite & Dark Room Learning Centres
Pillar Hall Learning Centre
Gallery Suite Learning Centre
CX Peripheral Workshop
738
Catering
418
Speaker Ready Room
736
Faculty Lounge
Dark Room Learning Centre
Gallery Suite & Dark Room Learning Centres Situated on the Gallery level above the Olympia Room
734
509
505
412
408
401 404
501
732
402
419
409
Faculty Registration
304
308
228
317
315
220
212
Book & Bag
311
Registration
208 725 720
718
223
217
215
211
209
207 122
119 118 117
116
114 113
110 BIBAMedTech Insights
213
716
714
712
710
112
CX Venous City (Workshop & Edited Cases)
London Room Learning Centre
Entrance
400
Plan your Symposium experience with the CX web-app
Browse the programmes Add sessions to your personal agenda Take part in live polling Network with fellow delegates View exhibitors Floorplan News
cx2019app.com
Get involved! How to get this year’s CX web-app: Log on to our Free WiFi WiFi: CX Symposium Password: CXSymposium2019 You’ll be automatically redirected to cx2019app.com
Simply sign in - no need to download any apps!
Activate your profile now! Make the most of your time at CX - Visit cx2019app.com to activate your profile
SPONSORED BY EDUCATION
INNOVATION EVIDENCE
Vascular & Endovascular Challenges Update
CX Executive Board Aortic
Dittmar Böckler
Professor of
Stéphan Haulon
Professor of
Vascular Surgery at University of Heidelberg and Head of Department of Vascular Surgery and Endovascular Surgery at University Hospital Heidelberg, Heidelberg, Germany
Vascular Surgery, Université Paris Sud, Hôpital Marie Lannelongue, Le Plessis Robinson, France
Tilo Kölbel
rofessor of Vascular Surgery, University of Hamburg, and Vascular P Surgeon at the University Heart Center Hamburg, Hamburg, Germany
Peripheral Arterial
Andrew Holden
Associate Professor of
Gunnar Tepe
Head of
Thomas Zeller
Professor of
Radiology at Auckland University School of Medicine and Director of Interventional Services at Auckland City Hospital, Auckland, New Zealand
Diagnostic and Interventional Radiology, RoMed Clinic, Rosenheim, Germany
Angiology at Albert-Ludwigs University of Freiburg and Head of Department of Angiology at Universitäts – Herzzentrum Freiburg, Bad Krozingen, Germany
Venous & Lymphatic
Stephen Black
onsultant Vascular Surgeon at Guy’s and St Thomas’ Hospital, London, C UK and Reader in Venous Surgery at Kings College London
Manj Gohel
onsultant Vascular & Endovascular Surgeon, Addenbrooke’s Hospital, C Cambridge, UK, and Honorary Senior Lecturer, Department of Surgery and Cancer, Imperial College London, London, UK
Acute Stroke
Hugh Markus
rofessor of Stroke Medicine, Honorary Consultant Neurologist, University P of Cambridge, Cambridge, UK
Barbara Rantner
ssociate Professor of Surgery, Medical University Innsbruck, Deputy Director, A Department of Vascular Surgery, University Hospital Innsbruck, Innsbruck, Austria
Vascular Access
Nicholas Inston
Consultant Surgeon and Clinical Lead for Renal Surgery and Transplantation at Queen Elizabeth Hospital Birmingham, Birmingham, UK
Domenico Valenti
Consultant Vascular Surgeon and Honorary Senior Lecturer at King’s College London, London, UK
2019
Vascular Malformations
Krassi Ivancev
Department of Vascular Medicine, University Hospital HamburgEppendorf, Hamburg, Germany; Honorary Professor, Division of Surgery
Fiona Rohlffs Department of Vascular Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany & Interventional Sciences, Faculty of Medical
Sciences, University College London, London, UK
iWounds
Michael Edmonds
Professor of
Keith Harding
Professor of
Una Adderley
Director, National Wound Care Strategy Programme (NHS England),
Diabetic Foot Medicine and Consultant Diabetologist at King’s College Hospital, London, UK
Wound Healing Research, School of Medicine, Cardiff University, Cardiff, UK
Academic Health Science Network and University of Leeds, Leeds, UK
CX Advisory Board
Frans Moll (Chairman)
Professor of
Vascular Surgery at University Medical Center Utrecht, Utrecht, Netherlands
Peripheral Arterial
Cliff Shearman
Emeritus Professor of Vascular Surgery, University of Southampton and NonExecutive Director, Royal Bournemouth and Christchurch NHS Foundation Trust
Giovanni Torsello
Professor, Chief
of the Department of Vascular Surgery at Franziskus Hospital, MĂźnster, Germany
Trevor Cleveland
Consultant Vascular Radiologist and Honorary Senior Lecturer at Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Robert Hinchliffe
rofessor of Vascular Surgery at University of Bristol and Vascular Surgeon P at North Bristol NHS Trust, Bristol, UK
Aortic
Frank Vermassen
Professor in Vascular and Thoracic Surgery Department of
Vascular
Surgery at Ghent University Hospital, Ghent, Belgium
Janet Powell
Professor of Vascular Biology and Medicine, Imperial College London, London, UK
Eric Verhoeven
hief, University Department of Vascular and Endovascular Surgery, C Paracelsus Medical University, General Hospital Nuremberg, Nuremberg, Germany
Venous & Lymphatic
Alun Davies
rofessor of Vascular Surgery, Head of Section of Vascular Surgery, Imperial P College London and Consultant Surgeon at Imperial College NHS Trust, Charing Cross Hospital and St Mary’s Hospital, London, UK
Gerard O’Sullivan
Consultant Interventional Radiologist, Galway University Hospitals, Galway, Ireland
Claudine Hamel-Desnos
ascular Physician, Hôpital Privé Saint-Martin, Caen, France, and President of V the French Society of Phlebology
Peter Mortimer
rofessor of Dermatological Medicine, Consultant Dermatologist, St George’s, P University of London, London, UK
Acute Stroke
Ross Naylor
Honorary Professor of
Vascular Surgery at University of Leicester and Consultant Vascular Surgeon at Leicester Royal Infirmary, Leicester, UK
Recruitment to Vascular Management
Armando Mansilha
Professor of Angiology and Vascular Surgery, Faculty of
Medicine at the University of Porto, Porto, Portugal, and Secretary General, UEMS Section and Board of Vascular Surgery
Sophie Renton
Consultant Vascular Surgeon at Northwick Park Hospital, Honorary Senior Lecturer for Imperial College London, London, UK, and Honorary Secretary, The Vascular Society for Great Britain and Ireland
CX Abstract Board Meryl Davis (Chair) Colin Bicknell
Paul Moxey
Daryll Baker
Marcus Brooks
Anna Prent
Rachel Bell
Robert Hinchliffe
Celia Riga
10:00-10:30
09:15 09:30 09:45
10:00-10:30
09:15 09:30 09:45
COFFEE BREAK
allenges – p22
edited cases) – p30
– p36
10:30 10:45 11:00 11:15 11:30 11:45 12:00 12:15
1
10:30 10:45 11:00 11:15 11:30 11:45 12:00 12:15
Medtronic Symposium – p22
Peripheral Proximal Arterial Ischaemia Challenges – p23
RD Global Symposium – p112
Venous & Lymphatic Challenges – p25
Gore Symposium – p30
● CX Aortic Techniques & Technologies (edited cases) – p30 CEC@CX – p31
Rising Stars and
ing Stars and Abstract
1
● CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 – p41 ● CX Acute Stroke Abstract Presentations – p36 ● CX Peripheral Workshop – Day 1 – p34 ● CX Aortic Workshop – Day 1 – p33 ● CX Acute Stroke Selected Posters Presentations – p44
09:15 09:30 09:45
● Peripheral T&T – p58
COFFEE BREAK
●
10:30 10:45 11:00 11:15 11:30 11:45 12:00 12:15
Gore Symposium – p52
Abdominal Aortic Challenges – p53
Intact Vascular Symposium – p58
● CX Peripheral Techniques & Technologies (live & edited cases) – p59 ● CX Vascular Access Masterclass – p62 iWounds – p65
Rising Stars and
s and
● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 – p71 ● CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 2 – p75 ● Venous T&T (edited cases) – ● CX Venous Workshop – Day 1 – p60 Day 1 – p60 ● CX Peripheral Workshop – Day 2 – p68 ● CX Aortic Workshop – Day 2 – p67
●
09:15 09:30 09:45
p87
COFFEE BREAK
10:30 10:45 11:00 11:15 11:30 11:45 12:00 12:15
Terumo Aortic Symposium – p84
Thoracic Aortic Challenges – p84
Cook Medical Symposium – p87
Peripheral Arterial Podium 1st Session – p88
C3@CX – p92
● ● ● ● CX Innovation Showcase – p92
ions – p104
● CX Abdominal Aortic Abstract Presentations – p105
Prize Session – p99
European Vascular Surgeons in Training – Prize Session – p99
s and
● CX Peripheral Abstract Presentations – Day 3 – p100 ● Venous T&T (edited cases) – ● CX Venous Workshop – Day 2 – p95 Day 2 – p95 CX iWounds Workshop – Day 2 – p98
● CX Vasc. Access T&T ● CX Vascular Access Workshop – p97 (edited cases) – p97
●
12:30-13:00
13:00-13:30
12:30-13:00 13:00 13:15 13:30 13:45 14:00 14:15 14:30 14:45 15:00 15:15 Acute Stroke Challenges – p16
LUNCH BREAK Philips Symposium – p23
13:30 13:45 14:00 14:15 14:30 14:45 15:00 15:15 Peripheral Proximal Arterial Ischaemia Challenges – p23 Venous & Lymphatic Challenges – p26 ● CX Aortic Techniques & Technologies (edited cases) – p31 ● ● CX Meets Latin America – p32 ● CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 – p41 ● CX Vascular Access Abstract Presentations – p42
CX Vascular Access Selected Posters Presentations – p45
● CX Venous Selected Posters Presentations – p46
LUNCH BREAK Getinge Symposium – p53
BD Symposium – p63
13:30 13:45 14:00 14:15 14:30 14:45 15:00 15:15 Abdominal Aortic Challenges – p53 ● CX Peripheral Techniques & Technologies (live & edited cases) – p59 ● CX Vascular Access Masterclass – p63 CX Vascular Malformations – p65
● Interactive Cases – p60
● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 – p71 ● CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 2 – p75 ● CX Venous Workshop – Day 1 – p60
CX iWounds Workshop – p69
● CX Peripheral Arterial Selected Posters – p76
LUNCH BREAK
Medtronic Symposium – p85
13:30 13:45 14:00 14:15 14:30 14:45 15:00 15:15 Thoracic Aortic Challenges – p85 Peripheral Critical Ischaemia Challenges – p88
MDR Symposium – p93
● ● ● ● CX Innovation Showcase – p93 ● CX Abdominal Aortic Abstract Presentations – p105
● CX Peripheral Abstract Presentations – Day 3 – p101 ● CX Venous Workshop – Day 2 – p95 ● Interactive Cases – p95
● CX Aortic Selected Posters Presentations – p107
2019 15:30-16:00 TEA BREAK TEA BREAK Gore Symposium – p24
16:00 16:15 16:30 16:45 17:00 17:15 17:30 17:45 18:00 Acute Stroke Challenges – p16
16:00 16:15 16:30 16:45 17:00 17:15 17:30 17:45 18:00 Peripheral Proximal Arterial Ischaemia Challenges – p24 Venous & Lymphatic Challenges – p26 ● CX Aortic Techniques & Technologies (edited cases) – p31 ● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1 – p38 ● CX Abdominal Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 – p39 ● CX Vascular Access Abstract Presentations – p43
TEA BREAK
16:00 16:15 16:30 16:45 17:00 17:15 17:30 17:45 18:00
Terumo Aortic Symposium – p54
Abdominal Aortic Challenges – p54
BD Symposium – p59
● CX Peripheral Techniques & Technologies – p59 ● CX Vascular Access Masterclass – p64 CX Vascular Malformations – p66 ● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 – p72 ● CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1 – p74
TEA BREAK
16:00 16:15 16:30 16:45 17:00 17:15 17:30 17:45 18:00 Thoracic Aortic Challenges – p86 Peripheral Critical Ischaemia Challenges – p89 ● ● ● ● CX Innovation Showcase – p94 ● CX Abdominal Aortic Abstract Presentations – p106
● CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 2 – p103
Vascular & Endovascular Challenges Update
Faculty Said Abisi, London, UK
Laurence Boon, Brussels, Belgium
Una Adderley, Wakefield, UK
Roshan Bootun, London, UK
Naseer Ahmad, Manchester, UK
Denis Borsuk, Chelyabinsk, Russia
Thomas Albrecht, Berlin, Germany
Dave Bosanquet, Cardiff, UK
Graeme Ambler, Bristol, United Kingdom
Marc Bosiers, Dendermonde, Belgium
Max Amor, Essey-les-Nancy, France
Kursat Bozkurt, Istanbul, Turkey
Konstantin Andreychuk, St Petersburg, Russia Andrew Bradbury, Birmingham, UK Gary Ansel, Columbus, United States
Daniela Branzan, Leipzig, Germany
Michele Antonello, Padua, Italy
Vincenzo Brizzi, Bordeaux, France
Petra Apell, Gothenburg, Sweden
Marianne Brodmann, Graz, Austria
Frank Arko, Charlotte, United States
Jocelyn Brookes, London, UK
John Aruny, New Haven, United States
Ali Baran Budak, Ankara, Turkey
Enrico Ascher, New York, United States
Bao Bui, Sherbrooke, Canada
Mohammed Aslam, London, UK
Nick Burfitt, London, UK
Leanne Atkins, Wakefield, UK
Luke Burke, Eindhoven, The Netherlands
Robert Attaran, Guilford, United States
Mark Burket, Toledo, United States
Martin Austermann, Münster, Germany
Jacques Busquet, Paris St Cloud, France
Domenico Baccellieri, Milan, Italy
Tom Carrell, Barrington, UK
Charles Bailey, San Antonio, United States
Mohamed Cassim, Nawala, Sri Lanka
Daryll Baker, London, UK
Guilherme Centofanti, São Paulo, Brazil
Nilesh Balar, Bronx, United States
Rabih Chaer, Pittsburgh, United States
Tibor Balazs, Bratislava, Slovakia
Yiu Che Chan, Hong Kong
Matteo Barattini, La Spezia, Italy
Sylvain Chastanet, Nice, France
Alex Barnacle, London, UK
Suk Fun (Amanda) Cheng, London, UK
Gareth Bate, Solihull, UK
Mikhail Chernyavskiy, St Petersburg, Russia
Jonathan Beard, Sheffield, UK
Ian Chetter, Hull, UK
Robert Beasley, Miami, United States
Roberto Chiesa, Milan, Italy
Jean-Pierre Becquemin, Champi-
Edward Choke, Singapore
gny-sur-Marne, France
Amine Chouiter, Neuchatel, Switzerland
Rachel Bell, London, UK
Joo-Young Chun, London, UK
Viony Belvroy, Houston, United States
Timothy Clark, Philadelphia, United States
Ruth Benson, Birmingham, UK
Trevor Cleveland, Sheffield, UK
Xavier Berard, Bordeaux, France
Andrew Clifton, London, UK
Luca Bertoglio, Milan, Italy
Rachel Clough, London, UK
Giancarlo Biamino, Mercogliano, Italy
Andreia Coelho, Porto, Portugal
Colin Bicknell, London, UK
Fiona Collins, Eastbourne, UK
Theodosios Bisdas, Athens, Greece
Jason Constantinou, London, UK
Martin Björck, Uppsala, Sweden
Michael Conte, San Francisco, United States
Patrick Bjorkman, Helsinki, Finland
Colette Cook, Wrexham, UK
Stephen Black, London, UK
Raphael Coscas, Boulogne-Billancourt, France
Dittmar Böckler, Heidelberg, Germany
Frank Criado, Baltimore, United States
2019
1
Vascular & Endovascular Challenges Update Csaba Csobay Novák, Budapest, Hungary Martin Czerny, Freiburg, Germany Michael Dake, Tucson, United States Ronald Dalman, Stanford, United States Clement Darling III, Albany, United States Saroj Das, Uxbridge, UK Rajesh Dave, Memphis, United States Alun Davies, London, UK Huw Davies, Birmingham, UK Meryl Davis, London, UK Gianmarco de Donato, Siena, Italy Rick de Graaf, Friedrichshafen, Germany Jean-Paul de Vries, Groningen, Netherlands Colin Deane, London, UK David Deaton, New York, United States Sebastian Debus, Hamburg, Germany Jon Deeks, Birmingham, UK Sapan Desai, Chicago, United States Celine Deslarzes-Dubuis, Stanford, United States
Brahman Dharmarajah, London, UK Lucas Marcelo Dias Freire, Campinas, Brazil Henrik Djerf, Gothenburg, Sweden Konstantinos Donas, Münster, Germany Walter Dorigo, Florence, Italy Steven Dubenec, Sydney, Australia Eric Ducasse, Bordeaux, France Mert Dumantepe, Istanbul, Turkey Sue Duval, Minneapolis, United States Hans-Henning Eckstein, Munich, Germany Michael Edmonds, London, UK Alan Edwards, Ruthin, UK Salma El Batti, Paris, France Ahmed Eleshra, Hamburg, Germany Steve Elias, Englewood, United States Mary Ellis, London, UK William Ennis, Oak Lawn, United States David Epstein, Granada, Spain Ignacio Escotto Sánchez, Mexico City, Mexico
Dominique Fabre, Le Plessis Robinson, France Marten Falkenberg, Gothenburg, Sweden Fabrizio Fanelli, Florence, Italy
2
2019
Jorge Fernández Noya, Santiago de Compostela, Spain
Roberto Ferraresi, Milan, Italy Luis Mariano Ferreira, Buenos Aires, Argentina
Ciro Ferrer, Roma, Italy Mark Field, Warrington, UK Melanie Field, Birmingham, UK Aloke Finn, Gaithersburg, United States Edmund Fitzgerald O'Connor, London, UK Louis Fligelstone, Swansea, UK Alexander Flor, Vienna, Austria Robert Frykberg, Phoenix, United States Gregory Fulton, Wilton, Ireland Luiz Furuya, São Paulo, Brazil Shawn Gage, Raleigh, United States Giambattista Gagliardo, Palermo, Italy Peter Gaines, Sheffield, UK Sidnei Galego, São Paulo, Brazil Raghvinder Gambhir, Chessington, UK Frances Game, Derby, UK Margaret Gardner, Ashtead, UK Mauro Gargiulo, Bologna, Italy Fredrik Gellerstedt, Goteborg, Sweden Patrick Geraghty, St Louis, United States Sergio Gianesini, Ferrara, Italy Athanasios Giannoukas, Larissa, Greece Paul Gibbs, Portsmouth, UK Richard Gibbs, London, UK Kathleen Gibson, Bellevue, United States Leeying Giet, London, UK James Gilbert, Oxford, UK Asimakis Gkremoutis, London, UK Manj Gohel, Cambridge, UK Alejandro Jose Gonzalez Ochoa, St Loius, Mexico
Yann Goueffic, Nantes, France David Gray, Eastbourne, UK Roger Greenhalgh, London, UK Stephen Greenhalgh, London, UK David Greenstein, London, UK Franco Grego, Padua, Italy Aina Greig, London, UK
Vascular & Endovascular Challenges Update Guillaume Guimbretiere, Nantes, France
Gurdeep Jandu, Bolton, UK
Nalaka Gunawansa, Colombo, Sri Lanka
Yee Jia Ng, Singapore
Daqiao Guo, Shanghai, China
Qizhuang Jin, Beijing, China
Wei Guo, Beijing, China
Oscar Johnson, London, UK
Adam Gwozdz, London, UK
Robert Jones, Birmingham, UK
Alison Halliday, Oxford, UK
William Jordan, Atlanta, United States
Claudine Hamel-Desnos, Caen, France
Matthieu Josnin, La Roche-sur-Yon, France
Keith Harding, Cardiff, UK
Jeffrey Jump, Mont-sur-Rolle, Switzerland
David Hargroves, Kent, UK
Michal Juszynski, Warsaw, Poland
Olivier Hartung, Marseille, France
Victor Kalinin, Nyagan, Russia
Stéphan Haulon, Le Plessis Robinson, France Gido Karges, Wangs, Switzerland Paul Hayes, Cambridge, UK
Achilleas Karkamanis, Uppsala, Sweden
Robin Heijmen, Nieuwegein, Netherlands
Narayan Karunanithy, London, UK
Thomas Heller, Rostock, Germany
Nikolaos Karydis, London, UK
Hans Henkes, Stuttgart, Germany
Konstantinos Katsanos, Patras, Greece
Adrien Hertault, Lille, France
Maria Katsarou, Milan, Italy
Jan Heyligers, Tilburg, Netherlands
Barry Katzen, Miami, United States
Phil Hickman, London, UK
Venu Kavarthapu, London, UK
Emily Hillier, London, UK
Narendra Nath Khanna, New Delhi, India
Robert Hinchliffe, Bristol, UK
Aurangzaib Khawaja, Birmingham, UK
Jade Hiramoto, San Francisco, United States
Mahine Kashi-Dakhil, Nanterre, France
Andrew Holden, Auckland, New Zealand
Neil Khilnani, New York, United States
Peter Holt, London, UK
Lois Kim, Cambridge, UK
Nick Hopkins, Buffalo, United States
David Kingsmore, Glasgow, UK
Adam Howard, Lamarsh Bures, UK
Panagiotis Kitrou, Patras, Greece
Dominic Howard, Oxford, UK
Sanne Klaphake, Rotterdam, Netherlands
York Hsiang, Vancouver, Canada
Christoph Knappich, Munich, Germany
Wen Hsien Hsu, Taipei, Taiwan
Tilo Kölbel, Hamburg, Germany
Jeffrey Hull, North Chesterfield, United States
Raghu Kolluri, Columbus, United States
Katie Hurst, Oxford, UK
Ralf Kolvenbach, Düsseldorf, Germany
Pavel Ignatenko, Novosibirsk, Russia
Ahmed Koshty, Siegen, Germany
Osamu Iida, Amagasaki, Japan
Jan Kovac, Leicester, UK
Karl Illig, Tampa, United States
Mario Lachat, Hinteregg, Switzerland
Nicholas Inston, Birmingham, UK
Elena Ladich, Hollywood, United States
Fatih Islamoglu, Bornova, Turkey
Alexander Lamprou, Groningen, Netherlands
Osama Ismail, Sohag, Egypt
Tristan Lane, London, UK
Sriram Iyer, Cresskill, United States
John Lantis, New York, United States
Krassi Ivancev, Hamburg, Germany
Christopher Lattimer, London, UK
Ounali Jaffer, Walton on Thames, UK
Regent Lee, Headington, UK
Usman Jaffer, London, UK
Matt Lemay, Boston, United States
Heinz Jakob, Essen, Germany
Sandro Lepidi, Padua, Italy
Houman Jalaie, Aachen, Germany
Qingle Li, Beijing, China
2019
3
Vascular & Endovascular Challenges Update Michael Lichtenberg, Arnsberg, Germany
Samuel Money, Phoenix, United States
Thomas Liebig, Munich, Germany
Hayley Moore, London, UK
Francesco Liistro, Arezzo, Italy
Randy Moore, Chestermere, Canada
Patrick Lintott, High Wycombe, UK
Robert Morgan, London, UK
Magnus Löndahl, Lund, Sweden
Sean Morris, Missouri City, United States
Lars Lönn, Copenhagen, Denmark
Nick Morrison, Scottsdale, United States
Hassan Lotfy, Alexandria, Egypt
Peter Mortimer, London, UK
Nicolas Louis, Créteil, France
Paul Moxey, London, UK
Ioannis Loukopoulos, London, UK
Alberto Muñoz, Bogotá, Colombia
Xinwu Lu, Shanghai, China
Erin Murphy, Charlotte, United States
Alan Lumsden, Houston, United States
Kieran Murphy, Toronto, Canada
Lindsay Machan, Vancouver, Canada
David Murray, Altrincham, UK
Michel Makaroun, Pittsburgh, United States
Mari Murumets, London, UK
Chris Malaisrie, Chicago, United States
Ahmed Naga, Alexandria, Egypt
Alexandros Mallios, Paris, France
Sriram Narayanan, Singapore
Martin Malina, London, UK
Ross Naylor, Leicester, UK
Misti Malone, Silver Spring, United States
Oskar Nelzen, Linköping, Sweden
Kevin Mani, Uppsala, Sweden
Yii Jia Ng, Singapore
Armando Mansilha, Porto, Portugal
Elias Noory, Bad Krozingen, Germany
Hugh Markus, Cambridge, UK
Isaac Nyamekye, Worcester, UK
John Martin, Annapolis, United States
Gerard O’Sullivan, Galway, Ireland
Kenta Masada, Osaka, Japan
Alfred Obermayer, Vienna, Austria
Tara Mastracci, London, UK
Gustavo Oderich, Rochester, United States
Susan Matthews, Oldham, UK
Thomas O'Donnell, Boston, United States
Francis Matthey, London, UK
Baris Ata Ozdemir, Bristol, UK
Erica Mayer, Boston, United States
Luis Mariano Palena, Abano Terme, Italy
Blandine Maurel, Nantes, France
Gustavo Paludetto Oliveira, Brasília, Brazil
Ian McCafferty, Birmingham, UK
Giuseppe Panuccio, Hamburg, Germany
Charles McCollum, Manchester, UK
Juan Esteban Paolini, Caba, Argentina
Richard McWilliams, Liverpool, UK
Rajiv Parakh, Gurgaon, India
Andrea Melloni, Milan, Italy
Insoo Park, Seoul, South Korea
Erica Menegatti, Ferrara, Italy
Daniel Patel, Daytona Beach, United States
Matthew Metcalfe, Stevenage, UK
Lorenzo Patrone, London, UK
Claude Mialhe, Monaco, Monaco
Chloé Peters, Breda, Netherlands
Jonathan Michaels, Sheffield, UK
Peter Phillips, Didcot, UK
Nicola Milburn, London, UK
Michele Piazza, Padua, Italy
Rene Milleret, Montpellier, France
Olivier Pichot, Grenoble, France
Aleem Mirza, Rochester, United States
Paul Pittaluga, Monaco
Hiren Mistry, London, UK
Mark Portou, London, UK
Bob Mitchell, Irvine, United States
Janet Powell, London, UK
Bijan Modarai, London, UK
Anna Prent, London, UK
Frans Moll, Utrecht, Netherlands
Robert Michal Proczka, Warsaw, Poland
4
2019
Vascular & Endovascular Challenges Update Phillip Puckridge, Marion, Australia
Guerkan Sengoelge, Vienna, Austria
Nadeem Qazi, London, UK
Tomas Serena, Warren, United States
Annette Quinn, London, UK
Carlo Setacci, Siena, Italy
Tarek Radwan, Cairo, Egypt
Nicla Settembre, Nancy, France
Johann Christoph Ragg, Berlin, Germany
Joseph Shalhoub, London, UK
Harishankar Ramachandran Nair,
Cliff Shearman, Southampton, UK
Trivandrum, India
ZhenYu Shi, Shanghai, China
Marta Ramirez Ortega, Madrid, Spain
Cynthia Shortell, Durham, United States
Christos Rammos, Essen, Germany
Daniel Shoukier, Zurich, Switzerland
Hazel Randall, London, UK
Chang Shu, Beijing, China
Barbara Rantner, Innsbruck, Austria
CJJM Sikkink, Bemmel, Netherlands
Hema Rao, London, UK
Henrik Sillesen, Copenhagen, Denmark
Vikram Ravikumar, New York, United States
Mitchell Silver, Columbus, United States
Sudip Ray, London, UK
Chung Sim Lim, London, UK
Álvaro Razuk, São Paulo, Brazil
Tej Singh, Los Altos Hills, United States
Michel Reijnen, Arnhem, Netherlands
Ravinder Singh-Ranger, Swindon, UK
Sophie Renton, London, UK
Aine Smalley, Santa Rosa, United States
Timothy Resch, Malmö, Sweden
Kim Smolderen, Kansas City, United States
Robert Rhee, New York, United States
Ronald Solar, San Diego, United States
Vincent Riambau, Barcelona, Spain
Kate Sommerville, London, UK
Celia Riga, London, UK
Peter Sotonyi, Budapest, Hungary
Steven Rogers, Manchester, UK
Paolo Spada, Milan, Italy
Fiona Rohlffs, Hamburg, Germany
Matjaz Span, Izola, Slovenia
Teresa Rola, London, UK
Konstantinos Spanos, Larissa, Greece
Dmitrii Rosukhovskii, St Petersburg, Russia
Ulrich Speck, Berlin, Germany
Ulrich Rother, Erlangen, Germany
Francesco Squizzato, Padova, Italy
Maria Antonella Ruffino, Turin, Italy
Gerry Stansby, Newcastle-upon-Tyne, UK
Javier Ruiz Aburto, Ponce, United States
Julie Stanton, Eastbourne, UK
Bartosz Rylski, Freiburg, Germany
Konstantinos Stavroulakis, Münster,
Nirvana Sadaghianloo, Nice, France
Germany
Prakash Saha, London, UK
Kate Steiner, Stevenage, UK
Simone Salvati, Milan, Italy
Tobias Steinke, Dusseldorf, Germany
Sandip Sarkar, London, UK
Sofia Stromberg, Gothenborg, Sweden
Dierk Scheinert, Leipzig, Germany
Timothy Sullivan, Minneapolis, United States
Bruno Scheller, Homburg/Saar, Germany
Jakob Susteric, Ljubljana, Slovenia
Marc Schermerhorn, Boston, United States
Attila Szabo, Budapest, Hungary
Andrej Schmidt, Leipzig, Germany
Michael Tal, Tel Aviv, Israel
Thomas Schmitz-Rixen, Frankfurt, Germany
Chas Taylor, Horsham, UK
Peter Schneider, Honolulu, United States
Rex Teeslink, Augusta, United States
Arne Schwindt, Münster, Germany
Gunnar Tepe, Rosenheim, Germany
Eric Secemsky, Boston, United States
Joerg Tessarek, Lingen, Germany
Roshan Rodney Sengodan, Coimbatore,
Bill Tettelbach, Marietta, United States
India
Sarah Thomis, Leuven, Belgium
2019
5
Vascular & Endovascular Challenges Update John Thompson, Exeter, UK
Ido Weinberg, Boston, United States
Matt Thompson, Irvine, United States
Martin Werner, Vienna, Austria
Narayanan Thulasidasan, London, UK
Rodney White, Torrance, United States
Ignace Tielliu, Groningen, Netherlands
Arno Wiersema, Amsterdam, Netherlands
Michael Tones, St Louis, United States
Jason Wilkins, London, UK
Giovanni Torsello, MĂźnster, Germany
Angela Williams, London, UK
Matteo Tozzi, Varese, Italy
Leith Williams, Liverpool, UK
Matthias Trenner, Munich, Germany
Teun Wilmink, Birmingham, UK
Santi Trimarchi, Milan, Italy
Emma Wilton, Oxford, UK
Konstantinos Tsagakis, Essen, Germany
Willem Wisselink, Amsterdam, Netherlands
Pavlos Tsantilas, Munich, Germany
Cees Wittens, Maastricht, Netherlands
Nikolaos Tsilimparis, Munich, Germany
Walter Wohlgemuth, Regensburg, Germany
Karen Tullett, Birmingham, UK
Rochelle Wolfe, Minneapolis, United States
Chris Twine, Cowbridge, UK
Weiwei Wu, Beijing, China
Jean-Francois Uhl, Paris, France
Wayne Yakes, Englewood, United States
Domenico Valenti, London, UK
Dai Yamanouchi, Madison, United States
Sjef van Baal, Almelo, Netherlands
Yaoguo Yang, Beijing, China
Jos van den Berg, Lugano, Switzerland
Halit Yerebakan, Istanbul, Turkey
Joost van Herwaarden, Utrecht, Netherlands
Kak Khee Yeung, Amsterdam, Netherlands
Maarit Venermo, Helsinki, Finland
Derek Young, Dublin, Ireland
Hence Verhagen, Rotterdam, Netherlands
Zhengya Yu, Beijing, China
Eric Verhoeven, Nuremberg, Germany
Jianing Yue, Shanghai, China
Frank Vermassen, Ghent, Belgium
Yoel Zabar, Rehovot, Israel
Fabio Verzini, Turin, Italy
Nicholas Zakikhani, London, UK
Harry Voesten, Drachten, Netherlands
Hany Zayed, London, UK
Robert Vogelzang, Chicago, United States
Thomas Zeller, Bad Krozingen, Germany
Sheng Wang, Beijing, China
Tomasz Zubilewicz, Lublin, Poland
Saima Waseem, Bexleyheath, UK Haimanot Wasse, Chicago, United States
Contents CX Executive Board, CX Advisory Board and CX Abstract Board Faculty Opening times Internet access Programme index Sponsors CME Exhibitors New products at CX 2019 Travel connections and hotels CX timetable Floorplan
6
2019
Cover 1 8 8 9–11 122 123 124 128 130 136 Back cover
Vascular & Endovascular Challenges Update
Welcome to CX 2019! The Charing Cross International Symposium (CX) continues its three-year cycle of raising vascular and endovascular controversies in order to challenge the available evidence and be able to reach a consensus after discussion with an expert audience. CX 2019 focuses on CHALLENGES. The four-day programme starts on Monday with an afternoon of exploring acute stroke challenges, which will include debates and frequent opportunity for audience participation and discussion. This will be followed by three days of peripheral, aortic, venous, vascular access, vascular malformations and wound care programmes. A number of “Highlight” sessions have been introduced to the CX 2019 programme. On Tuesday, there is amazing interest in a metaanalysis by Dr Katsanos from Greece suggesting a raised mortality in the follow-up of patients treated with paclitaxel-coated balloons and paclitaxel-eluting stents in the femoropopliteal segment. The FDA and MHRA take this seriously. At CX, “Paclitaxel: The last word” will feature these genuine concerns for patients and the way forward by the entire vascular community in the patient’s interest. Wednesday will host a special session on the durability of endovascular aortic intervention and will explore the possible impacts of the draft UK NICE guidelines. CX is also proud to support the initiative of the Vascular Society for Great Britain and Ireland to investigate the concern for recruitment into the vascular specialty. On Thursday, in a discussion on the Stroke from Thoracic Endovascular Procedures (STEP) study, investigators will share the latest findings on reducing the risk of stroke following complex thoracic endovascular procedures. This year also boasts a record 26 Podium 1st presentations to highlight new data from late-breaking trials. This year CX is displaying exciting, innovative features such as live cases with virtual reality. Of the eight live cases scheduled to illustrate data being presented in the programme, four will showcase virtual reality educational aspects – a first for a vascular and endovascular symposium. Another launch for this year’s CX is the iWounds programme and workshop. This new, interdisciplinary initiative will focus on challenges and innovations in wound care – it will feature three days of activities, with dedicated sessions in the venous and peripheral programmes, the main iWounds programme running across half a day on Wednesday, and the workshop taking place on Wednesday and Thursday. We hope you have an enjoyable and informative week at CX 2019.
Roger Greenhalgh, on behalf of the CX Executive Board
2019
7
Vascular & Endovascular Challenges Update
Registration desk opening hours Monday 15 April
12.30-18.00
Tuesday 16 April
07.30-18.00
Wednesday 17 April
07.30-18.00
Thursday 18 April
07.30-18.00
Exhibition opening hours Tuesday 16 April
08.00-18.00
Wednesday 17 April
08.00-18.00
Thursday 18 April
08.00-18.00
General session hours – Main Auditorium Monday 15 April
13.00-17.30
Tuesday 16 April
08.00-18.00
Wednesday 17 April
08.00-18.00
Thursday 18 April
07.30-18.00
CX Collection Point Please visit the CX Collection Point to collect the CX Delegate bag and CX Book (for full registrations only). The CX Collection Point is located on stand 202.
Internet access Free WiFi access is available at CX. Access codes are ON YOUR BADGE.
8
2019
Vascular & Endovascular Challenges Update
Monday Plenary Programme Acute Stroke Challenges
16
Tuesday Plenary Programme Peripheral Proximal Arterial Ischaemia Challenges
22
Venous and Lymphatic Challenges
25
CX Additional Events CX Aortic Techniques & Technologies (edited cases)
30
CEC@CX
31
CX Meets Latin America
32
CX Aortic Workshop – Day 1
33
CX Peripheral Workshop – Day 1
34
CX Global Stars and Rising Stars and Abstract sessions CX Acute Stroke Abstract Presentations
36
CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1
37
CX Abdominal Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1
39
CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1
40
CX Vascular Access Abstract Presentations
42
CX Acute Stroke Selected Posters Presentations
44
CX Vascular Access Selected Posters Presentations
45
CX Venous Selected Posters Presentations
46
Sponsored Satellite
112
Booth and pavilion activities
112
2019
9
Vascular & Endovascular Challenges Update
Wednesday Plenary Programme Aortic Podium 1st Session
52
Abdominal Aortic Challenges
53
CX Additional Events LINC@CX
58
CX Peripheral Techniques & Technologies (live & edited cases)
58
CX Venous Techniques & Technologies (edited cases) – Day 1
60
CX Venous Workshop – Day 1
60
Vascular Access Masterclass
62
iWounds
64
CX Vascular Malformations
65
CX Aortic Workshop – Day 2
67
CX Peripheral Workshop – Day 2
68
CX iWounds Workshop – Day 1
69
CX Global Stars and Rising Stars and Abstract sessions CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2
70
CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1
73
CX Thoracic Aortic Abstract Presentations – Day 2
75
CX Peripheral Arterial Selected Posters Presentations – Day 2
76
An Introduction to Vascular Surgery – Day 1
78
Booth and pavilion activities
10 2019
116
Vascular & Endovascular Challenges Update
Thursday Plenary Programme Thoracic Aortic Challenges
84
Peripheral Critical Ischaemia Challenges
87, 88
Peripheral Arterial Podium 1st Session
88
CX Additional Events CX Innovation Showcase
92
CX Venous Techniques & Technologies (edited cases) – Day 2
95
CX Venous Workshop – Day 2
95
CX Vascular Access Techniques & Technologies (edited cases)
97
CX Vascular Access Workshop
97
CX iWounds Workshop – Day 2
98
European Vascular Surgeons in Training – Prize Session
99
CX Global Stars and Rising Stars and Abstract sessions CX Peripheral Arterial Abstract Presentations – Day 3
100
CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 2
102
CX Abdominal Aortic Abstract Presentations – Day 2
104
CX Aortic Selected Posters Presentations
107
An Introduction to Vascular Surgery – Day 2
108
Booth and pavilion activities
120
2019
11
Monday 15 April 2019
Monday
Plenary Programme
Vascular & Endovascular Challenges Update Pillar Hall Learning Centre Acute Stroke Challenges
16
Monday 15 April 2019
Monday
Vascular & Endovascular Challenges Update
Monday 15 April 2019 Monday 15 April 2019
ACUTE STROKE CHALLENGES
Pillar Hall Learning Centre Hot carotid challenges
Chairing: Barbara Rantner, Innsbruck, Austria Moderator: Ross Naylor, Leicester, United Kingdom 13:00-13:12
X Debate: It is reasonable to offer urgent carotid endarterectomy C (within the first 48 hours) in patients suffering a minor stroke For the motion: 13:00-13:06 Clement Darling III, Albany, United States Against the motion: 13:06-13:12 Sofia Stromberg, Gothenborg, Sweden
13:12-13:19
Audience participation, discussion and polling
13:19-13:26 ACST-2 lessons to be learnt from the largest trial comparing stenting and surgery Alison Halliday, Oxford, United Kingdom 13:26-13:31
Audience participation and discussion
13:31-13:43
X Debate: The majority of patients with asymptomatic carotid C disease do not benefit from carotid interventions For the motion: 13:31-13:37 Ross Naylor, Leicester, United Kingdom Against the motion: 13:37-13:43 Alun Davies, London, United Kingdom
13:43-13:48
Audience participation, discussion and polling
13:48-13:55 Influence of stenosis severity on risk of stroke distal to asymptomatic carotid stenosis Dominic Howard, Oxford, United Kingdom 13:55-14:00
Audience participation and discussion
14:00-14:07 Local anaesthesia is associated with a lower periprocedural risk in carotid endarterectomy in symptomatic patients – data from ICSS, CREST, EVA3-S, SPACE and GALA (on behalf of the carotid stenosis trialist collaboration) Christoph Knappich, Munchen, Germany 14:07-14:12
Audience participation and discussion
14:12-14:24
X Debate: Carotid revascularisation (surgery or stenting) is safe to C be performed early after stroke thrombolysis For the motion: 14:12-14:18 Maarit Venermo, Helsinki, Finland Against the motion: 14:18-14:24 Alun Davies, London, United Kingdom
14:24-14:29
Audience participation, discussion and polling
14:29-14:41
X Debate: Newer technologies and innovations now make carotid C artery stenting as safe as carotid endarterectomy in the first 14 days after onset of transient ischaemic attack/stroke For the motion: 14:29-14:35 Peter Schneider, Honolulu, United States Against the motion: 14:35-14:41 Ross Naylor, Leicester, United Kingdom
14:41-14:46
Audience participation, discussion and polling
14:46-14:53 A short interval between the neurological index event is a risk factor for carotid artery stenting but not for carotid endarterectomy – data from a national registry on >56,000 symptomatic carotid patients in Germany Pavlos Tsantilas, Munich, Germany 14:53-15:00
Audience participation and discussion
15:00-15:30
TEA
Hot carotid challenges (continued)
Chairing: Barbara Rantner, Innsbruck, Austria Moderator: Ross Naylor, Leicester, United Kingdom
15:30-15:37 Carotid plaque volume as a measure of stroke risk, where next? Charles McCollum, Manchester, United Kingdom 15:37-15:41
16 2019
Audience participation and discussion
15:41-15:48 Carotid intraplaque haemorrhage and carotid artery risk score are associated with positive microembolic signals on transcranial Doppler monitoring Suk Fun (Amanda) Cheng, London, United Kingdom 15:48-15:52
Audience participation and discussion
cute stroke challenges – Intracranial A thrombectomy
Chairing: Hugh Markus, Cambridge, United Kingdom Moderator: Barbara Rantner, Innsbruck, Austria
15:52-16:03 What thrombectomy trials really tell us and how can the findings be implemented into routine clinical practice? David Hargroves, Kent, United Kingdom 16:03-16:07
Audience participation and discussion
16:07-16:19
X Debate: Intracranial thrombectomy should be limited to C neurointerventionists For the motion: 16:07-16:13 Andrew Clifton, London, United Kingdom Against the motion: 16:13-16:19 Jan Kovac, United Kingdom
16:19-16:28
Audience participation, discussion and polling
16:28-16:35 The impact of virtual reality on the quality of thrombectomy training Thomas Liebig, Munich, Germany 16:35-16:39
Audience participation and discussion
16:39-16:46 Arterial transit artefacts on magnetic resonance imaging correlate with presence of recent symptoms and absent collateral pathways in patients with carotid stenosis Suk Fun (Amanda) Cheng, London, United Kingdom 16:46-16:50 Audience participation and discussion 16:50-16:57 Choices of intracranial thrombectomy stent rival and technique innovation Thomas Liebig, Munich, Germany 16:57-17:01 Audience participation and discussion
Stroke after cardiac surgery
Chairing: Nick Hopkins, Buffalo, United States Moderator: Hugh Markus, Cambridge, United Kingdom 17:01-17:12 Hot topic talk: Stroke after cardiac surgery: More common than appreciated Nick Hopkins, Buffalo, United States 17:12-17:16
Audience participation and discussion
17:16-17:23 Clinical impact of carotid stenosis in patients undergoing transcatheter aortic valve implantation Sandro Lepidi, Padua, Italy 17:23-17:27
Audience participation and discussion
2019
17
Monday 15 April 2019
Vascular & Endovascular Challenges Update
Tuesday 16 April 2019
Tuesday
Plenary Programme & Additional Events
Tuesday Vascular & Endovascular Challenges Update Main Auditorium
Venous and Lymphatic Challenges
25
CX Additional Events CX Aortic Techniques & Technologies (edited cases)
30
CEC@CX 31 CX Meets Latin America
32
CX Aortic Workshop – Day 1
33
CX Peripheral Workshop – Day 1
34
CX Global Stars and Rising Stars and Abstract sessions CX Acute Stroke Abstract Presentations
36
CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1 37 CX Abdominal Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 39 CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 40 CX Vascular Access Abstract Presentations
42
CX Acute Stroke Selected Posters Presentations 44 CX Vascular Access Selected Posters Presentations 45 CX Venous Selected Posters Presentations
46
Tuesday 16 April 2019
Peripheral Proximal Arterial Ischaemia Challenges 22
Vascular & Endovascular Challenges Update
Tuesday 16 April 2019 PERIPHERAL PROXIMAL ARTERIAL ISCHAEMIA CHALLENGES
Upper Main Auditorium – 08:00-18:00 Peripheral arterial disease issues
Chairing: Cliff Shearman, Southampton, United Kingdom Moderator: Barry Katzen, Miami, United States 08:00-08:08 Treatment of claudication is aimed to increase walking distance, improve quality of life and prevent cardiovascular events by reducing risk factors Sanne Klaphake, Rotterdam, Netherlands
Tuesday 16 April 2019
08:08-08:16 Female gender is a risk factor for poor outcomes after revascularisation for peripheral arterial disease Ruth Benson, Birmingham, United Kingdom 08:16-08:24
Audience participation and discussion
08:24-08:32 Office-based lower extremity arterial interventions are feasible, safe, cost-effective and patients love it Enrico Ascher, Brooklyn, United States 08:32-08:40 Ambulatory treatment of arterial disease – European perspective Yann Goueffic, Nantes, France 08:40-08:48
Audience participation, discussion and polling
08:48-08:56 Appropriate follow-up of patients after endovascular procedures Marianne Brodmann, Graz, Austria 08:56-09:04 Open or endovascular repair for popliteal artery aneurysms – A casecontrol study Martin Björck, Uppsala, Sweden 09:04-09:12
Audience participation and discussion
Imaging
Chairing: Robert Morgan, President CIRSE, London, United Kingdom Moderator: Andrew Holden, Auckland, New Zealand 09:12-09:20 Assessment of the perfusion with indocyanine green fluorescence imaging (ICG-FI) before and after revascularisation tells the success of revascularisation Maarit Venermo, Helsinki, Finland 09:20-09:28 Tips and tricks to optimise CO2 angiography (including work-up with no-contrast MR angiography) Jos van den Berg, Lugano, Switzerland 09:28-09:36 Audience participation and discussion 09:36-09:44 IVUS sizing improves outcomes of DCB therapy in the femoropopliteal segment Phillip Puckridge, Marion, Australia 09:44-09:52 Contrast-enhanced tomographic 3D ultrasound imaging of peripheral arterial disease and potential autologous bypass grafts Steven Rogers, Manchester, United Kingdom 09:52-10:00
Audience participation, discussion and polling
10:00-10:30 COFFEE AND VISIT TO HANDS-ON WORKSHOPS
Coffee Symposium: The paclitaxel safety controversy – from patient-level data to big data: What the newest clinical evidence is telling us Chairing: Peter Schneider, Honolulu, United States Moderator: Giovanni Torsello, Münster, Germany
10:03-10:09 Patient-level data from the IN.PACT Clinical Programme: Is paclitaxel safe for treatment of PAD? Peter Schneider, Honolulu, United States 10:09-10:15 Two-year outcomes from four pooled multicentre RCTs: Safety after treatment with paclitaxel-coated devices Thomas Albrecht, Berlin, Germany 10:15-10:21 Big data: What does it tell us about survival following PAD revascularisation using drug technologies? Eric Secemsky, Boston, United States 10:21-10:28 Audience participation and discussion
22 2019
Vascular & Endovascular Challenges Update
Paclitaxel debate
Chairing: Gunnar Tepe, Rosenheim, Germany Moderator: Thomas Zeller, Bad Krozingen, Germany 10:30-10:40
X Debate: DCB alone is enough for the popliteal segment C For the motion: 10:30-10:35 Marc Bosiers, Dendermonde, Belgium Against the motion: 10:35-10:40 Theodosios Bisdas, Athens, Greece
10:40-10:50
Audience participation, discussion and polling
Paclitaxel: The last word
Chairing: Roger Greenhalgh, London, United
Kingdom
Moderators: Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany Thomas Zeller, Bad Krozingen, Germany
Review of the findings of the VIVA Forum
10:50-11:00 Paclitaxel summary of VIVA 11:00-11:10
Gary Ansel, Columbus, United States
Audience participation and discussion
The potential problem
11:10-11:20 My choices of DCB and DES data to combine in meta-analysis and my conclusions Konstantinos Katsanos, Patras, Greece 11:20-11:27 BASIL 3 – withdrawal of paclitaxel use Jonathan Michaels, Sheffield, United Kingdom 11:27-11:34 SWEDEPAD trials – withdrawal of paclitaxel use Marten Falkenberg, Gothenburg, Sweden 11:34-11:50
Audience participation, discussion and polling
Scrutiny of paclitaxel and the way forward
11:50-12:00 Statistical review of methodology and legitimacy of results Sue Duval, Minneapolis, United States 12:00-12:10
Statistical issues
12:10-12:30
Audience participation, discussion and polling
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Jon Deeks, Birmingham, United Kingdom
Lunch Symposium: Optimising DCB results for long-term success Chairing: Michael Lichtenberg, Arnsberg, Germany Moderator: Gary Ansel, Columbus, United States
12:33-12:41 Long-term safety and efficacy of a low-dose DCB Gary Ansel, Columbus, United States 12:41-12:49 The benefits of IVUS in DCB treatment of the femoropopliteal segment Phillip Puckridge, Marion, Australia 12:49-12:58 The value of effective vessel preparation before DCB use Theodosios Bisdas, Athens, Greece
Review of paclitaxel usage: The way forward Chairing: Roger Greenhalgh, London, United Kingdom Moderators: Andrew Holden, Auckland, New Zealand Gunnar Tepe, Rosenheim, Germany Thomas Zeller, Bad Krozingen, Germany
13:30-13:38 What the FDA are looking for in data requested Misti Malone, Silver Spring, United States 13:38-13:46 What MHRA are looking for 13:46-13:56
Hazel Randall, London, United Kingdom
Audience participation, discussion and polling
13:56-14:04 Paclitaxel early advances to limit restenosis Ulrich Speck, Berlin, Germany 14:04-14:12 Paclitaxel: Why a chemotherapeutic was chosen to prevent restenosis – rationale and early experience Lindsay Machan, Vancouver, Canada
2019
23
Tuesday 16 April 2019
Vascular & Endovascular Challenges Update 14:12-14:20 Paclitaxel as primary therapy in oncology – benefits, doses, levels compared Erica Mayer, Boston, United States 14:20-14:35
Audience participation, discussion and polling
14:35-14:43 Lessons learned from the experience in the coronary arteries – sirolimus, paclitaxel and everolimus Bruno Scheller, Homburg/Saar, Germany 14:43-14:51 Potential toxicity of paclitaxel in vascular interventions and pharmacokinetic aspects Aloke Finn, Gaithersburg, United States 14:51-14:59 Paclitaxel effects on the human artery wall and insights from pathology Elena Ladich, Hollywood, FL, United States 14:59-15:30
Audience participation, discussion and polling
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
Tea Symposium: Aortoiliac obstructive disease: Endoluminal solutions Tuesday 16 April 2019
Chairing: Michele Antonello, Padua, Italy
15:33-15:39 Complexity of iliac occlusive disease, current treatment algorithm and treatment gaps Michele Antonello, Padua, Italy 15:39-15:45 Challenging bilateral iliac case treated with a new balloonexpandable endoprosthesis Hany Zayed, London, United Kingdom 15:45-15:51 Complex iliac occlusive disease: Treatment with covered stent grafts Gianmarco de Donato, Siena, Italy 15:51-15:58
Audience participation and discussion
Edited case
Chairing: Michele Antonello, Padua, Italy
16:00-16:30 Edited case: Treating iliac occlusive disease with a covered endoprosthesis Andrew Holden, Auckland, New Zealand
Interventional techniques
Chairing: Gunnar Tepe, Rosenheim, Germany Moderator: Robert Hinchliffe, Bristol, United Kingdom 16:30-16:37 Advantages and results of treating SFA-popliteal occlusive lesions with a dual component stent: From the Austrian Registry Martin Werner, Vienna, Austria 16:37-16:44 How to treat in-stent-restenosis in the femoropopliteal tract – what the literature tells us Marc Bosiers, Dendermonde, Belgium 16:44-16:51 The case for spot stenting – similarities and differences between techniques Thomas Zeller, Bad Krozingen, Germany
Edited case
16:51-17:21 Edited case: Focal dissection repair after femoropopliteal angioplasty Michael Lichtenberg, Arnsberg, Germany 17:21-17:28 Femoropopliteal bypasses with heparin-bonded PTFE are a durable treatment for long SFA-popliteal occlusions: When they are the best treatment and why Walter Dorigo, Florence, Italy 17:28-17:40
Audience participation and discussion
Open bypass
17:40-17:50
X Debate: In the absence of suitable venous graft material C prosthetic bypass is the answer For the motion: 17:40-17:45 Clement Darling III, Albany, United States Against the motion: 17:45-17:50 Andrew Holden, Auckland, New Zealand
17:50-18:00
Audience participation, discussion and polling
24 2019
Vascular & Endovascular Challenges Update
Tuesday 16 April 2019 VENOUS AND LYMPHATIC CHALLENGES
Lower Main Auditorium – 08:00-18:00 Superficial veins
Chairing: Stephen Black, London, United Kingdom Moderator: Raghu Kolluri, Columbus, United States
Truncal vein treatment
08:08-08:16 Foam sclerotherapy can replace phlebectomy for the management of varicosities Claudine Hamel-Desnos, Caen, France 08:16-08:24 The benefit of non-thermal modalities Steve Elias, Englewood, United States 08:24-08:32 Technique and strategy are as important as modality in the treatment of superficial reflux Manj Gohel, Cambridge, United Kingdom 08:32-08:48
Audience participation and discussion
08:48-08:56 Podium 1st: VeClose Extension Study five-year results Nick Morrison, Scottsdale, United States 08:56-09:04 Post-procedure care after cyanoacrylate glue closure Kathleen Gibson, Bellevue, United States 09:04-09:12 The evolution of superficial venous management has moved away from thermal techniques Kursat Bozkurt, Istanbul, Turkey 09:12-09:28
Audience participation, discussion and polling
09:28-09:36 3RF Trial: Randomised trial of three radiofrequency devices for great saphenous vein ablation Isaac Nyamekye, Worcester, United Kingdom 09:36-09:44 Current theories on indications and techniques for perforator ablation Kathleen Gibson, Bellevue, United States 09:44-10:00
Audience participation and discussion
10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
10:00-10:30
Coffee Symposium
Read more on page 112
Advanced venous disease
Chairing: Manj Gohel, Cambridge, United Kingdom Moderator: Kathleen Gibson, Bellevue, United States 10:30-10:37 Role of elevated central venous pressures in chronic venous insufficiency Raghu Kolluri, Columbus, United States 10:37-10:44 Chronic venous hypertension: What to do when there is no venous disease to treat Sergio Gianesini, Ferrara, Italy
Lymphoedema
10:44-10:51 Optimal lymphoedema diagnosis and management in 2019 Peter Mortimer, London, United Kingdom 10:51-10:58 A pragmatic approach to the assessment of swollen legs Sarah Thomis, Leuven, Belgium 10:58-11:12
Audience participation and discussion
Venous ulceration
11:12-11:19 Novel treatments for intractable leg ulcers Alfred Obermayer, Vienna, Austria 11:19-11:26 How to maximise implementation and impact post-EVRA Alun Davies, London, United Kingdom 11:26-11:33 Optimal assessment and treatment pathways for recalcitrant leg ulcers Thomas O'Donnell, Boston, United States 11:33-11:40 Novel wound dressings to meet the challenge of recalcitrant venous ulcers Keith Harding, Cardiff, United Kingdom 11:40-11:54
Audience participation, discussion and polling
2019
25
Tuesday 16 April 2019
08:00-08:08 How to choose between endovenous modalities Armando Mansilha, Porto, Portugal
Vascular & Endovascular Challenges Update
Pelvic venous disease
11:54-12:01 How to decide when pelvic venous reflux is clinically relevant and pelvic congestion syndrome Neil Khilnani, New York, United States 12:01-12:15
X Debate: The dangers of stenting for Nutcracker syndrome far C outweigh any benefits For the motion: 12:01-12:08 Gerard O’Sullivan, Galway, Ireland Against the motion: 12:08-12:15 Olivier Hartung, Marseille, France
12:15-12:30
Audience participation, discussion and polling
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOP
Deep venous system
Chairing: Alun Davies, London, United Kingdom Moderator: Rick de Graaf, Friedrichshafen, Germany
Tuesday 16 April 2019
Chronic venous outflow obstruction/ Acute DVT treatment/ Deep venous reflux
13:30-13:38 Optimising pathways for acute DVT treatment Prakash Saha, London, United Kingdom 13:38-13:54
X Debate: Aggressive thrombus removal for iliofemoral DVT is C overutilised as most patients do not develop significant PTS For the motion: 13:38-13:46 Manj Gohel, Cambridge, United Kingdom Against the motion: 13:46-13:54 Michael Lichtenberg, Arnsberg, Germany
13:54-14:08
Audience participation, discussion and polling
14:08-14:16 Optimal outcomes assessment after acute DVT thrombolysis Raghu Kolluri, Columbus, United States 14:16-14:26
CAVA trial
Cees Wittens, Maastricht, Netherlands
14:26-14:34 Where next after ATTRACT and CAVA Mitchell Silver, Columbus, United States 14:34-14:48
Audience participation and discussion
14:48-14:56 Complications and disasters during deep venous stenting procedures Gerard O’Sullivan, Galway, Ireland 14:56-15:04 An update on stent trials and the role of IVUS Erin Murphy, Charlotte, United States 15:04-15:12 The challenge of inflow – how can we assess it and what to look for Houman Jalaie, Aachen, Germany 15:12-15:20 What next when stents fail
Stephen Black, London, United Kingdom
15:20-15:30
Audience participation and discussion
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOP
Deep venous disease (continued)
Chairing: Manj Gohel, Cambridge, United Kingdom Moderator: Stephen Black, London, United Kingdom
16:00-16:07 The challenge of the femoral vein – treating post-thrombotic syndrome with normal iliac outflow Steve Elias, Englewood, United States 16:07-16:14 Latest advances with percutaneous deep venous valves Steven Dubenec, Sidney, Australia 16:14-16:21 Endovascular rescue strategies for in-stent thrombus lining and occlusion Erin Murphy, Charlotte, United States 16:21-16:35
Audience participation and discussion
16:35-16:42 Meeting the challenges of upper limb venous outflow obstruction Rick de Graaf, Friedrichshafen, Germany 16:42-16:56
Audience participation and discussion
16:56-17:03 Central vein obstruction – stenting in the SVC and IVC Narayanan Thulasidasan, London, United Kingdom 17:03-17:10 Strategies and pitfalls for venous stents for the upper limb Steven Dubenec, Sidney, Australia
26 2019
Vascular & Endovascular Challenges Update
Miscellaneous venous topics
17:10-17:17 Latest advances in managing C1 disease Paul Pittaluga, Monaco, Monaco 17:17-17:24 New horizons for venous specialists
Sriram Narayanan, Singapore
17:24-17:31 IVUS in venous interventions – reduction in radiation exposure Narayan Karunanithy, London, United Kingdom 17:31-17:38 Where do we stand with IVC filters in 2019 Richard McWilliams, Liverpool, United Kingdom 17:38-17:45 The current and future role of medical apps in venous care Oscar Johnson, London, United Kingdom Audience participation and discussion
Tuesday 16 April 2019
17:45-18:00
2019
27
Tuesday 16 April 2019
Tuesday
Additional Events
2019
29
Vascular & Endovascular Challenges Update
CX Aortic Techniques & Technologies (edited cases) l Pillar Hall Learning Centre – 08:00-18:00
B est of Aortic Live and Paris Endovascular Aortic Course
Chairing: Tilo Kölbel, Hamburg, Germany Moderator: Heinz Jakob, Essen, Germany
08:00-08:20 Total endovascular repair in chronic type A aortic dissection Stéphan Haulon, Le Plessis Robinson, France
Tuesday 16 April 2019
08:20-08:40 Frozen elephant trunk in chronic type A aortic dissection Konstantinos Tsagakis, Essen, Germany 08:40-09:00 Fenestrated arch repair in chronic type B aortic dissection Tilo Kölbel, Hamburg, Germany 09:00-09:20 In situ laser fenestration in ruptured aortic arch aneurysm Dominique Fabre, Le Plessis Robinson, France 09:20-09:40 TEVAR and candy-plug in chronic type B aortic dissection Fiona Rohlffs, Hamburg, Germany 09:40-10:00 Full transfemoral branched EVAR for thoracoabdominal aortic aneurysms Nikolaos Tsilimparis, Munich, Germany 10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
Coffee symposium: Innovative solutions for the treatment of visceral arteries in complex aortic procedures Chairing: Dittmar Böckler, Heidelberg, Germany
10:03-10:13 Best practices of fenestrated cases and the EXPAND registry Mauro Gargiulo, Bologna, Italy 10:13-10:23 Comparison with existing devices – case presentations and best practices Martin Austermann, Münster, Germany 10:23-10:28
Discussion and conclusion
New device
Chairing: Dittmar Böckler, President DGG, Heidelberg, Germany
10:30-11:00 Edited case: New balloon-expandable endoprosthesis in complex aortic procedures Jorge Fernández Noya, Santiago de Compostela, Spain
Hybrid procedure
Chairing: Michel Makaroun, Pittsburgh, United States Moderator: Tara Mastracci, London, United Kingdom 11:00-11:30 Branched frozen elephant trunk as a platform for second stage TEVAR Mark Field, Warrington, United Kingdom
Type B dissections
11:30-11:50 Endovascular repair of chronic post-dissection thoracoabdominal aortic aneurysms Gustavo Oderich, Rochester, United States 11:50-12:10 Open and endovascular treatment of acute type B dissections Franco Grego, Padua, Italy
Conversion to open repair
12:10-12:30 Open conversion of endovascular failures Michel Makaroun, President SVS, Pittsburgh, United States 12:30-13:30
30 2019
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Vascular & Endovascular Challenges Update
TEVAR
Chairing: Tilo Kölbel, Hamburg, Germany Moderator: Barry Katzen, Miami, United States 13:30-14:00 Precise placement and conformability with a thoracic aortic stent graft Dittmar Böckler, President DGG, Heidelberg, Germany
Imaging
14:00-14:30 Artificial intelligence: Deformable anatomy tool for accurate smart overlays Tara Mastracci, London, United Kingdom Cynthia Shortell, Durham, United States
Thoracoabdominal aneurysms
15:00-15:30 Expedited treatment of TAAAs with proven durability: My experience with an off-the-shelf branched stent graft Bijan Modarai, London, United Kingdom 15:30-16:00 TEA AND VISIT TO HANDS-ON WORKSHOPS
Juxtarenal aneurysms
Chairing: Timothy Resch, Malmö, Sweden Moderator: Heinz Jakob, Essen, Germany 16:00-16:30 Complex juxtarenal abdominal aortic aneurysm repair with a fenestrated stent graft Michel Reijnen, Arnhem, Netherlands 16:30-16:50 Endovascular repair of complex juxtarenal aortic aneurysm using a combined reverse branched endograft and chimney technique Wei Guo, Beijing, China 16:50-17:10 Easy open repair instead of complex fenestrations Dittmar Böckler, President DGG, Heidelberg, Germany
Infection
17:10-17:40 The best open approach for aortic (graft) infection – tips & tricks Xavier Berard, Bordeaux, France 17:40-18:00 Infections after vascular reconstructions Konstantin Andreychuk, Saint Petersburg, Russia
CEC@CX London Room Learning Centre – 10:30-12:30 Co-chairs: Wei Guo, Beijing, China Daqiao Guo, China Sheng Wang, Beijing, China Discussants: ZhenYu Shi, Shanghai, China Zhengya Yu, Beijing, China Weiwei Wu, China
CX co-chair: F rans Moll, CX Advisory Board, Utrecht, Netherlands
CX moderator: Tilo Kölbel, Hamburg, Germany CX discussant: Heinz Jakob, Essen, Germany
10:30-10:38 New DCB era for BTK: Six-month results from the China AcoArt Study Wei Guo, Beijing, China 10:38-10:46 Treatment of type II endoleak after endovascular abdominal aortic aneurysm repair Sheng Wang, Beijing, China 10:46-10:54 The endovascular treatment of distal entry of TBAD after proximal TEVAR ZhenYu Shi, Shanghai, China 10:54-11:10
Audience participation and discussion
11:10-11:18 What are the key points for endovascular repair of ruptured abdominal aortic aneurysm? Yaoguo Yang, Beijing, China
2019
31
Tuesday 16 April 2019
14:30-15:00 Branched repair of type II thoracoabdominal aneurysm with trackable and flexible covered stents Said Abisi, London, United Kingdom
Vascular & Endovascular Challenges Update 11:18-11:26 Endotension following EVAR: Is it real, what causes it and what to do about it? Jianing Yue, Shanghai, China 11:26-11:34 Modified PAI technique for dialysis access-associated Steal Syndrome Zhengya Yu, Beijing, China 11:34-11:50
Audience participation and discussion
11:50-11:58 In situ laser fenestration of aortic arch stent graft during thoracic endovascular aortic repair of Stanford type A aortic dissection Xinwu Lu, Shanghai, China 11:58-12:06 Effect evaluation of intravascular thrombolysis for pulmonary embolism with low-dose recombinant tissue plasminogen activator Weiwei Wu, Beijing, China 12:06-12:14 Management of endoleaks after EVAR for AAA Qingle Li, Beijing, China 12:14-12:30
Audience participation and discussion
Tuesday 16 April 2019
CX Meets Latin America l l London Room Learning Centre – 13:00-15:30 Lunch served in the London Room Learning Centre
Chairing: Luis Mariano Ferreira, Buenos Aires, Argentina Juan Esteban Paolini, President, Argentine College of Cardiovascular Surgery, Caba, Argentina
Moderators: Álvaro Razuk, São Paulo, Brazil Ignacio Escotto Sánchez, Mexico City, Mexico
13:30-13:38 Endovascular treatment of ruptured aortic arch aneurysms Gustavo Paludetto Oliveira, Brasília, Brazil 13:38-13:42
Audience participation and discussion
13:42-13:50 Updates in how to improve results on outpatient EVAR programme Álvaro Razuk, São Paulo, Brazil 13:50-13:54
Audience participation and discussion
13:54-14:02 FEVAR due proximal neck dilatation after EVAR Luis Mariano Ferreira, Buenos Aires, Argentina 14:02-14:06
Audience participation and discussion
14:06-14:14 Endovascular treatment of Lerich Syndrome Juan Esteban Paolini, President, Argentine College of Cardiovascular Surgery, Caba, Argentina 14:14-14:18
Audience participation and discussion
14:18-14:26 Value of drug-coated balloon in patients with CLI and DM with complex real-world lesions undergoing endovascular interventions in below-the-knee arteries Ignacio Escotto Sánchez, Mexico City, Mexico 14:26-14:30
Audience participation and discussion
14:30-14:38
Short necks – how to do it
14:38-14:42
Audience participation and discussion
Guilherme Centofanti, São Paulo, Brazil
14:42-14:50 Common iliac artery aneurysm: Revascularisation or embolisation Luiz Furuya, São Paulo, Brazil 14:50-14:54
Audience participation and discussion
14:54-15:02 Why endografting is my first choice to treat popliteal artery aneurysm Lucas Marcelo Dias Freire, São Paulo, Brazil 15:02-15:06
Audience participation and discussion
15:06-15:14 Strategies on the treatment for complex disease in the femoropopliteal artery Sidnei Galego, São Paulo, Brazil 15:14-15:18
Audience participation and discussion
15:18-15:26 Fenestrated and branched stent-grafting after previous surgery Luis Mariano Ferreira, Buenos Aires, Argentina 15:26-15:30
32 2019
Audience participation and discussion
Vascular & Endovascular Challenges Update
CX Aortic Workshop – Day 1 l CX Aortic Workshop – 10:00-16:00
Facilitators: A nna Prent, London, United Kingdom Kevin Mani, Uppsala, Sweden
Cydar EV
10:00-10:30 Fusion imaging simplified
Tom Carrell, Barrington, United Kingdom
Fusion imaging simplified
Tom Carrell, Barrington, United Kingdom
15:30-16:00 Fusion imaging simplified
Tom Carrell, Barrington, United Kingdom
12:30-13:30
Complex TAAA
12:30-13:30 Case discussion of complex TAAA repair with pre-case CT and tips & tricks for a good outcome Said Abisi, London, United Kingdom 15:30-16:00 Case discussion of complex TAAA repair with pre-case CT and tips & tricks for a good outcome Said Abisi, London, United Kingdom
EVAR ASSIST 2
10:00-10:30 How to simplify fenestrated EVAR procedures using fusion imaging with EVAR ASSIST 2? Gustavo Oderich, Rochester, United States 15:30-16:00 How to simplify fenestrated EVAR procedures using fusion imaging with EVAR ASSIST 2? Gustavo Oderich, Rochester, United States
FEVAR
10:00-10:30 Terumo Aortic individualised solutions (Abdominal Aorta) – Fenestrated Anaconda Michel Reijnen, Arnhem, Netherlands 12:30-13:30 Terumo Aortic individualised solutions (Abdominal Aorta) – Fenestrated Anaconda Michel Reijnen, Arnhem, Netherlands Nick Burfitt, London, United Kingdom 15:30-16:00 Terumo Aortic individualised solutions (Abdominal Aorta) – Fenestrated Anaconda Nick Burfitt, London, United Kingdom
Filler: Aneurysms and AVMs
Murat Katitas, Ankara, Turkey Egemen Okur, Ankara, Turkey
IVUS
10:00-10:30 Technical aspects of IVUS in EVAR and TEVAR procedures Joerg Tessarek, Lingen, Germany 12:30-13:30 Technical aspects of IVUS in EVAR and TEVAR procedures Joerg Tessarek, Lingen, Germany 15:30-16:00 Technical aspects of IVUS in EVAR and TEVAR procedures Joerg Tessarek, Lingen, Germany
PIUR tomographic ultrasound
Vikki Galgerud, Vienna, Austria
2019
33
Tuesday 16 April 2019
he CX Aortic Workshop is open from 10:00 to 16:00 on Tuesday and T Wednesday. Participants are invited to visit the workshop as they please to explore the aortic technologies available. During break times there will be supervised learning with key opinion leaders.
Vascular & Endovascular Challenges Update
VesselNavigator image fusion
10:00-10:30 How VesselNavigator Image Fusion benefits complex EVAR procedures Karin Prins, Philips Healthcare, Best, Netherlands Alice Jay, Philips Healthcare, Leusden, Netherlands 12:30-13:30 How VesselNavigator Image Fusion benefits complex EVAR procedures Blandine Maurel, Nantes, France 15:30-16:00 How VesselNavigator Image Fusion benefits complex EVAR procedures Karin Prins, Philips Healthcare, Best, Netherlands Alice Jay, Philips Healthcare, Leusden, Netherlands
Tuesday 16 April 2019
CX Peripheral Workshop – Day 1 l CX Peripheral Workshop – 10:00-16:00 he CX Peripheral Workshop is open from 10:00 to 16:00 on Tuesday and T Wednesday. Participants are invited to visit the workshop as they please to explore the peripheral technologies available. During break times there will be supervised learning with key opinion leaders.
Facilitator: F rank Vermassen, Ghent, Belgium
ABPI and early detection of PAD
Matjaz Span, Izola, Slovenia Jakob Susteric, United Kingdom
Carnelian, Pulsar-18 T3 and Fortress Georg Bach, Biotronik, Bulach, Switzerland Dabra Excimer Laser Atherectomy Max Amor, Essey-les-Nancy, France Charles Bailey, San Antonio, United States EndoWars Simulator Challenge SFA Lynne Teece, Cook Medical, Bournemouth, United Kingdom Indigo System and large volume coils Miriam Bondrop, Penumbra, Berlin, Germany Jaguar self-expanding nitinol stent Robert Michal Proczka, Warsaw, Poland Lutonix BTK DCB
Luis Mariano Palena, Abano Terme, Italy
See clearly: The value of peripheral arterial IVUS in decision making Konstantinos Stavroulakis, Münster, Germany Stealth 360 Peripheral Orbital Atherectomy Konstantinos Donas, Münster, Germany Supera and peripheral guidewires Sanchita Pasi, Abbott Vascular, Diegem, Belgium Tack – how I optimise balloon angioplasty? Michael Lichtenberg, Arnsberg, Germany Temren atherectomy and Extender drug-coated balloon Berna Ozata, Ankara, Turkey Evren Ekingen, Batman, Turkey
The surgical Doppler probe
Jon Evans, Cardiff, United Kingdom
Treat optimally: The use of the Phoenix Atherectomy System Theodosios Bisdas, Athens, Greece Vessel preparation with JetStream Atherectomy system and Ranger DCB Tibor Balazs, Bratislava, Slovakia
34 2019
Vascular & Endovascular Challenges Update
CX Acute Stroke Abstract Presentations l Dark Room Learning Centre – 08:00-11:30 Acute Stroke Abstract Presentations
Chairing: H ugh Markus, Cambridge, United Kingdom Barbara Rantner, Innsbruck, Austria
08:00-08:05 Preoperative prediction of a vulnerable carotid plaque using the Speculate score in patients submitted for carotid endarterectomy Daniela Mazzaccaro, San Donato Milanese, Italy 08:05-08:10
Audience participation and discussion
Tuesday 16 April 2019
08:10-08:15 Evaluation of kinetic imaging in carotid and cerebral X-ray angiography Viktor Orias, Budapest, Hungary 08:15-08:20
Audience participation and discussion
08:20-08:25 Carotid plaque volume measured by 3D tomographic ultrasound Steven Rogers, Manchester, United Kingdom 08:25-08:30
Audience participation and discussion
08:30-08:35 Correlation between plaque characteristics and presence of preoperative white matter lesions in patients undergoing carotid endarterectomy Marjolijn Rots, Utrecht, Netherlands 08:35-08:40
Audience participation and discussion
08:40-08:45 Impact of carotid artery stenosis and carotid endarterectomy on ipsilateral ocular flow density measured by optical coherence tomography angiography Elena Marchiori, Muenster, Germany 08:45-08:50
Audience participation and discussion
08:50-08:55 Ferumoxytol-enhanced magnetic resonance imaging study of patients with symptomatic and asymptomatic carotid artery disease – An exploratory study Umar Sadat, Cambridge, United Kingdom 08:55-09:00
Audience participation and discussion
09:00-09:05 Prevention of neurologic morbidity in carotid surgery Salvatore Turiano, Nicolosi, Italy 09:05-09:10
Audience participation and discussion
09:10-09:15 Prevention of acute strokes by screening the senior population with a quick carotid scan George Lavenson, Lahaina, United States 09:15-09:20
Audience participation and discussion
09:20-09:25 Guidelines compliance in the use of statins and LDL target in patient in carotid surgery plan Fernando Belcastro, Buenos Aires, Argentina 09:25-09:30
Audience participation and discussion
09:30-09:35 Comparative analysis of carotid artery stenting and carotid endarterectomy in clinical practice Alexey Khmelnitskiy, San Petersburg, Russia 09:35-09:40
Audience participation and discussion
09:40-09:45 Short non-patch arteriotomy in carotid endarterectomy Marco Leopardi, L’Aquila, Italy 09:45-09:50
Audience participation and discussion
09:50-09:55 Intermediate results of a prospective randomised study in carotid artery revascularisation: The Acculink stent vs. the mesh covered stent comparative aspect Alexey Khmelnitskiy, San Petersburg, Russia 09:55-10:00
Audience participation and discussion
10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
10:30-10:35 Symptomatic carotid artery stenosis undergoing surgical revascularisation: Improvement in cognitive performance and cerebral haemodynamics Gabriele Pagliariccio, Senigallia (AN), Italy 10:35-10:40
Audience participation and discussion
10:40-10:45 Our experience of surgical treatment at patients with Takayasu disease Viktoriya Tsay, Tashkent, Uzbekistan 10:45-10:50
Audience participation and discussion
10:50-10:55 Incidence and outcomes of cerebral hyperperfusion syndrome after carotid endarterectomy Mary Weisters, Aylesbury, United Kingdom
36 2019
Vascular & Endovascular Challenges Update 10:55-11:00
Audience participation and discussion
11:00-11:05 Patient cooperative general anaesthesia for carotid endarterectomy: A third option Yao Pey Yong, Huddersfield, United Kingdom 11:05-11:10
Audience participation and discussion
11:10-11:15 The clinical relevance of preoperative cerebral small vessel disease for adverse events following carotid endarterectomy Nathalie Timmerman, Amsterdam, Netherlands 11:15-11:20
Audience participation and discussion
11:20-11:25 Preoperative embolisation of carotid body tumours: Yes or no? Tiago Soares, Matosinhos, Portugal Audience participation and discussion
CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1 l London Room Learning Centre
C X Peripheral Arterial Global Stars and Rising Stars (08:00-10:00) Chairing: P aul Hayes, Cambridge, United Kingdom Robert Hinchliffe, Bristol, United Kingdom
08:00-08:05 The fate of the claudicant; 25 years after Dormandy Katie Hurst, Oxford, United Kingdom 08:05-08:10
Audience participation and discussion
08:10-08:15 Rotational atherectomy vs. surgical endarterectomy for common femoral artery atherosclerotic disease in high haemorrhagic risk patients: A comparative study Mahine Kashi-Dakhil, Argenteuil, France 08:15-08:20
Audience participation and discussion
08:20-08:25 Podium 1st: FINNPTX final results
Patrick Bjorkman, Helsinki, Finland
08:25-08:30 Audience participation and discussion 08:30-08:35 Zilver PTX drug-eluting stent for treating femoropopliteal lesions: Results from the Zilver PTX China Daqiao Guo, Shanghai, China 08:35-08:40
Audience participation and discussion
08:40-08:45 Patients with infrapopliteal artery lesions treated with a paclitaxel covered balloon in a real-world clinical trial. Twenty four-month results of the BIOLUX P-III all comers registry Gunnar Tepe, Rosenheim, Germany 08:45-08:50
Audience participation and discussion
08:50-08:55 Real world long-term outcome of patients with femoropopliteal helical interwoven nitinol stents Yiu Che Chan, Hong Kong 08:55-09:00
Audience participation and discussion
09:00-09:05 The variant of improving the long-term results after stenting of the superficial femoral artery: Two-year results of a pilot prospective randomised study Pavel Ignatenko, Novosibirsk, Russia 09:05-09:10
Audience participation and discussion
09:10-09:15 A pilot study to determine vascular functions and patency through interventional atherectomy in peripheral artery disease (safety and efficacy of atherectomy on vascular functions – the SAVIOR trial): Methodology and study design Christos Rammos, Essen, Germany 09:15-09:20
Audience participation and discussion
09:20-09:25 Aspiration thrombectomy for acute limb ischaemia: A single-centre experience Maria Antonella Ruffino, Turin, Italy 09:25-09:30
Audience participation and discussion
2019
37
Tuesday 16 April 2019
11:25-11:30
Vascular & Endovascular Challenges Update 09:30-09:35 Comparison of adjuvant non-drug coated and drug-coated balloon angioplasty populations undergoing peripheral arterial disease interventions involving laser assisted atherectomy Javier Ruiz Aburto, Ponce, Puerto Rico 09:35-09:40
Audience participation and discussion
09:40-09:45 Challenging baseline lesion characteristics: Subgroup analysis of patients treated in the IMPERIAL randomised trial Frank Vermassen, Ghent, Belgium 09:45-09:50
Audience participation and discussion
09:50-09:55 Safety and effectiveness of the novel Temren Atherectomy System combined used with Extender drug-eluting balloon in lower extremity arteries Halit Yerebakan, Turkey 09:55-10:00
Tuesday 16 April 2019
Audience participation and discussion
C X Peripheral Arterial Global Stars and Rising Stars (16:00-18:00) Chairing: F rank Vermassen, Ghent, Belgium Enrico Ascher, New York, United States
16:00-16:05 Podium 1st: DRASTICO study two-year results Francesco Liistro, Arezzo, Italy 16:05-16:10
Audience participation and discussion
16:10-16:15 Podium 1st: Results from the PORTRAIT Claudication Registry Kim Smolderen, Kansas City, United States 16:15-16:20
Audience participation and discussion
16:20-16:25 Treatment of peripheral arterial disease with endoluminal bypass in long de novo lesions and in-stent restenosis Athanasios Giannoukas, Larissa, Greece 16:25-16:30
Audience participation and discussion
16:30-16:35 Two-year results of vasculomimetic stents in tortuous, angulated territories, other than the SFA Rajiv Parakh, Gurgaon, India 16:35-16:40
Audience participation and discussion
16:40-16:45 High outward force of self-expanding BMS in the SFA could be a significant risk factor for restenosis at 12 months Mark Burket, Toledo, United States 16:45-16:50
Audience participation and discussion
16:50-16:55 DCB only vs Bail-out stented outcomes at 24-months, a sub-analysis of BIOLUX P-III global Passeo-18 Lux registry Marianne Brodmann, Graz, Austria 16:55-17:00
Audience participation and discussion
17:00-17:05 Challenging lesions: Is calcium the Achilles heel of endovascular procedures? Theodosios Bisdas, MĂźnster, Germany 17:05-17:10
Audience participation and discussion
17:10-17:15 Fusion techniques for treatment of peripheral interventions Yann Goueffic, Nantes, France 17:15-17:20
Audience participation and discussion
17:20-17:25 DCB in real world complexities: the SAVER registry Giovanni Torsello, MĂźnster, Germany 17:25-17:30
Audience participation and discussion
17:30-17:35 Endovascular treatment of popliteal aneurysms: Long-term outcomes Ignace Tielliu, Groningen, Netherlands 17:35-17:40
Audience participation and discussion
17:40-17:45 The final results of the hybrid procedure in comparison with the aortofemoral bypass in patients with haemodynamically significant lesions of the iliac arteries and the common femoral artery (type TASC II C, D) Pavel Ignatenko, Novosibirsk, Russia 17:45-17:50
Audience participation and discussion
17:50-17:55 Algorithm for approaching long complex lesions Jos van den Berg, Lugano, Switzerland 17:55-18:00
38 2019
Audience participation and discussion
Vascular & Endovascular Challenges Update
CX Abdominal Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 l
C X Abdominal Aortic Global Stars and Rising Stars Chairing: R onald Dalman, Stanford, United States Samuel Money, Phoenix, United States
16:00-16:05 Magnetic resonance imaging volumetric assessment of small abdominal aortic aneurysm for growth monitoring – implications for power calculation in longitudinal interventional studies Achilleas Karkamanis, Stockholm, Sweden 16:05-16:10
Audience participation and discussion
16:10-16:15 Next-generation pan-vascular suite: Optimising patient management and outcomes Barry Katzen, Miami, United States 16:15-16:20
Audience participation and discussion
16:20-16:25 Abstract Winner CX 2018 – Integrated physiological and biochemical assessments for the prediction of growth of abdominal aortic aneurysm in humans Regent Lee, Headington, United Kingdom 16:25-16:30
Audience participation and discussion
16:30-16:35 Segmental arterial mediolysis 16:35-16:40
Samuel Money, Phoenix, United States
Audience participation and discussion
16:40-16:45 Episode-based cost reductions in EVAR Ronald Dalman, Stanford, United States 16:45-16:50
Audience participation and discussion
16:50-16:55 Many EVAR costs are triggered by unnecessary treatment of type II endoleaks: New data indicate that most are benign and do not require intervention Michel Reijnen, Arnhem, Netherlands 16:55-17:00
Audience participation and discussion
17:00-17:05 Early results of a new treatment for large abdominal aortic aneurysms with recurrent endoleaks: Combined endovascular and laparoscopic endoleak repair Adam Howard, Lamarsh Bures, United Kingdom 17:05-17:10
Audience participation and discussion
17:10-17:15 Mid-term results from the ANCHOR registry: When the use of endoanchors benefits EVAR Colin Bicknell, London, United Kingdom 17:15-17:20
Audience participation and discussion
17:20-17:25 Five-year results from the US IDE trial on the Anaconda stent graft system Randy Moore, Calgary, Canada 17:25-17:30
Audience participation and discussion
17:30-17:35 Emergencies treated with covered stents Maria Antonella Ruffino, Turin, Italy 17:35-17:40
Audience participation and discussion
17:40-17:45 Post-EVAR graft limb kinking: Aetiology, impact as a cause of limb occlusion and management Andreia Coelho, Porto, Portugal 17:45-17:50
Audience participation and discussion
17:50-17:55 A lifetime efficacy proven by clinical evidence: Twelve years of results of the Excluder endograft Jan Heyligers, Tilburg, Netherlands 17:55-18:00
Audience participation and discussion
18:00-18:05 Clinical study and extended application in complicated AAA with a new IBD Wei Guo, Beijing, China 18:05-18:10
Audience participation and discussion
2019
39
Tuesday 16 April 2019
Gallery Suite Learning Centre – 16:00-18:10
Vascular & Endovascular Challenges Update
CX Thoracic Aortic Global Stars and Rising Stars and Abstract Presentations – Day 1 l Gallery Suite Learning Centre – 08:00-15:30
Tuesday 16 April 2019
C X Thoracic Aortic Global Stars and Rising Stars Chairing: G ustavo Oderich, Rochester, United States Anna Prent, London, United Kingdom
08:00-08:05 Relative change in temperature and atmospheric pressure are critical mechanistic factors in acute aortic syndrome occurrence in France Guillaume Guimbretiere, Nantes, France 08:05-08:10
Audience participation and discussion
08:10-08:15 Routine use of cone beam influence on long-term outcomes Adrien Hertault, Lille, France 08:15-08:20
Audience participation and discussion
08:20-08:25 Cerebroembolic outcomes of right vs. left upper extremity access during fenestrated/branched endovascular aortic repair Aleem Mirza, United States 08:25-08:30
Audience participation and discussion
08:30-08:35 Physician modified double fenestrated stent grafts for total endovascular aortic arch repair Baris Ata Ozdemir, Bristol, United Kingdom 08:35-08:40
Audience participation and discussion
08:40-08:45 Endovascular repair of aortic disease from aortic arch to iliac arteries Konstantinos Spanos, Larissa, Greece 08:45-08:50
Audience participation and discussion
08:50-08:55 Three-years’ follow-up of succesful endovascular interventions in Takayasu arteritis involving aorta and aortic arch vessels Narendra Nath Khanna, New Delhi, India 08:55-09:00
Audience participation and discussion
09:00-09:05 Subclavian artery plug embolisation (SAPE study): A real experience about endovascular subclavian occlusion prior to thoracic vascular repair Simone Salvati, Monza, Italy 09:05-09:10
Audience participation and discussion
09:10-09:15 Hybrid procedures in aortic arch aneurysm surgery in high risk patients Mikhail Chernyavskiy, St Petersburg, Russia 09:15-09:20
Audience participation and discussion
09:20-09:25 Evaluation of the TAG thoracic branch endoprosthesis in the treatment of proximal descending thoracic aortic aneurysms Michael Dake, Stanford, United States 09:25-09:30
Audience participation and discussion
09:30-09:35 Thoraflex Hybrid FDA clinical trial: Early results Chris Malaisrie, Chicago, United States 09:35-09:40
Audience participation and discussion
09:40-09:45 Interactions between frozen elephant trunk and thoracic endograft Martin Czerny, Freiburg, Germany 09:45-09:50
Audience participation and discussion
09:50-09:55 Systematic review on current evidence of type Ib endoleak after thoracic endovascular aortic repair Viony Belvroy, Houston, United States 09:55-10:00
Audience participation and discussion
10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
40 2019
Vascular & Endovascular Challenges Update
C X Thoracic Aortic Global Stars and Rising Stars Chairing: B arry Katzen, Miami, United States Martin Malina, London, United Kingdom
10:30-10:35 Outcomes from open surgical repair of Extent IV thoracoabdominal aortic aneurysms: Experience with the use of adjunctive distal perfusion, cerebrospinal drainage, MEP monitoring and Coselli branched grafts Mark Field, Warrington, United Kingdom 10:35-10:40
Audience participation and discussion
10:40-10:45 Selective vs. routine preoperative coronary computerised tomography angiography for patients undergoing thoracoabdominal aortic aneurysm open repair Maria Katsarou, Milan, Italy Audience participation and discussion
10:50-10:55 Short-term outcomes of VBX stent grafts compared to Atrium iCAST stent grafts for fenestrated endovascular repair Celine Deslarzes-Dubuis, Stanford, United States 10:55-11:00
Audience participation and discussion
11:00-11:05 Outcomes of percutaneous endovascular repair of thoracic and thoraco-abdominal aneurysms with larger introducers and in patients with previous open or percutaneous accesses Andrea Melloni, Milan, Italy 11:05-11:10
Audience participation and discussion
11:10-11:15 Systematic multistaged endovascular repair of thoracoabdominal aneurysms with fenestrated and branched endografts (STEAR study) Maria Katsarou, Milan, Italy 11:15-11:20
Audience participation and discussion
11:20-11:25 Totally percutaneous access for thoracic and thoracoabdominal endovascular aortic repair: Upper extremity access Andrea Melloni, Milan, Italy 11:25-11:30
Audience participation and discussion
11:30-11:35 Aortic aneurysms in Takayasu’s arteritis – outcomes after open surgical treatment Harishankar Ramachandran Nair, Trivandrum, India 11:35-11:40
Audience participation and discussion
11:40-11:45 Endovascular therapy for ischaemic vs. non-ischaemic complicated acute type B aortic dissection Ahmed Eleshra, Hamburg, Germany 11:45-11:50
Audience participation and discussion
11:50-11:55 The use of frozen elephant trunk techniques for acute and chronic type B dissections Celia Riga, London, United Kingdom 11:55-12:00
Audience participation and discussion
12:00-12:05 FEVAR in octogenarians 12:05-12:10
Bijan Modarai, London, United Kingdom
Audience participation and discussion
12:10-12:15 The place of renal revascularisation of late occluded renal artery following complex aortic repair Nikolaos Tsilimparis, Munich, Germany 12:15-12:20
Audience participation and discussion
12:20-12:25 Procedure complexity in fenestrated and branched endovascular aneurysm repair depends on number of revascularised branches Kevin Mani, Uppsala, Sweden 12:25-12:30
Audience participation and discussion
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
C X Thoracic Aortic Global Stars and Rising Stars Chairing: F rank Criado, Baltimore, United States Asimakis Gkremoutis, London, United Kingdom
13:30-13:35 What we have learned from in vitro chimney studies Kak Khee Yeung, Amsterdam, Netherlands 13:35-13:40
Audience participation and discussion
13:40-13:45 First experience with a noval device with inner branches and funnel like ostium in the treatment of thoracoabdominal and juxrarenal aneurysms as a first step in the development of an “off-the-shelf” stent graft Ahmed Koshty, Siegen, Germany
2019
41
Tuesday 16 April 2019
10:45-10:50
Vascular & Endovascular Challenges Update 13:45-13:50
Audience participation and discussion
13:50-13:55 Experience with covered stents in FEVAR procedures Daniela Branzan, Leipzig, Germany 13:55-14:00
Audience participation and discussion
14:00-14:05 Global experience with balloon-expandable covered stents as chimney grafts: Insights from the PERICLES registry Konstantinos Donas, Münster, Germany 14:05-14:10
Audience participation and discussion
14:10-14:15 Results of a novel double layer PTFE graft in the thoracic aorta Ralf Kolvenbach, Dusseldorf, Germany 14:15-14:20
Audience participation and discussion
14:20-14:25 TEVAR for aortic dissection combined with visceral artery ischaemia Chang Shu, Beijing, China 14:25-14:30
Tuesday 16 April 2019
Audience participation and discussion
Thoracic Aortic Abstract Presentations
14:30-14:35 Matching analysis between classic and arch first technique in frozen elephant trunk for aortic arch repair Alessandra Fittipaldi, Salerno, Italy 14:35-14:40
Audience participation and discussion
14:40-14:45 Endovascular outcomes of aortic arch disease treated with multiple parallel stents technique Baolei Guo, Shanghai, China 14:45-14:50
Audience participation and discussion
14:50-14:55 Methods and clinical outcomes of in situ fenestration for aortic arch revascularisation during thoracic endovascular aortic repair Hailei Li, Shenzhen, China 14:55-15:00
Audience participation and discussion
15:00-15:05 Complications of cerebrospinal fluid drainage in TEVAR narrows the therapeutic window Gokay Deniz, Ankara, Turky 15:05-15:10
Audience participation and discussion
15:10-15:15 Mid-term results of TEVAR for thoracic aortic pathologies – a singlecentre experience Carlota Fernandez Prendes, Oviedo, Spain 15:15-15:20
Audience participation and discussion
15:20-15:25 Outcomes after one-stage vs. two-stage open repair of type II thoracoabdominal aortic aneurysms Drosos Kotelis, Aachen, Germany 15:25-15:30
Audience participation and discussion
CX Vascular Access Abstract Presentations Dark Room Learning Centre – 13:30-17:52
Vascular Access Abstract Presentations Chairing: J ames Gilbert, Oxford, United Kingdom Kate Steiner, Stevenage, United Kingdom
13:30-13:35 Long-term patency of arteriovenous fistulas as a vascular access in paediatric age group patients with end-stage renal disease – Egyptian experience Hassan Lotfy, Alexandria, Egypt 13:35-13:38
Audience participation and discussion
13:38-13:43 Systematic review and meta-analysis of randomised-controlled trials comparing drug-coated balloons angioplasty vs. plain balloon angioplasty in arteriovenous fistulae salvage Fui Jin Chong, Singapore 13:43-13:46
Audience participation and discussion
13:46-13:51 Brachial vein transposition versus arteriovenous grafts – 24 months results Ines Antunes, Porto, 13:51-13:54
42 2019
Audience participation and discussion
Vascular & Endovascular Challenges Update 13:54-13:59 Results of a pivotal trial of vonapanitase to increase fistula use for haemodialysis and secondary patency Steven Burke, Sudbury, United States 13:59-14:02
Audience participation and discussion
14:02-14:07 Our experience of primary patency of PTFE patch closure at the venous anastomotic site for arteriovenous graft thrombosis Chandrashekar AR, Bangalore, India 14:07-14:10
Audience participation and discussion
14:10-14:15 Use undersized stent grafts to treat haemodialysis access-related severe central venous occlusive disease: Midterm results Chien Hwa Chang, New Taipei City, Taiwan 14:15-14:18
Audience participation and discussion
14:18-14:23 Over 80s renal failure patients – radiocephalic vs. brachiocephalic outcomes Nuno Coelho, Vila Nova de Gaia, Portugal Audience participation and discussion
14:26-14:31 The need for an early fistuloplasty as a poor prognostic factor for vascular access patency Mohamed Elzawahry, London, United Kingdom 14:31-14:34
Audience participation and discussion
14:34-14:39 “Low-flow“ vascular access grafts 14:39-14:42
Marco Franchin, Varese, Italy
Audience participation and discussion
14:42-14:47 The Surfacer system – a single-centre prospective observational study in central venous occlusion to demonstrate safety and efficacy Tobias Steinke, Dusseldorf, Germany 14:47-14:50
Audience participation and discussion
14:50-14:55 Long-term outcomes of a new technique of brachiobasilic elevation fistula for haemodialysis Manel Gharbi, Besancon, France 14:55-14:58
Audience participation and discussion
14:58-15:03 Significant reduction of radiation exposure using wrist access with the second generation 4F endoAVF catheter system to create endovascular AV fistulae Tobias Steinke, Dusseldorf, Germany 15:03-15:06
Audience participation and discussion
15:06-15:11 Can we define adequate surveillance timing for arteriovenous grafts? Andrej Isaak, Basel, Switzerland 15:11-15:14
Audience participation and discussion
15:14-15:19 Longivety and outcomes of central double lumen permanent catheters for haemodialysis Mohamed Ismail, Cairo, Egypt 15:19-15:22
Audience participation and discussion
15:22-15:27 Stent grafting as first intervention for venous stenosis improves outcomes in incident arteriovenous grafts Andrej Isaak, Basel, Switzerland 15:27-15:30
Audience participation and discussion
15:30-16:00
TEA AND VISIT TO HANDS ON WORKSHOPS
Vascular Access Abstract Presentations Chairing: H iren Mistry, London, United Kingdom Paul Gibbs, Portsmouth, United Kingdom
16:00-16:05 Risk of iodinated contrast use in predialysis patients undergoing percutaneous endovascular arteriovenous fistula formation: A singlecentre experience Aurangzaib Khawaja, Birmingham, United Kingdom 16:05-16:08
Audience participation and discussion
16:08-16:13 Artificial intelligence and functional maturation of radiocephalic arteriovenous fistula Ali Kordzadeh, Broomfield, United Kingdom 16:13-16:16
Audience participation and discussion
16:16-16:21 A study of upper extremity AV grafts and single-stage basilic vein transposition: A single-centre analysis from South India Luv Luthra, Bangalore, India 16:21-16:24
Audience participation and discussion
16:24-16:29 A new technique to repair high-flow arteriovenous fistula using a novel external support device Vladimir Matoussevitch, Cologne, Germany 16:29-16:32
Audience participation and discussion
2019
43
Tuesday 16 April 2019
14:23-14:26
Vascular & Endovascular Challenges Update 16:32-16:37 Distal revascularisation and interval ligation for the treatment of dialysis access steal syndrome: A systematic review Ali Kordzadeh, Broomfield, United Kingdom 16:37-16:40
Audience participation and discussion
16:40-16:45 Transradial approach for arteriovenous fistula salvage: An Indian perspective Pranay Pawar, Chennai, India 16:45-16:48
Audience participation and discussion
16:48-16:53 Revision using distal inflow for the treatment of dialysis access steal syndrome: A systematic review Ali Kordzadeh, Broomfield, United Kingdom 16:53-16:56
Audience participation and discussion
16:56-17:01 Paediatric haemodialysis in the UK – time for national guidance? Muhammad Khurram, London, United Kingdom 17:01-17:04
Audience participation and discussion
17:04-17:09 VITAE Registry: Vascular access Indigo CATD thromboaspiration registry Marco Tadiello, Castronno, Italy
Tuesday 16 April 2019
17:09-17:12
Audience participation and discussion
17:12-17:17 Arteriovenous fistula surveillance using 3D tomographic ultrasound Steven Rogers, Manchester, United Kingdom 17:17-17:20
Audience participation and discussion
17:20-17:25 Ultrasound assessment of arteriovenous access stenosis in native arteriovenous fistulae and correlation with histology analysis Kate Steiner, Stevenage, United Kingdom 17:25-17:28
Audience participation and discussion
17:28-17:33 The impact of type of anastomosis of AVF in ESRD on the rate of maturation: A randomised controlled trial Mohammed Elkassaby, Galway, Ireland 17:33-17:36
Audience participation and discussion
17:36-17:41 Interim results of a randomised controlled trial comparing the incidence of steal syndrome in two types of antecubital fossa arteriovenous fistulae Aaron Goh, London, United Kingdom 17:41-17:44
Audience participation and discussion
17:44-17:49 Haemodialysis access induced distal ischaemia; effectiveness of different types of revisional surgeries Hesham Aly Mohamed Sharaf Eldin, Mansoura, Egypt 17:49-17:52
Audience participation and discussion
CX Acute Stroke Selected Posters Presentations l Poster Gallery – 12:00-12:30
Acute Stroke Poster Presentations
Chairing: Daryll Baker, London, United Kingdom Moderators: Dominic Howard, Oxford, United Kingdom Nick Hopkins, Buffalo, United States
12:00-12:03 Two strategies in patients with severe bilateral carotid stenosis in cardiac surgery plan Fernando Belcastro, Buenos Aires, Argentina 12:03-12:05
Audience participation and discussion
12:05-12:08 Endovascular treatment of rare supra-aortic steal syndrome Nelson Camacho, Lisbon, Portugal 12:08-12:10
Audience participation and discussion
12:10-12:13 Evaluation of [18F]NaF uptake in symptomatic and asymptomatic carotid plaques and assessment of predictive vulnerable plaque patterns Marta Mari, Padua, Italy 12:13-12:15
44 2019
Audience participation and discussion
Vascular & Endovascular Challenges Update 12:15-12:18 External to internal carotid transposition to treat a symptomatic internal carotid aneurysm: An open surgical challenge on the endovascular era Nelson Camacho, Lisbon, Portugal 12:18-12:20
Audience participation and discussion
12:20-12:23 A case series about the changed antiplatelet protocol for carotid endarterectomy in a teaching hospital: More patients with complications? Martijn Marsman, Tilburg, Netherlands 12:23-12:25
Audience participation and discussion
12:25-12:28 Utility of ferumoxytol-enhanced three-dimensional magnetic resonance imaging of carotid atheroma – feasibility and temporal dependance study Ammara Usman, Cambridge, United Kingdom Audience participation and discussion
Tuesday 16 April 2019
12:28-12:30
CX Vascular Access Selected Posters Presentations Poster Gallery – 12:30-13:00
Vascular Access Poster Presentations
Chairing: James Gilbert, Oxford, United Kingdom Moderator: Robert Jones, Birmingham, United Kingdom
12:30-12:33 Use of incisional negative pressure wound therapy in preventing brachial-basilic arteriovenous fistula infection Muthaiah Arunaachalam, Singapore 12:33-12:35
Audience participation and discussion
12:35-12:38 Paclitaxel-coated balloon vs. plain angioplasty balloon for dysfunctional dialysis access: A prospective double-blinded randomised controlled trial – six-month result shows promising outcome in DCB group Skyi Yin Chun Pang, Hong Kong 12:38-12:40
Audience participation and discussion
12:40-12:43 A prospective randomised study comparing the use of an uncoated balloon for primary balloon angioplasty vs. hydrostatic dilatation to prepare the cephalic vein prior to creation of radiocephalic arteriovenous for dialysis Mohamed Rizk, Cairo, Egypt 12:43-12:45
Audience participation and discussion
12:45-12:48 Covered stent grafts are an important endovascular option for haemodialysis patients Tobias Steinke, Dusseldorf, Germany 12:48-12:50
Audience participation and discussion
12:50-12:53 Five years’ follow-up to of endovascular management of arteriovenous fistula complications Nelson Encarnacion Santana, Mexico City, Mexico 12:53-12:55 Audience participation and discussion 12:55-12:58 Arterial percutaneous angioplasty in haemodialysis access-induced distal ischaemia Ines Antunes, Porto, Portugal 12:58-13:00
Audience participation and discussion
2019
45
Vascular & Endovascular Challenges Update
CX Venous Selected Posters Presentations l Poster Gallery – 13:00-13:30
Venous Poster Presentations
Chairing: Alun Davies, London, United Kingdom Moderators: Chung Sim Lim, London, United Kingdom Mitchell Silver, Columbus, United States
Tuesday 16 April 2019
13:00-13:03 Adrenal vein sampling for primary aldosteronism: Long-term experience from a national referral centre Anita Dobrovolec, Velenje, Slovenia 13:03-13:05
Audience participation and discussion
13:05-13:08 Concomitant sclerotherapy during endovenous laser ablation Chia-Ying Lin, Taichung, Taiwan 13:08-13:10
Audience participation and discussion
13:10-13:13 Radiofrequency ablation of isolated calf perforator reflux; a simple and highly effective treatment for resistant venous ulcers Nalaka Gunawansa, Colombo, Sri Lanka 13:13-13:15
Audience participation and discussion
13:15-13:18 Aspirin is more effective than LMWH in prevention of rethrombosis in pregnancy Mosaad Soliman, Mansoura, Egypt 13:18-13:20
Audience participation and discussion
13:20-13:23 Residual reflux despite technical successful treatment of great saphenous vein incompetence using plethysmography and Duplex ultrasound: One-year data Oskar Nelzen, LinkĂśping, Sweden 13:23-13:25
Audience participation and discussion
13:25-13:28 New approach for hemorrhoidal disease by intravascular ultrasound and iliac venous system stenting Juan Guilleuma, Madrid, Spain 13:28-13:30
46 2019
Audience participation and discussion
Wednesday 17 April 2019
Wednesday
Plenary Programme & Additional Events
Wednesday Vascular & Endovascular Challenges Update Main Auditorium Aortic Podium 1st Session
52
Abdominal Aortic Challenges
53
CX Additional Events
CX Peripheral Techniques & Technologies (live & edited cases)
58
CX Venous Techniques & Technologies (edited cases) – Day 1
60
CX Venous Workshop – Day 1
60
Vascular Access Masterclass
62
iWounds 64 CX Vascular Malformations
65
CX Aortic Workshop – Day 2
67
CX Peripheral Workshop – Day 2
68
CX iWounds Workshop – Day 1
69
CX Global Stars and Rising Stars and Abstract sessions CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 70 CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1
73
CX Thoracic Aortic Abstract Presentations – Day 2
75
CX Peripheral Arterial Selected Posters Presentations – Day 2
76
An Introduction to Vascular Surgery – Day 1
78
Wednesday 17 April 2019
LINC@CX 58
Vascular & Endovascular Challenges Update
Wednesday 17 April 2019 AORTIC PODIUM 1ST SESSION
Upper Main Auditorium – 08:00-10:00 Chairing: Dittmar Böckler, President DGG, Heidelberg, Germany Moderator: Michel Makaroun, President SVS, Pittsburgh, United States
Abdominal Aortic
08:00-08:07 Podium 1st: ACT-guided heparinisation during non-cardiac arterial interventions: First results of the ACTION trial Arno Wiersema, Amsterdam, Netherlands 08:07-08:14 Podium 1st: Potential EVAS cardiovascular mortality benefit through active sac management when compared to EVAR Marc Schermerhorn, Boston, United States 08:14-08:21 Podium 1st: Exercise for abdominal aortic aneurysm patients: Early results from the AAA Get Fit Trial Charles McCollum, Manchester, United Kingdom Audience participation and discussion
08:21-08:31
08:31-08:38 Podium 1st: Early results and implication of internal iliac preservation on quality of life Fabio Verzini, Turin, Italy 08:38-08:45 Podium 1st: EVAR plus endoanchors in the treatment of short proximal necks is a viable option: Two-year clinical results Frank Arko, Charlotte, United States Audience participation, discussion and polling
08:45-08:55
08:55-09:02 Podium 1st: FRONTIER IV data with a large bore closure device Daniela Branzan, Leipzig, Germany
Wednesday 17 April 2019
09:02-09:09 Podium 1st: New developments in fusion imaging – artificial intelligence that deforms anatomy to maintain accuracy Bijan Modarai, London, United Kingdom 09:09-09:16 Podium 1st: The impact of polymer sealing on neck-related adverse events: Five-year results from ENCORE Hence Verhagen, Rotterdam, Netherlands Audience participation, discussion and polling
09:16-09:26
Thoracic Aortic
Chairing: Tilo Kölbel, Hamburg, Germany Moderator: Frank Vermassen, Ghent, Belgium 09:26-09:33 Podium 1st: Thirty-day clinical results of global cohort with new thoracic aortic endograft Fabio Verzini, Turin, Italy 09:33-09:40 Podium 1st: Use of inner branches in complex aneurysms – early results of the Iberian Study Jorge Fernández Noya, Santiago de Compostela, Spain 09:40-09:47 Podium 1st: T-branch registry: Results of an off-the-shelf endograft for thoracoabdominal aneurysms Martin Austermann, Münster, Germany 09:47-10:00
Audience participation and discussion
10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
Coffee Symposium: Expanding aortic treatment indications
Chairing: Robert Rhee, New York, United States
10:03-10:09 The importance of precise placement, optimal seal and conformability in treating challenging thoracic aortic cases Dittmar Böckler, President DGG, Heidelberg, Germany 10:09-10:15 An innovative solution to expand on-label aortic treatment Salma El Batti, Paris, France 10:15-10:21 A treatment algorithm for EVAR: Anatomical considerations, disease state and proper device selection Michel Reijnen, Arnhem, Netherlands 10:21-10:28
52 2019
Audience participation and discussion
Vascular & Endovascular Challenges Update
ABDOMINAL AORTIC CHALLENGES
Upper Main Auditorium – 10:30-18:00
Edited case
Chairing: Robert Rhee, New York, United States
10:30-11:00 Edited case: Expanding EVAR indications with a next-generation AAA endograft conforming to 90-degree neck angulations and seal in short 10mm necks Jorge Fernández Noya, Santiago de Compostela, Spain
D urability of endovascular aneurysm repair and the NICE guidelines
11:00-12:30 Chairing: Roger Greenhalgh, London, United
Kingdom
Moderators: Tilo Kölbel, Hamburg, Germany Maarit Venermo, Helsinki, Finland
Live case with virtual reality from Paris
Low-profile abdominal aortic stent graft (30min) Stéphan Haulon, Le Plessis Robinson, France NICE aortic guidelines – the latest (5min) Andrew Bradbury, Birmingham, United Kingdom EVAR – a standard of care (5min)
Tara Mastracci, London, United Kingdom
Sac reduction as primary indicator of success after EVAR (5min) Vincent Riambau, Barcelona, Spain
Audience participation, discussion and polling (10min)
Estimation of Long-Term Aortic Risk (LEAR) Model to improve EVAR surveillance (5min) Peter Holt, London, United Kingdom EVAR durability and endoleaks in 2019 the US perspective (5min) Ronald Dalman, Vice-President SVS, Stanford, United States Indications for reinterventions after EVAR (5min) Lars Lönn, Copenhagen, Denmark
Audience participation, discussion and polling (10min)
Optimising surveillance and reintervention strategy following elective EVAR Fiona Rohlffs, Hamburg, Germany (4min) Maarit Venermo, Helsinki, Finland (4min) Lois Kim, Cambridge, United Kingdom (10min) David Epstein, Granada, Spain (5min) Roger Greenhalgh, London, United Kingdom (1min)
Audience participation, discussion and polling (10min)
12:20-12:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Lunch symposium: Over 15 years of experience with a reliable, proven, trusted balloon-expandable covered stent Chairing: Jean-Paul de Vries, Groningen, Netherlands
12:30-12:40 Reliable performance and proven long-term results of a balloonexpandable covered stent Eric Verhoeven, Nuremberg, Germany 12:40-12:50 How does the leading balloon-expandable covered stent make a difference? Tilo Kölbel, Hamburg, Germany 12:50-13:00
Audience participation and discussion
2019
53
Wednesday 17 April 2019
NICE AAA draft guidelines: a viewpoint from Wales (5min) Louis Fligelstone, Swansea, United Kingdom
Vascular & Endovascular Challenges Update
G lobal recruitment into the Vascular Specialty This session is in support of the Vascular Society for Great Britain and Ireland’s efforts to tackle the slow recruitment into the Vascular Specialty.
Chairing: Trevor Cleveland, President BSIR, Sheffield, United Kingdom Moderator: Ronald Dalman, Vice-President SVS, Stanford, United States 13:30-13:35 The sooner the better – How can medical students be attracted to (vascular) surgery Hans-Henning Eckstein, Munich, Germany 13:35-13:40 Recruitment into the venous specialty in Wales Louis Fligelstone, Swansea, United Kingdom 13:40-13:45
Audience participation and discussion
13:45-13:50 The European perspective Henrik Sillesen, President ESVS, Copenhagen, Denmark 13:50-13:55 The US perspective Michel Makaroun, President SVS, Pittsburgh, United States 13:55-14:00
Audience participation and discussion
14:00-14:05 The Latin American perspective Alberto Muñoz, President WFVS, Bogotá, Colombia 14:05-14:10 The EBVS perspective
Armando Mansilha, President EBVS, Porto, Portugal
14:10-14:15 The UK perspective Sophie Renton, Secretary General VSGBI, London, United Kingdom 14:15-14:20
Audience participation, discussion and polling
Volume and outcomes
Chairing: Janet Powell, London, United Kingdom Moderator: Eric Verhoeven, Nuremberg, Germany
Wednesday 17 April 2019
14:20-14:27 Impact of the patient risk on the volume-outcome effect for AAA surgery Matthias Trenner, Munich, Germany 14:27-14:34 Volume outcome in AAA repair Marc Schermerhorn, Boston, United States 14:34-14:41 Systematic review of volume-outcome relationship in open and endo AAA repair Dittmar Böckler, President DGG, Heidelberg, Germany 14:41-14:48 Regionalisation of ruptured abdominal aortic aneurysm is safe and cost-effective Clement Darling III, Albany, United States 14:48-15:00
Audience participation, discussion and polling
Challenging aortic issues
Chairing: Frans Moll, CX Advisory Board, Utrecht, Netherlands Moderator: Ronald Dalman, Vice-President SVS, Stanford, United States 15:00-15:07 Innovation in 3D navigation using light instead of fluoroscopy: First-in-human trial and case review Joost van Herwaarden, Utrecht, Netherlands 15:07-15:14 Risk prediction model of in-hospital mortality following elective abdominal aortic aneurysm repair Thomas Schmitz-Rixen, Immediate Past President DGG, Frankfurt, Germany 15:14-15:21 Late secondary rupture after EVAR: 10 years' experience Vincenzo Brizzi, Bordeaux, France 15:21-15:30
Audience participation, discussion and polling
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
Tea symposium: From infrarenal AAA to complex TAAA repair: Endovascular outcomes and future hybrid innovations Chairing: David Murray, Altrincham, United Kingdom
15:32-15:40 Early results from a registry of endovascular repair of abdominal aortic aneurysm David Murray, Altrincham, United Kingdom 15:40-15:48 Fenestrated endovascular treatment of juxtarenal and suprarenal aortic aneurysms Randy Moore, Chestermere, Canada 15:48-15:56 Future innovations to address complex TAAA repair Sebastian Debus, Hamburg, Germany
54 2019
Vascular & Endovascular Challenges Update
Challenging aortic issues (continued)
Chairing: Tara Mastracci, London, United Kingdom Moderator: Tilo Kölbel, Hamburg, Germany 16:00-16:10
X Debate: Hostile necks should be treated with standard EVAR C devices For the motion: 16:05-16:10 Hence Verhagen, President Elect Dutch Vascular Society, Rotterdam, Netherlands Against the motion: 16:05-16:10 Giovanni Torsello, Münster, Germany
16:10-16:15 Audience participation, discussion and polling 16:15-16:22 On-label treatment of short and angulated necks with a new conformable EVAR device Robert Rhee, New York, United States 16:22-16:29 Gender disparities in the outcome of aortic repair Janet Powell, London, United Kingdom 16:29-16:36 Impact of female gender in the outcomes of severe aortoiliac obstructive disease Michele Antonello, Padua, Italy 16:36-16:43 Patients with familial abdominal aortic aneurysm have more complications and a higher 30-day mortality after EVAR Hence Verhagen, Rotterdam, Netherlands
16:50-17:05
Audience participation and discussion
17:05-17:15
X Debate: The vast majority of failed EVARs can be treated C endovascularly For the motion: 17:05-17:10 Jean-Pierre Becquemin, Champigny-sur-Marne, France Against the motion: 17:10-17:15 Michel Makaroun, Pittsburgh, United States
17:15-17:20
Audience participation, discussion and polling
17:20-17:27 Embolisation of renal artery aneurysms Joo-Young Chun, London, United Kingdom 17:27-17:34 Management of visceral artery aneurysms Lindsay Machan, Vancouver, Canada 17:34-17:41 Sac embolisation during EVAR – results from a prospective randomised study Dominique Fabre, Le Plessis Robinson, France 17:41-17:48 Endoleak diagnosis and clinical outcomes of embolisation with a liquid embolic agent Frank Arko, Charlotte, United States 17:48-18:00
Audience participation and discussion
2019
55
Wednesday 17 April 2019
16:43-16:50 The changing face of aortic disease – the implications of an ageing population Dominic Howard, Oxford, United Kingdom
Vascular & Endovascular Challenges Update
Monday 15 April 2019
Tuesday 16 April 2019
Wednesday 17 April 2019
Thursday 18 April 2019
56 2019
Wednesday 17 April 2019
Wednesday
Additional Events
2019
57
Vascular & Endovascular Challenges Update
LINC@CX l Lower Main Auditorium – 08:00-09:30
P ioneering techniques for BTK revascularisation in CLI Moderator: Giancarlo Biamino, Mercogliano, Italy Moderator: Dierk Scheinert, Leipzig, Germany Panel: Andrej Schmidt, Leipzig, Germany Panel: Marianne Brodmann, Graz, Austria Panel: Daniela Branzan, Leipzig, Germany Panel: Luis Mariano Palena, Abano Terme, Italy 08:00-08:10 Percutaneous deep venous arterialisation for end-stage CLI – current experience Daniela Branzan, Leipzig, Germany 08:10-08:25 Edited case: Percutaneous deep venous arterialisation Andrej Schmidt, Leipzig, Germany 08:25-08:35 Latest experience with a minimal metal solution technology for focal sealing of dissections Marianne Brodmann, Graz, Austria 08:35-08:45 Local drug delivery: Early results with sirolimus in BTK arteries Dierk Scheinert, Leipzig, Germany 08:45-09:00 Edited case: Local delivery of xylocaine for local anaesthesia during treatment of highly calcified arteries Andrej Schmidt, Leipzig, Germany 09:00-09:10 Real-world experience with the Lutonix DCB in BTK arteries Luis Mariano Palena, Abano Terme, Italy 09:10-09:25 Edited case: BTK recanalisation with DCB treatment and focal scaffolds Andrej Schmidt, Leipzig, Germany
Wednesday 17 April 2019
09:25-09:30
Discussion
CX Peripheral Techniques & Technologies (live & edited cases) l Lower Main Auditorium – 09:30-17:30
Peripheral live and edited cases
Chairing: Barry Katzen, Miami, United States Moderator: Gunnar Tepe, Rosenheim, Germany
09:30-10:00 Live case from Bad Krozingen: The rationale for using a swirling flow stent in combination with DCB Thomas Zeller, Bad Krozingen, Germany 10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
Coffee Symposium: The rationale and evidence for focal dissection repair Chairing: Marianne Brodmann, Graz, Austria
10:03-10:10 A minimal metal solution for dissection repair David Deaton, New York, United States 10:10-10:17 TOBA II trial one-year results
Marianne Brodmann, Graz, Austria
10:17-10:24 Optimised treatment strategies for post-PTA dissection Andrew Holden, Auckland, New Zealand 10:24-10:28
58 2019
Discussion
Vascular & Endovascular Challenges Update
Peripheral live and edited cases (continued)
Chairing: Barry Katzen, Miami, United States Moderator: Gunnar Tepe, Rosenheim, Germany
10:30-11:00 Edited case: Excimer laser atherectomy in retrograde, no stump SFA case Max Amor, Essey-les-Nancy, France 11:00-11:30 Edited case: IN.PACT drug-coated balloon in AV access Andrew Holden, Auckland, New Zealand 11:30-12:00 From simple to complex with an interwoven nitinol stent Lorenzo Patrone, London, United Kingdom 12:00-12:30 Edited case: Challenging diabetic foot management with DCB Luis Mariano Palena, Abano Terme, Italy 12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Peripheral live and edited cases (continued)
Chairing: Samuel Money, Phoenix, United States Moderator: Gunnar Tepe, Rosenheim, Germany
13:30-14:00 Live case with virtual reality from Bad Krozingen: Directional atherectomy plus drug-coated balloon in the common femoral artery Thomas Zeller, Bad Krozingen, Germany 14:00-14:30 Edited case: Using percutaneous deep vein arterialisation to treat end-stage critical limb ischaemia Andrew Holden, Auckland, New Zealand 14:30-15:00 Live case from Bad Krozingen: Orbital atherectomy in below-theknee lesions Thomas Zeller, Bad Krozingen, Germany
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
Tea symposium: Data update on a safe and efficient DCB in lower limb
15:33-15:40 Long-term safety data: Deep analysis of the LEVANT 2 studies, analysis of Lutonix Global Registry, IDE AV and IDE BTK Marianne Brodmann, Graz, Austria 15:40-15:47 Comparing SFA CTO to non-CTO subjects from the Levant 2, Levant 2 Continued Access, Global Registry and Long Lesion studies Patrick Geraghty, St Louis, United States 15:47-15:54 Comparison of overall LTX BTK IDE six-month outcomes to Global Registry Marianne Brodmann, Graz, Austria 15:54-15:58
Audience participation and discussion
Peripheral live and edited cases (continued)
Chairing: Enrico Ascher, Brooklyn, United States Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 16:00-16:30
ive case with virtual reality from Münster: New L balloon-expandable endoprosthesis in iliac lesions Arne Schwindt, Münster, Germany
16:30-17:00
ive case from Bad Krozingen: Below-the-knee intervention with a L pedal access device Thomas Zeller, Bad Krozingen, Germany
17:00-17:30 How to manage repeating TLR Luis Mariano Palena, Abano Terme, Italy
2019
59
Wednesday 17 April 2019
15:00-15:30 Edited case: Crossing occlusions for endovascular treatments remains a challenge – intraluminal approach Trevor Cleveland, President BSIR, Sheffield, United Kingdom
Vascular & Endovascular Challenges Update
CX Venous Techniques & Technologies (edited cases) – Day 1 l Venous City – 09:30-10:30 and 13:00-13:30
CX Venous edited cases – Morning Chairing: Stephen Black, London, United Kingdom Moderator: Steve Elias, Englewood, United States 09:30-09:50 Customised superficial therapy in advanced venous disease and ulceration Manj Gohel, Cambridge, United Kingdom 09:50-10:10 VenaSeal procedure
Kathleen Gibson, Bellevue, United States
10:10-10:30 Ultrasound valve diagnostics
Johann Christoph Ragg, Berlin, Germany
CX Venous edited cases – Afternoon
13:00-13:30 Interactive case vignettes
Manj Gohel, Cambridge, United Kingdom Stephen Black, London, United Kingdom
Wednesday 17 April 2019
CX Venous Workshop – Day 1 l Venous City – 09:30-15:30
Practical hands-on skills
Facilitators: T ristan Lane, London, United Kingdom Hayley Moore, London, United Kingdom
Cannulation
Roshan Bootun, London, United Kingdom
Device positioning Tumescent anaesthesia
Gregory Fulton, Wilton, Ireland Saroj Das, Uxbridge, United Kingdom Joseph Shalhoub, London, United Kingdom Matthew Metcalfe, Stevenage, United Kingdom
D iagnostic venous ultrasound
Diagnostic venous ultrasound
Mary Ellis, London, United Kingdom Hema Rao, London, United Kingdom
PIUR tomographic ultrasound
Gurdeep Jandu, Bolton, United Kingdom
Thermal ablation techniques
Endothermal treatment (laser and RF) of very large veins Denis Borsuk, Chelyabinsk, Russia Dmitrii Rosukhovskii, St Petersburg, Russia ClosureFast EVRF Steam ablation Thermal station
Ravinder Singh-Ranger, Swindon, United Kingdom Attila Szabo, Budapest, Hungary Rudi Devers, Antwerp, Belgium Huw Davies, Birmingham, United Kingdom Rene Milleret, Montpellier, France Egemen Okur, Ankara, Turkey
Microwave therapeutic system for varicose vein Brian Day, Nanjing, China Hands-on with the new SnakeBack technology Philippe Rochon, Loos, France
60 2019
Vascular & Endovascular Challenges Update
Non-thermal ablation techniques
Flebogrif method for saphenous reflux
Marek Ilzecki, Lublin, Poland Tomasz Zubilewicz, Lublin, Poland
VariClose adhesive
Kursat Bozkurt, Istanbul, Turkey
ClariVein mechanochemical ablation Leith Williams, Liverpool, United Kingdom VenaSeal closure device
Kathleen Gibson, Bellevue, United States
VenaBLOCK/VeinOFF/ICT
Talha Kocer, RD Global, Ankara, Turkey
Tributary treatment
Foam phlebectomy
Rochelle Wolfe, Minneapolis, United States
Aesthetic phlebology
Hand vein treatment options
Alexander Flor, Vienna, Austria
Surgical treatment of reticular veins
Sylvain Chastanet, Nice, France
Sclerotherapy
Foam sclerotherapy for tributaries Isaac Nyamekye, Worcester, United Kingdom Foam sclerotherapy for truncal reflux Gareth Bate, Solihull, United Kingdom
Plethysmography
Air plethysmography
Christopher Lattimer, London, United Kingdom Teresa Rola, London, United Kingdom
Strain gauge plethysmography
Oskar Nelzen, Linkรถping, Sweden
Lymphoedema
Surgical procedures for lymphoedema Harry Voesten, Drachten, Netherlands Aina Greig, London, United Kingdom Alexander Lamprou, Groningen, Netherlands Graded hydrotherapy for lymphoedema
Compression techniques
Novel compression device
Erica Menegatti, Ferrara, Italy
Johann Christoph Ragg, Berlin, Germany
Compression bandaging techniques Angela Williams, London, United Kingdom
Additional stations
Treatment of perforator veins
Steve Elias, Englewood, United States
Venous embryology and anatomy and virtual reality teaching Jean-Francois Uhl, Paris, France Cynoacrylate glue to treat erectile dysfunction Sriram Narayanan, Singapore Choosing between endovenous modalities Armando Mansilha, Porto, Portugal AVM treatment strategy Hydroptherapy for leg oedema Assessment of swollen legs
Walter Wohlgemuth, Regensburg, Germany Sergio Gianesini, Ferrara, Italy Sarah Thomis, Leuven, Belgium
Decision making for pelvic vein disease Neil Khilnani, New York, United States PPG for dynamic assessment of venous function Mohammed Aslam, London, United Kingdom
Saphenous sparing treatment
Sergio Gianesini, Ferrara, Italy
2019
61
Wednesday 17 April 2019
Sclerotherapy for reticular veins and telangiectasia Margaret Gardner, Ashtead, United Kingdom Claudine Hamel-Desnos, Caen, France Matthieu Josnin, La Roche-sur-Yon, France
Vascular & Endovascular Challenges Update
CX Vascular Access Masterclass Pillar Hall Learning Centre – 08:00-17:55
Maintaining and optimising dialysis access Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom
Introduction: Defining the problem
08:00-08:08 Why vascular access fails
Nicholas Inston, Birmingham, United Kingdom
08:08-08:16 Central venous catheters – are they bad or are they badly managed? Haimanot Wasse, President of ASDIN, Chicago, United States
Preventing failure
08:16-08:24 The use of AVGs instead of CVCs helps to reduce infection rates in patients needing haemodialysis Ioannis Loukopoulos, London, United Kingdom 08:24-08:32 Graft failure: How much is cannulation to blame? Shawn Gage, Raleigh, United States 08:32-08:37
Audience participation and discussion
Stenosis 08:37-08:45
Are all stenoses the same?
Kate Steiner, Stevenage, United Kingdom
08:45-08:53 Preventing stenosis – the RADAR technique Nirvana Sadaghianloo, Nice, France
Wednesday 17 April 2019
08:53-09:01 Preventing stenosis – pharmacological Paul Gibbs, Portsmouth, United Kingdom 09:01-09:09 Preventing stenosis – mechanical Nikolaos Karydis, London, United Kingdom 09:09-09:17 Can we prevent stenosis with AVGs? David Kingsmore, Glasgow, United Kingdom 09:17-09:25 Drug-coated balloons in preventing restenosis in vascular access – the Lutonix AV Global Registry Panagiotis Kitrou, Patras, Greece
AVF stenosis: Case-based presentations Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom
09:25-09:33
Surgical
Karl Illig, Tampa, United States
09:33-09:41 How to investigate and when to treat Haimanot Wasse, President of ASDIN, Chicago, United States 09:41-09:49
Endovascular
09:49-09:57
USS-guided angioplasty
09:57-10:03
Audience participation and discussion
10:03-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
Robert Jones, Birmingham, United Kingdom Olivier Pichot, Grenoble, France
Can we prevent thrombosis?
Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom
10:30-10:38
Role of surveillance
10:38-10:44
Audience participation and discussion
Colin Deane, London, United Kingdom
T reating thrombosis in VA: Case-based presentations
10:44-10:52
Surgery
Teun Wilmink, Birmingham, United Kingdom
10:52-11:00
Interventional radiology
Robert Jones, Birmingham, United Kingdom
11:00-11:08
When to treat, when to give up
11:08-11:14
Audience participation and discussion
62 2019
Jason Wilkins, London, United Kingdom
Vascular & Endovascular Challenges Update
Treating vascular thoracic outlet stenosis
11:14-11:22
Surgical approaches
11:22-11:30
Radiological
11:30-11:36
Audience participation and discussion
Karl Illig, Tampa, United States
Jeffrey Hull, North Chesterfield, United States
Central stenosis
11:36-11:44 Classifying central venous stenosis: When to treat? How to treat? John Aruny, New Haven, United States 11:44-11:50
Audience participation and discussion
Central occlusion
11:50-11:58
Recanalisation – inside/out
James Gilbert, Oxford, United Kingdom
11:58-12:06
Recanalisation – outside/in
Timothy Clark, Philadelphia, United States
12:06-12:21 The access algorithm: Can we define an algorithmic approach to vascular access preservation and maintenance? Nicholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom 12:21-12:30
Audience participation and discussion
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Lunch Symposium: New technologies and multi-disciplinary approach: How I treat failing access in my ESRD patients Chairing: Haimanot Wasse, President of ASDIN, Chicago, United States
Using WavelinQ for fistula creation
12:41-12:49
Patient with a stenosed fistula
12:49-12:57
Patient with a stenosed central vein Ounali Jaffer, London, United Kingdom
Panagiotis Kitrou, Patras, Greece Tobias Steinke, Dusseldorf, Germany
I nnovations in vascular access: Technologies, techniques, and trial updates Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom
Pre-access optimisation
13:30-13:38 Fist Assist: Coming to Europe for fistula vein enlargement Tej Singh, Los Altos Hills, United States 13:38-13:46 Choosing the right vessel prep device to optimise long-term results for dialysis access patients Matteo Tozzi, Varese, Italy 13:46-13:54 Reducing pain for dialysis access patients: How to improve comfort by using a new balloon technology Narayan Karunanithy, London, United Kingdom 13:54-14:09
Wednesday 17 April 2019
12:33-12:41
Audience participation and discussion
Pharmacology
14:09-14:17 Vonapanitase PATENCY-2 trial results in radiocephalic fistulae Paul Gibbs, Portsmouth, United Kingdom 14:17-14:25 AV fistula outcomes following intra-operative pharmacologic intervention using a perivascularly delivered sirolimus formulation Sriram Iyer, Cresskill, United States 14:25-14:37
Audience participation and discussion
Drug-coated balloons (trial updates)
14:37-14:41 Latest update on the Lutonix AV Global Registry & IDE Trial Panagiotis Kitrou, Patras, Greece 14:41-14:49 A study of haemodialysis arteriovenous fistulae stenosis treated with Aperto Qizhuang Jin, Beijing, China 14:49-14:57 IN.PACT AV: Baseline data from the full cohort Andrew Holden, Auckland, New Zealand
14:57-15:17 DCBs: Is the data on PVD applicable to vascular access? Moderator: Nicholas Inston, Birmingham, United Kingdom Panel: P anagiotis Kitrou, Patras, Greece Andrew Holden, Auckland, New Zealand Robert Jones, Birmingham, United Kingdom Kate Steiner, Stevenage, United Kingdom 15:17-15:30
Audience participation and discussion
2019
63
Vascular & Endovascular Challenges Update 15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
AV fistulae
Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom
16:00-16:08 Vascular access – using patient reporting to guide decision making Melanie Field, Birmingham, United Kingdom 16:08-16:16 AV fistulae – VasQ device 16:16-16:28
Nikolaos Karydis, London, United Kingdom
Audience participation and discussion
Grafts and stent grafts
16:28-16:36 Avoiding central venous catheters: How early cannulation grafts decrease complications and improve patient care Sapan Desai, Arlington Heights, United States 16:36-16:44 Thrombotic failures: Making the case for use of stent grafts to treat AV access circuits John Aruny, New Haven, United States 16:44-16:52 Viabahn stent for haemodialysis shunt: Efficacy, long segment recanalisation and prognostic factors for reintervention Matteo Barattini, La Spezia, Italy 16:52-17:00 Results of stent graft placement to treat cephalic arch stenosis in hemodialysis patients with dysfunctional brachiocephalic arteriovenous fistulae Robert Jones, Birmingham, United Kingdom
Wednesday 17 April 2019
17:00-17:12
Audience participation and discussion
17:12-17:32
X Debate: Interventional nephrology improves dialysis patient C outcomes For the motion: 17:12-17:22 Haimanot Wasse, Chicago, United States Against the motion: 17:22-17:32 Paul Gibbs, Portsmouth, United Kingdom
17:32-17:42
Audience participation, discussion and polling
17:42-17:50
Summary and close of day 1
London Room Learning Centre – 08:00-12:30 In collaboration with the American College of Wound Healing and Tissue Repair
Wound care challenges
Chairing: Una Adderley, England, United Kingdom Moderator: Michael Edmonds, London, United Kingdom 08:00-08:10 The problem of underperforming ankle-brachial index measurements Matjaz Span, Izola, Slovenia 08:10-08:20 Advances in diagnostic biomarkers and imaging for chronic wounds Tomas Serena, President of AAWC, Warren, United States 08:20-08:30 Surgical wound healing by secondary intention management pathway – from assessment to treatment Ian Chetter, Hull, United Kingdom 08:30-08:35
Audience participation and discussion
08:35-08:45 Designing services to optimise wound care: One-stop assessment clinics Naseer Ahmad, Manchester, United Kingdom 08:45-08:55 Imaging and adjudication of lower extremity wounds in arterial and venous clinical trials Raghu Kolluri, Columbus, United States 08:55-09:00
Audience participation and discussion
09:00-09:10 The importance of collaborative work between disciplines in wound care Keith Harding, Cardiff, United Kingdom
64 2019
Vascular & Endovascular Challenges Update 09:10-09:20 How to measure success in wound healing patients Dave Bosanquet, Cardiff, United Kingdom 09:20-09:30 Setting up research studies with wound patients Robert Hinchliffe, Bristol, United Kingdom 09:30-09:35
Audience participation and discussion
09:35-09:45 The role of podiatrists in wound healing
TBA
09:45-09:55 The approach to the ischaemic limb Susan Matthews, Oldham, United Kingdom 09:55-10:00
Audience participation and discussion
10:00-10:30 COFFEE AND VISIT TO HANDS-ON WORKSHOPS
Innovations in wound care
Chairing: Robert Hinchliffe, Bristol, United Kingdom Moderator: Keith Harding, Cardiff, United Kingdom 10:30-10:38
Optical detection of bacteria: Results from a multicentre clinical trial Tomas Serena, President of AAWC, Warren, United States
10:38-10:46 Wound outcomes, artificial intelligence and predictive analytics, necessary or nice to have William Ennis, Oak Lawn, United States 10:46-10:54
LeucoPatch Study
Magnus Löndahl, Lund, Sweden
10:54-11:02 MMP inhibitor dressing — Explorer study Michael Edmonds, London, United Kingdom 11:02-11:09
Audience participation and discussion
11:09-11:17 Nitric oxide release dressing
Michael Edmonds, London, United Kingdom
11:17-11:25 Multicentre clinical study of healing of diabetic foot ulcers using EpiFix Bill Tettelbach, Marietta, United States 11:25-11:45 Edited case: Epifix – a credible option for hard to heal venous ulcers Leanne Atkins, Wakefield, United Kingdom Audience participation and discussion
11:53-12:01 Therapeutic approaches for leg ulcers in patients with sickle cell disease John Lantis, New York, United States 12:01-12:09
Natrox Study
Paul Hayes, Cambridge, United Kingdom
12:09-12:17
TWO2 Study
Robert Frykberg, Phoenix, United States
12:17-12:25 Plastic surgery – alternatives to skin grafts Edmund Fitzgerald O’Conner, London, United Kingdom 12:25-12:30
Audience participation and discussion
CX Vascular Malformations London Room Learning Centre – 13:30-18:00
Introduction
Speaker: Fiona Rohlffs, Hamburg, Germany
Basic background
Chairing: Fiona Rohlffs, Hamburg, Germany Moderator: Ian McCafferty, Birmingham, United Kingdom 13:32-13:40 ISSVA classification and what recent genetics can teach us in the management of VMs Laurence Boon, Brussels, Belgium 13:40-13:48 The need for a classification system in the treatment of high-flow VMs Fiona Rohlffs, Hamburg, Germany 13:48-13:56 Finding a useful classification for the treatment of low-flow VMs Jocelyn Brookes, London, United Kingdom 13:56-14:00
Audience participation and discussion
Low-flow malformations
Chairing: Walter Wohlgemuth, Regensburg, Germany Moderator: Wayne Yakes, Englewood, United States 14:00-14:08 Management of low-flow VMs – technique and materials Walter Wohlgemuth, Regensburg, Germany
2019
65
Wednesday 17 April 2019
11:45-11:53
Vascular & Endovascular Challenges Update 14:08-14:16 Results and long follow-up of treatment of low-flow VMs Ian McCafferty, Birmingham, United Kingdom 14:16-14:24 Intraosseous vascular malformations
Fiona Rohlffs, Hamburg, Germany
14:24-14:32 Egyptian experience with capillary venous malformations Tarek Radwan, Cairo, Egypt 14:32-14:40 Managing dangerous communications in low flow malformations – how to avoid disasters! Robert Vogelzang, Chicago, United States 14:40-14:48 Extreme and complex venous lymphatic low-flow VM – results Wayne Yakes, Englewood, United States 14:48-14:56 Patient radiation exposure from embolo-sclerotherapy of vascular malformations Leeying Giet, London, United Kingdom
Debate
Chairing: Fiona Rohlffs, Hamburg, Germany Moderator: Laurence Boon, Brussels, Belgium 14:56-15:16
ow do we define “cure” in low-flow VMs? Can we actually “cure H them” – Yes/No? Yes: Wayne Yakes, Englewood, United States No: Ian McCafferty, Birmingham, United Kingdom Yes: Robert Vogelzang, Chicago, United States No: Walter Wohlgemuth, Regensburg, Germany
15:16-15:24 Rebuttal
Wayne Yakes, Englewood, United States Ian McCafferty, Birmingham, United Kingdom Robert Vogelzang, Chicago, United States Walter Wohlgemuth, Regensburg, Germany
15:24-15:30
Conclusion and vote
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
Wednesday 17 April 2019
High-flow malformations
Chairing: Robert Vogelzang, Chicago, United States Moderator: Wayne Yakes, Englewood, United States 16:00-16:08 Failure to control symptomatic AVMs using polymerising agents, salvaged by alcohol embolotherapy Robert Vogelzang, Chicago, United States 16:08-16:16 Outcomes and follow-up of treatment of AVMs Robert Vogelzang, Chicago, United States 16:16-16:24 Management of extreme AVMs
Wayne Yakes, Englewood, United States
Imaging
16:24-16:32 Imaging: pre- and post-treatment of VMs Alex Barnacle, London, United Kingdom
The complimentary role of surgery in VMs
Chairing: Robert Vogelzang, Chicago, United States Moderator: Wayne Yakes, Englewood, United States
16:32-16:40 Deciding whether surgery and rapamycine are friends or enemies Laurence Boon, Brussels, Belgium 16:40-16:48 Surgical management of arteriovenous malformation Laurence Boon, Brussels, Belgium
Case presentations: Help, I am stuck!!
Panel: All speakers 16:48-17:48 Optimisation of methods of diagnostics and treatment of arteriovenous forms of congenital vascular malformations of extremities
Summary and closing remarks
17:48-18:00
66 2019
Speaker: Wayne Yakes, Englewood, United States
Vascular & Endovascular Challenges Update
CX Aortic Workshop – Day 2 l CX Aortic Workshop – 10:00-16:00 he CX Aortic Workshop is open from 10:00 to 16:00 on Tuesday and T Wednesday. Participants are invited to visit the workshop as they please to explore the aortic technologies available. During break times there will be supervised learning with key opinion leaders.
Facilitators: A nna Prent, London, United Kingdom Kevin Mani, Uppsala, Sweden Mari Murumets, London, United Kingdom
Complex TAAA, BEVAR/FEVAR
10:00-10:30 Case discussion of complex TAAA repair with pre-case CT and tips & tricks for a good outcome Said Abisi, London, United Kingdom 12:30-13:30 Introduction into complex BEVAR/FEVAR cases CJJM Sikkink, Bemmel, Netherlands
Cydar EV
10:00-10:30 Fusion imaging simplified
Tom Carrell, Barrington, United Kingdom
12:30-13:30 Fusion imaging simplified
Tom Carrell, Barrington, United Kingdom
15:30-16:00 Fusion imaging simplified
Tom Carrell, Barrington, United Kingdom
Filler: Aneurysms and AVMs
Murat Katitas, Ankara, Turkey Egemen Okur, Ankara, Turkey
IVUS
10:00-10:30 Technical aspects of IVUS in EVAR and TEVAR procedures Fabrizio Fanelli, Florence, Italy 12:30-13:30 Technical aspects of IVUS in EVAR and TEVAR procedures Fabrizio Fanelli, Florence, Italy 15:30-16:00 Technical aspects of IVUS in EVAR and TEVAR procedures Fabrizio Fanelli, Florence, Italy
TEVAR
10:00-10:30 Terumo Aortic Thoracic Individualised Solutions (Thoracic Aorta) – RelayPLUS Ciro Ferrer, Rome, Italy 12:30-13:30 Terumo Aortic Thoracic Individualised Solutions (Thoracic Aorta) – RelayPLUS Ciro Ferrer, Rome, Italy 15:30-16:00 Terumo Aortic Thoracic Individualised Solutions (Thoracic Aorta) – RelayPLUS Ciro Ferrer, Rome, Italy
VesselNavigator Image Fusion
10:00-10:30 How VesselNavigator Image Fusion benefits complex EVAR procedures Karin Prins, Philips Healthcare, Best, Netherlands Alice Jay, Philips Healthcare, Leusden, Netherlands 12:30-13:30 How VesselNavigator Image Fusion benefits complex EVAR procedures Blandine Maurel, Nantes, France 15:30-16:00 How VesselNavigator Image Fusion benefits complex EVAR procedures Karin Prins, Philips Healthcare, Best, Netherlands Alice Jay, Philips Healthcare, Leusden, Netherlands
2019
67
Wednesday 17 April 2019
15:30-16:00 Introduction into complex BEVAR/FEVAR cases CJJM Sikkink, Bemmel, Netherlands
Vascular & Endovascular Challenges Update
CX Peripheral Workshop – Day 2 l CX Peripheral Workshop – 10:00-16:00 he CX Peripheral Workshop is open from 10:00 to 16:00 on Tuesday and T Wednesday. Participants are invited to visit the workshop as they please to explore the peripheral technologies available. During break times there will be supervised learning with key opinion leaders.
Facilitator: F rank Vermassen, Ghent, Belgium ABPI and early detection of PAD
Matjaz Span, Izola, Slovenia Jakob Susteric, United Kingdom
Carnelian, Pulsar-18 T3 and Fortress Georg Bach, Biotronik, Bulach, Switzerland Dabra Excimer Laser Atherectomy Max Amor, Essey-les-Nancy, France Charles Bailey, San Antonio, United States EndoWars Simulator Challenge BTK Lynne Teece, Cook Medical, Bournemouth, United Kingdom Indigo System and large volume coils Miriam Bondrop, Penumbra, Berlin, Germany Jaguar self-expanding nitinol stent Robert Michal Proczka, Warsaw, Poland Lutonix BTK DCB
Luis Mariano Palena, Abano Terme, Italy
Wednesday 17 April 2019
See clearly: The value of peripheral arterial IVUS in decision making Konstantinos Stavroulakis, Münster, Germany Stealth 360 Peripheral Orbital Atherectomy Konstantinos Donas, Münster, Germany Supera and peripheral guidewires Sanchita Pasi, Abbott Vascular, Diegem, Belgium Tack – how I optimise balloon angioplasty? Michael Lichtenberg, Arnsberg, Germany Temren atherectomy and Extender drug-coated balloon Berna Ozata, Ankara, Turkey Evren Ekingen, Batman, Turkey
The surgical Doppler probe
Jon Evans, Cardiff, United Kingdom
Treat optimally: The use of the Phoenix Atherectomy System Theodosios Bisdas, Athens, Greece How to simplify peripheral CTO recanalisation using fusion imaging with Vessel ASSIST Nicolas Louis, Créteil, France (10:00-10:30 and 15:30-16:00) Vessel preparation with JetStream Atherectomy system and Ranger DCB Tibor Balazs, Bratislava, Slovakia
68 2019
Vascular & Endovascular Challenges Update
X C Day 1
Workshop –
CX iWound Workshop – 13:30-15:30
Facilitators: W illiam Ennis, Oak Lawn, United States Keith Harding, Cardiff, United Kingdom John Lantis, New York, United States Thomas O’Donnell, Boston, United States
Complex lower limb compression
Curettage wound debridement
Julie Stanton, United Kingdom David Gray, United Kingdom
Automatic ankle-brachial index system Anita Roberts, Cardiff, United Kingdom Debridement and compression solutions
Epifix/ReGen
Matjaz Span, Izola, Slovenia Jakob Susteric, United Kingdom
Bill Tettelbach, Marietta, United States Leanne Atkins, United Kingdom
Optical detection of bacteria
3C Patch autologous therapy
Oxygen therapy
Tomas Serena, Warren, United States Magnus Löndahl, Lund, Sweden Robert Frykberg, Phoenix, United States
Diabetic foot and infra-red tomography Susan Matthews, Oldham, United Kingdom Michael Edmonds, London, United Kingdom Geko for leg ulcers
Mölnlycke Granulox
Dawn Smiles, Leeds, United Kingdom Andrew Costello, Milton Keynes, United Kingdom
Footwear technology for diabetic foot ulcer patients Sjef van Baal, Almelo, Netherlands
2019
69
Wednesday 17 April 2019
Vascular & Endovascular Challenges Update
CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 l Gallery Suite Learning Centre – 08:00-17:30
C X Peripheral Arterial Global Stars and Rising Stars Chairing: G ary Ansel, Columbus, United States Jonathan Beard, Sheffield, United Kingdom
08:00-08:05 Medicolegal issues including issues of content Jonathan Beard, Sheffield, United Kingdom 08:05-08:10
Audience participation and discussion
08:10-08:15 High platelet reactivity and low platelet response to aspirin in patients with peripheral artery disease treated with percutaneous transluminal angioplasty of the arteries of lower limbs Michal Juszynski, Warsaw, Poland 08:15-08:20
Audience participation and discussion
Wednesday 17 April 2019
08:20-08:25 Antiplatelet therapy in peripheral arterial disease: Umbrella review, meta-analysis and rationale for randomised trial after endovascular intervention Chris Twine, Bristol, United Kingdom 08:25-08:30
Audience participation and discussion
08:30-08:35 Indocyanine green fluorescence imaging in predicting wound healing after limb revascularisation Nicla Settembre, Vandoeuvre Les Nancy, France 08:35-08:40
Audience participation and discussion
08:40-08:45 Open repair vs. endovascular treatment of complex aortoiliac lesions in low-risk patients Francesco Squizzato, Castelfranco V (TV), Italy 08:45-08:50
Audience participation and discussion
08:50-08:55 Treatment of iliac occlusive disease with new balloon-expandable endoprosthesis Ahmed Koshty, Siegen, Germany 08:55-09:00
Audience participation and discussion
09:00-09:05 Advances in treatment for aortoiliac occlusive disease Frank Arko, Charlotte, United States 09:05-09:10
Audience participation and discussion
09:10-09:15 IN.PACT SFA Japan: Three-year clinical outcomes Osamu Iida, Amagasaki, Japan 09:15-09:20
Audience participation and discussion
09:20-09:25 How do drug-coated balloons perform over the long term? An analysis of drug-coated balloon clinical outcomes 3–5 years postprocedure Giovanni Torsello, Münster, Germany 09:25-09:30
Audience participation and discussion
09:30-09:35 Do IDE study results mirror the results we see in our real-world patients? Insights from the three-year IN.PACT global study outcomes Gary Ansel, Columbus, United States 09:35-09:40
Audience participation and discussion
09:40-09:45 The SUPER B randomised controlled trial shows Viabahn endografts perform as well as open surgical femoropopliteal bypass grafts for two years Michel Reijnen, Arnhem, Netherlands 09:45-09:50
Audience participation and discussion
09:50-09:55 Heparin-bonded covered stents vs. bare metal stents for complex femoropopliteal artery lesions Csaba Csobay Novák, Budapest, Hungary 09:55-10:00
Audience participation and discussion
10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
70 2019
Vascular & Endovascular Challenges Update
C X Peripheral Arterial Global Stars and Rising Stars Chairing: C liff Shearman, Southamptom, United Kingdom Asimakis Gkremoutis, London, United Kingdom
10:30-10:35 Comparative study of clinical outcomes of post-intervention good vs. poor pedal runoff in successful infrapopliteal angioplasty Roshan Rodney Sengodan, Coimbatore, India 10:35-10:40
Audience participation and discussion
10:40-10:45 Changes and significance of T helper 9 T lymphocytes and interleukin-9 expression in patients with atherosclerotic chronic lower limb ischaemia Hassan Lotfy, Alexandria, Egypt 10:45-10:50
Audience participation and discussion
10:50-10:55 Risk of major amputation following revascularisation for intermittent claudication – a population-based study Henrik Djerf, Gothenburg, Sweden 10:55-11:00
Audience participation and discussion
11:00-11:05 Tibial occlusive arterial disease in patients with chronic kidney disease; saving the limb and the kidney Nalaka Gunawansa, Colombo, Sri Lanka 11:05-11:10
Audience participation and discussion
11:10-11:15 Autologous platelet-rich plasma in diabetic foot ulcers, new preparation technique Osama Ismail, Sohag, Egypt 11:15-11:20
Audience participation and discussion
11:20-11:25 Cost-effectiveness of the treatments for critical limb ischaemia in the elderly population Chloé Peters, Breda, Netherlands Audience participation and discussion
11:30-11:35 International consensus document on the treatment of chronic, nonhealing wounds Leanne Atkins, Wakefield, United Kingdom 11:35-11:40
Audience participation and discussion
11:40-11:45 Simultaneous and staged reconstruction on brachiocephalic arteries Victor Kalinin, Nyagan, Russia 11:45-11:50
Audience participation and discussion
11:50-11:55 Impact of calcification modelling and planning circles with fusion imaging for the chronical total occlusion of iliac and femoropopliteal arteries Nicolas Louis, Créteil cx, France 11:55-12:00
Audience participation and discussion
12:00-12:05 Digital variance angiography as a risk reduction measure in peripheral endovascular interventions Peter Sotonyi, Budapest, Hungary 12:05-12:10
Audience participation and discussion
12:10-12:15 A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord allograft for the treatment of diabetic foot ulcers Bill Tettelbach, Marietta, United States 12:15-12:20
Audience participation and discussion
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Peripheral Arterial Abstract Presentations Chairing: T BA
13:30-13:35 The role of female gender on outcomes after stenting for aortoiliac arterial obstructive disease Francesco Squizzato, Castelfranco V. (TV), Italy 13:35-13:40
Audience participation and discussion
13:40-13:45 Biomechanical properties of subclavian and iliac arteries and implications for endovascular implant design Tina Cohnert, Graz, Austria 13:45-13:50
Audience participation and discussion
13:50-13:55 Atherectomy for peripheral arterial disease Bethany Wardle, Bristol, United Kingdom 13:55-14:00
Audience participation and discussion
14:00-14:05 Patient injuries in treatment of peripheral arterial disease in Finland: Review of national patient insurance charts Minna Laukkavirta, Piikkio, Finland 14:05-14:10
Audience participation and discussion
2019
71
Wednesday 17 April 2019
11:25-11:30
Vascular & Endovascular Challenges Update 14:10-14:15 Distal embolisation at the below the knee and common femoral artery. Endovascular management Claudia Martinez, Dublin, Ireland 14:15-14:20
Audience participation and discussion
14:20-14:25 Blunt brachial artery injury in pediatric patients Ahmed Naga, Alexandria, Egypt 14:25-14:30
Audience participation and discussion
14:30-14:35 Implementation of a multidisciplinary team approach in lower extremity amputation prevention programme for diabetic foot ulcers referral from primary healthcare to a tertiary centre vascular surgery clinic: Initial experience in an Asian population Irene Ng, Singapore 14:35-14:40
Audience participation and discussion
14:40-14:45 Peripheral endovascular training in live animals: Appropriate hands on training in UK Shadeh Parsapour, London, United Kingdom 14:45-14:50
Audience participation and discussion
14:50-14:55 In-stent restenosis: Can vessel preparation improve procedural outcomes? John Pigott, Toledo, United States 14:55-15:00
Audience participation and discussion
15:00-15:05 Safety and feasibility of vascular surgical procedures in nonagenarians in the era of increasing life expectancy and advanced ageing Zachary Chadwick, Staten Island, United States 15:05-15:10
Audience participation and discussion
15:10-15:15 Novel use of infrared thermal imaging to monitor graft patency of infrainguinal bypass in the immediate postoperative period and assess the angiosome concept Julien Al Shakarchi, Halesowen, United Kingdom 15:15-15:20
Audience participation and discussion
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
Wednesday 17 April 2019
Peripheral Arterial Abstract Presentations Chairing: P aul Moxey, London, United Kingdom Meryl Davis, London, United Kingdom
16:00-16:05 Safety and efficacy of covered endovascular reconstruction of the aortic bifurcation technique for complex aortoiliac occlusive disease: A single-centre experience Maria Antonella Ruffino, Turin, Italy 16:05-16:10
Audience participation and discussion
16:10-16:15 Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): Results from a multicentre randomised-controlled feasibility trial Graeme Ambler, United Kingdom 16:15-16:20
Audience participation and discussion
16:20-16:25 New scoring method to assess lesions involving the common femoral artery: Its relation to the stage of ischaemia and revascularisation method Alexey Baryshnikov, Chelyabinsk, Russia 16:25-16:30
Audience participation and discussion
16:30-16:35 Predictive failure’s results in the spectral analysis during the surveillance of infrainguinal revascularisation through vascular ultrasound Ricardo Bernardo da Silva, Londrina, Brazil 16:35-16:40
Audience participation and discussion
16:40-16:45 First-in-human results from a novel device providing real time, quantitative feedback on tissue perfusion during peripheral intervention Paul Hayes, Cambridge, United Kingdom 16:45-16:50
Audience participation and discussion
16:50-16:55 Distal hybrids for long chronic total occlusion of superficial femoral artery with severely compromised runoff Pavel Kuryanov, Saint Petersburg, Russian Federation 16:55-17:00
Audience participation and discussion
17:00-17:05 Single-centre experience of subintimal recanalisation of femoropopliteal TASC II C-D disease using primary stenting with mimetic stents Ornella Pancheri, Livonia, Italy 17:05-17:10
72 2019
Audience participation and discussion
Vascular & Endovascular Challenges Update 17:10-17:15 Chronic total occlusion of popliteal artery with vs. without distal landing zone: Comparison of PVI outcome Pavel Kuryanov, Saint Petersburg, Russian Federation 17:15-17:20
Audience participation and discussion
17:20-17:25 Safety and feasibility of intravascular lithotripsy for treatment of common femoral artery stenosis Marianne Brodmann, Graz, Austria 17:25-17:30
Audience participation and discussion
CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1 l Dark Room Learning Centre
C X Venous Global Stars and Rising Stars (08:00-09:30) Chairing: A lun Davies, London, United Kingdom Johann Christoph Ragg, Berlin, Germany
08:05-08:10
Audience participation and discussion
08:10-08:15 Mid-term clinical outcome of minimally invasive vein restoring treatment method for chronic venous insufficiency Serdar Gunaydin, Ankara, Turkey 08:15-08:20
Audience participation and discussion
08:20-08:25 Kissing stents for bilateral iliac venous outflow obstruction Wen Hsien Hsu, Taipei, Taiwan 08:25-08:30
Audience participation and discussion
08:30-08:35 Obturator hook sign as a marker of chronic iliofemoral venous outflow obstruction in computed tomography venography: Multicentric evaluation of incidence and clinical significance Andreia Coelho, Porto, Portugal 08:35-08:40
Audience participation and discussion
08:40-08:45 Acute improvement in haemodynamic parameters in patients treated with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension Ido Weinberg, Boston, United States 08:45-08:50
Audience participation and discussion
08:50-08:55 Early results of mechanochemical ablation, ClariVein, under automatic injection technique using a syringe pump Insoo Park, Seoul, South Korea 08:55-09:00
Audience participation and discussion
09:00-09:05 Podium 1st: UK Celect Platinum data Richard McWilliams, Liverpool, United Kingdom 09:05-09:10
Audience participation and discussion
09:10-09:15 Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting Robert Attaran, Guilford, United States 09:15-09:20
Audience participation and discussion
09:20-09:25 The use of cyanoacrylate in geriatric patients Kathleen Gibson, Bellevue, United States 09:25-09:30
Audience participation and discussion
2019
73
Wednesday 17 April 2019
08:00-08:05 Viscous biomatrix sclerofoam for large recurrent varices Johann Christoph Ragg, Berlin, Germany
Vascular & Endovascular Challenges Update
C X Venous Global Stars and Rising Stars (16:00-16:10) Chairing: M anj Gohel, Cambridge, United Kingdom Stephen Black, London, United Kingdom
16:00-16:05 Patient radiation exposure in endovascular unilateral iliofemoral stenting for chronic central venous outflow obstruction Saima Waseem, Bexleyheath, United Kingdom 16:05-16:10
Audience participation and discussion
C X Venous Abstract Presentations (16:10-18:10)
16:10-16:15 Neuroinflamation and venous lesion of the neck veins in patients with Ménière’s disease Aldo Bruno, Benevento, Italy 16:15-16:20
Audience participation and discussion
16:20-16:25 Single-centre experience with open and endovascular treatment of the Nutcracker syndrome Alessandro Grandi, Milan, Italy 16:25-16:30
Audience participation and discussion
16:30-16:35 Age-adjusted D-dimer cut-off level and idiopathic distal deep vein thrombosis in outpatients Xavier Jimenez-Guiu, Barcelona, Spain 16:35-16:40
Audience participation and discussion
16:40-16:45 Early results of a randomised clinical trial of mechanochemical ablation vs. cyanoacrylate adhesive for the treatment of varicose veins Amjad Belramman, London, United Kingdom 16:45-16:50
Audience participation and discussion
16:50-16:55 Randomised controlled trial of compression following endothermal ablation (COMETA trial) Roshan Bootun, London, United Kingdom 16:55-17:00
Audience participation and discussion
Wednesday 17 April 2019
17:00-17:05 Long-term vein diameter reduction by perivenous hyaluronan instead of tumescence for endovenous procedures Johann Christoph Ragg, Berlin, Germany 17:05-17:10
Audience participation and discussion
17:10-17:15 Endovascular management of arteriovenous malformation: Tips and tricks Hesham Aly Mohamed Sharaf Eldin, Mansoura, Egypt 17:15-17:20
Audience participation and discussion
17:20-17:25 Six stages of acquired vein valve insufficiency Johann Christoph Ragg, Berlin, Germany 17:25-17:30
Audience participation and discussion
17:30-17:35 Ascending venogram in patients with active ulcer to predict wound healing: A single centre experience Vimalin Samuel, Vellore, India 17:35-17:40
Audience participation and discussion
17:40-17:45 Mid-term improvement of persistent headaches in patients with multiple sclerosis undergoing balloon venoplasty of internal jugular veins Pierfrancesco Veroux, Catania, Italy 17:45-17:50
Audience participation and discussion
17:50-17:55 Treating veins with EVRF monopolar radiofrequency – six years’ follow-up results and modified pullback Attila Szabo, Budapest, Hungary 17:55-18:00
Audience participation and discussion
18:00-18:05 Endovascular management of iliac vein compression syndrome: A prospective case series of 61 patients Ahmed Allam, Benha, Egypt 18:05-18:10
74 2019
Audience participation and discussion
Vascular & Endovascular Challenges Update
CX Thoracic Aortic Abstract Presentations – Day 2 l Dark Room Learning Centre – 10:30-15:10
Thoracic Aortic Abstract Presentations Chairing: P aul Moxey, London, United Kingdom Emma Wilton, Beaconsfield, United Kingdom
10:30-10:35 The impact of bird-beak configuration after TEVAR on postoperative outcomes: A systematic review and meta-analysis Benedetta Spampinato, Milan, Italy 10:35-10:40
Audience participation and discussion
10:40-10:45 Management of patients with intramural haematoma or penetrating aortic ulcer of the thoracic aorta Salvatore Turiano, Nicolosi, Italy 10:45-10:50
Audience participation and discussion
10:50-10:55 The rationale of endovascular aortic graft repair for penetrating atherosclerotic ulcer of abdominal aorta Mingli Li, Taichung, Taiwan 10:55-11:00
Audience participation and discussion
11:00-11:05 Experimental evaluation of endovascular fenestration scissors in an ovine model of aortic dissection Iannis Ben Abdallah, Paris, France 11:05-11:10
Audience participation and discussion
11:15-11:20
Audience participation and discussion
11:20-11:25 A single-centre review of aortic remodelling in patients with type B aortic dissection in an Asian population Jun Han Tang, Singapore 11:25-11:30
Audience participation and discussion
11:30-11:35 Extend petticoat strategy in difussed (DeBakey III) aortic dissection type B. New strategy to stop aneurysmatic degeneration Piotr Gutowski, Bezrzecze, Poland 11:35-11:40
Audience participation and discussion
11:40-11:45 Influence of TEVAR on blood pressure in type B aortic dissection patients with refractory and non-refractory arterial hypertension Marco Virgilio Usai, Muenster, Germany 11:45-11:50
Audience participation and discussion
11:50-11:55 Aortic dilatation following type B aortic dissection: A single-centre retrospective study Kitty Hiu Fung Wong, Bristol, United Kingdom 11:55-12:00
Audience participation and discussion
12:00-12:05 Feasibility and early results of a new-generation Candy Plug II for endovascular false lumen occlusion with TEVAR in chronic aortic dissection Ahmed Eleshra, Hamburg, Germany 12:05-12:10
Audience participation and discussion
12:10-12:15 Intentional targeted false lumen occlusion after aortic dissection Konstantinos Spanos, Larissa, Greece 12:15-12:20
Audience participation and discussion
12:20-12:25 Renal stent complications following standard fenestrated endovascular aneurysm repair Kenneth Tran, California, United States 12:25-12:30
Audience participation and discussion
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Thoracic Aortic Abstract Presentations Chairing: R achel Bell, London, United Kingdom Jason Constantinou, London, United Kingdom
13:30-13:35 Relevance of SLPI as biomarker of acute kidney injury after open and endovascular complex aortic surgery Alexander Gombert, Aachen, Germany 13:35-13:40
Audience participation and discussion
2019
75
Wednesday 17 April 2019
11:10-11:15 Risk factors for distal stent graft-induced new entry in type B aortic dissections: A systematic review and meta-analysis Reuban D'Cruz, Singapore
Vascular & Endovascular Challenges Update 13:40-13:45 Endovascular repair of juxtarenal and thoracoabdominal aortic aneurysms with fenestrated/branched endografts after previous aortic repair Maciej Juszczak, Birmingham, United Kingdom 13:45-13:50
Audience participation and discussion
13:50-13:55 Modular branched stent grafts for redo and urgent interventions to treat pararenal and thoracoabdominal aortic aneurysm Reinhard Kopp, Zurich, Switzerland 13:55-14:00
Audience participation and discussion
14:00-14:05 Percutaneous F/BEVAR in patients with post-dissection thoracoabdominal aortic aneurysm: Midterm results of a prospective observational study Jost Philipp Schaefer, Kiel, Germany 14:05-14:10
Audience participation and discussion
14:10-14:15 A single-centre experience using automated intracranial pressurecontrolled cerebrospinal fluid external drainage Maria Pilar Lamarca Mendoza, Toledo, Spain 14:15-14:20
Audience participation and discussion
14:20-14:25 Evolution of graft design, proximal sealing zone and outcomes in early vs. late experience with fenestrated and branched stent grafts Pablo Marques de Marino, Nuremberg, Germany 14:25-14:30
Audience participation and discussion
14:30-14:35 Percutaneous F/BEVAR in patients with thoracoabdominal aortic aneurysm: Midterm results Jost Philipp Schaefer, Kiel, Germany 14:35-14:40
Audience participation and discussion
14:40-14:45 Kidney autotransplant for treatment of complex aneurysms of the renal artery Marco Franchin, Varese, Italy 14:45-14:50
Audience participation and discussion
Wednesday 17 April 2019
14:50-14:55 Impact of aortic stent graft oversizing on outcomes of the chimney endovascular technique based on a new analysis of the PERICLES registry Marco Virgilio Usai, Muenster, Germany 14:55-15:00
Audience participation and discussion
15:00-15:05 The impact of suprarenal aortic diameters on outcomes following endovascular aneurysm repair Arunesh Majumder, Dunedin, New Zealand 15:05-15:10
Audience participation and discussion
CX Peripheral Arterial Selected Posters Presentations l Poster Gallery – 12:30-13:30
Peripheral Poster Presentations
Chairing: Meryl Davis, London, United Kingdom Moderator: TBA
12:30-12:33 Catheter-directed thrombolysis with alteplase in treatment of acute arterial occlusion: Challenging cases Gulen Sezer Erkul, Kutahya, Turkey 12:33-12:35
Audience participation and discussion
12:35-12:38 Role of catheter-directed thrombolysis in patients with acute on chronic limb ischaemia due to Buerger's disease with no distal reformation Sridhar Murugesan, Chennai, India 12:38-12:40
Audience participation and discussion
12:40-12:43 Drug coated balloons in BTK disease – an Indian perspective Nadumaskeri Subraya Rahul, Bengaluru, India
76 2019
Vascular & Endovascular Challenges Update 12:43-12:45
Audience participation and discussion
12:45-12:48 Low velocity rotational artherectomy with variable tip radius for chronic total occlusions: Preliminary results of a CE-mark trial Joerg Tessarek, Lingen, Germany 12:48-12:50
Audience participation and discussion
12:50-12:53 Tibiopedal retrograde access for treatment of critical limb ischaemia – experience at a vascular centre in Mexico City Fausto Julian Virgen Barron, Mexico City, Mexico 12:53-12:55
Audience participation and discussion
12:55-12:58 The level of the qualitative and the quantitative malnutrition in patients suffering from the critical limb ischaemia Anna Danowsa, Warszawa, Poland 12:58-13:00
Audience participation and discussion
13:00-13:03 Infection risk in vascular surgery; a wound based classification Thomas Joseph, Preston, United Kingdom 13:03-13:05
Audience participation and discussion
13:05-13:08 Experience of hybrid revascularisations over a period of two years at the Centre for Cardiovascular Surgery in Vienna, Austria Karin Elisabeth Schimdt, Vienna, Austria 13:08-13:10
Audience participation and discussion
13:10-13:13 Endovascular patient with renal insufficiency – techniques that need minimum volume of iodine contrast Piotr Myrcha, Warsaw, Poland 13:13-13:15
Audience participation and discussion
13:15-13:18 Portable infrared thermography: A useful tool in the management of diabetic feet? Colette Cook, Wrexham, United Kingdom Audience participation and discussion
13:20-13:23 Modified surgical approach to treat thoracic outlet compression syndrome: The venetian blind technique Ali Navi, London, United Kingdom 13:23-13:25
Audience participation and discussion
13:25-13:28 Pediatric vascular trauma experience: 10-year review Ronza Salem, Jerusalem, Israel 13:28-13:30
Audience participation and discussion
2019
77
Wednesday 17 April 2019
13:18-13:20
Vascular & Endovascular Challenges Update
An Introduction to Vascular Surgery An Introduction to Vascular Surgery, Exhibition Hall – 09:00-15:30 The Vascular Society of Great Britain & Ireland, Rouleaux Club and CX Symposium are running An Introduction to Vascular Surgery for medical students, foundation doctors and core surgical trainees considering a career in Vascular Surgery.
Chairing: Sophie Renton, Secretary General VSGBI, London, United Kingdom
09:00-09:30
Registration
09:30-10:15
elcome and introduction to the Course W What is Vascular Surgery? A career in Vascular Surgery – a junior’s perspective
10:15-12:15 Groups A and B: Hands-on training in vascular anastomosis Groups C and D: Visit CX Venous Workshop (venous duplex and US-guided cannulation) Visit to workshops
Wednesday 17 April 2019
12:15-13:00
LUNCH
13:00-13:30
ow to prepare your portfolio H How to apply for training in Vascular Surgery Why choose Vascular Surgery?
13:30-15:30
roups C and D: Hands-on training in vascular anastomosis G Groups A and B: Visit CX Venous Workshop (venous duplex and US-guided cannulation) Visit to workshops
15.30
Feedback and close
78 2019
Plenary Programme & Additional Events
Thursday 18 April 2019
Thursday
Thursday Vascular & Endovascular Challenges Update Main Auditorium Thoracic Aortic Challenges
84
Peripheral Arterial Podium 1st
88
Peripheral Critical Ischaemia Challenges
87, 88
CX Additional Events CX Innovation Showcase
92
CX Venous Techniques & Technologies (edited cases) – Day 2
95
CX Venous Workshop – Day 2
95
CX Vascular Access Workshop
97
CX iWounds Workshop – Day 2
98
European Vascular Surgeons in Training – Prize Session
99
CX Global Stars and Rising Stars and Abstract sessions CX Peripheral Arterial Abstract Presentations – Day 3
100
CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 2
102
CX Abdominal Aortic Abstract Presentations – Day 2
104
CX Aortic Selected Posters Presentations
107
An Introduction to Vascular Surgery – Day 2
108
Thursday 18 April 2019
CX Vascular Access Techniques & Technologies (edited cases) 97
Vascular & Endovascular Challenges Update
Thursday 18 April 2019 THORACIC AORTIC CHALLENGES
Upper Main Auditorium – 08:00-18:00 S troke from Thoracic Endovascular Procedures
Chairing: Roger Greenhalgh, London, United Kingdom Moderator: Stéphan Haulon, Le Plessis Robinson, France Moderator: Tilo Kölbel, Hamburg, Germany Speaker: Fiona Rohlffs, Hamburg, Germany Moderator: Hugh Markus, Cambridge, United Kingdom Moderator: Heinz Jakob, Essen, Germany
Live case with virtual reality from Hamburg
New low-profile thoracic aortic stent graft (30min) Giuseppe Panuccio, Tilo Kölbel's group, Hamburg, Germany STEP Study Phase 2: DW MRI – a standard of care (7min) Fiona Rohlffs, Hamburg, Germany STEP 2 Hamburg experience (7min) Tilo Kölbel, Hamburg, Germany Discussant: Hugh Markus, Cambridge, United Kingdom STEP 2 Paris experience (7min) Stéphan Haulon, Le Plessis Robinson, France Discussant: Hugh Markus, Cambridge, United Kingdom Arch branch repair using single, double or triple branched devices (7min) Gustavo Oderich, Rochester, United States Discussant: Hugh Markus, Cambridge, United Kingdom Audience participation, discussion and polling (11min)
The value of TCD during thoracic endovascular procedures involving the ascending aorta and aortic arch (7min) Alan Lumsden, Houston, United States New updates on ascending aortic endografts (7min) Rodney White, Torrance, United States Discussant: Hugh Markus, Cambridge, United Kingdom Audience participation and discussion (7min) Prospective MRI findings of cerebral infarction after TEVAR for aortic arch pathologies (7min) Kenta Masada, Osaka, Japan Stroke prevention in thoracic endografting (7min) Richard Gibbs, London, United Kingdom Incidence and prediction of neurological complications after TEVAR: Global Registry data (7min) Michele Piazza, Padua, Italy
Thursday 18 April 2019
Audience participation and discussion (7min)
10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
Coffee Symposium: A roundtable on global trends and outcomes in aortic arch repair Chairing: Robin Heijmen, Nieuwegein, Netherlands
10:03-10:12 Italian and Dutch national registry results with double-branch devices for aortic arch disease Ciro Ferrer, Rome, Italy 10:12-10:21 Complex arch repair: When and why to treat with hybrid or endovascular Robin Heijmen, Nieuwegein, Netherlands 10:21-10:30 The right ratio of open to endovascular repair of complex arch aneurysms and type A aortic dissections Joost van Herwaarden, Utrecht, Netherlands
Live case from Bad Krozingen
Chairing: Robin Heijmen, Nieuwegein, Netherlands
10:30-11:00 Live case: Distal TEVAR extension after total aortic arch replacement in a complex anatomy Martin Czerny, Bad Krozingen, Germany Bartosz Rylski, Bad Krozingen, Germany
84 2019
Vascular & Endovascular Challenges Update
Chosen access for aortic reconstruction
Chairing: Tilo Kölbel, Hamburg, Germany Moderator: Michel Makaroun, President SVS, Pittsburgh, United States 11:00-11:07 Transfemoral access in complex aortic repair Stéphan Haulon, Le Plessis Robinson, France 11:07-11:14 Comparison of fascial closure technique to cut-down in TEVAR Nikolaos Tsilimparis, Munich, Germany 11:14-11:21 Percutaneous subclavian access 11:21-11:30
Luca Bertoglio, Milan, Italy
Audience participation, discussion and polling
Thoracoabdominal aortic aneurysms
11:30-11:37 Innovative modalities for organ protection during thoracoabdominal aortic aneurysm open repair Roberto Chiesa, Milan, Italy 11:37-11:44 Anatomical suitability and challenges with an off-the-shelf branched endoprosthesis – analysis of CT scans of 500 patients Luca Bertoglio, Milan, Italy 11:44-11:51 Clinical outcomes with a balloon-expandable covered stent in BEVAR cases – multicentre experience Eric Verhoeven, Nuremberg, Germany 11:51-12:00
Audience participation and discussion
Radiation
Chairing: Dittmar Böckler, President DGG, Heidelberg, Germany Moderator: Andrew Holden, Auckland, New Zealand 12:00-12:07
Radiation dose to the eye
Lindsay Machan, Vancouver, Canada
12:07-12:14 IVUS in aortic repair to reduce radiation and contrast use Joerg Tessarek, Lingen, Germany 12:14-12:21 Occupational radiation exposure and risk of cancer Bijan Modarai, London, United Kingdom 12:21-12:30
Audience participation, discussion and polling
12:30-13:30 LUNCH AND VISIT TO HANDS-ON WORKSHOP
Lunch Symposium: The freedom to do more with a new conformable and low-profile thoracic endograft Chairing: Colin Bicknell, London, United Kingdom Moderator: Dittmar Böckler, President DGG, Heidelberg, Germany
12:33-12:40 Key findings and insights from the global clinical trial with new stent graft Fabio Verzini, Turin, Italy 12:40-12:47 How to expand patient applicability with a new-generation thoracic endograft Paul Hayes, Cambridge, United Kingdom
12:54-12:57
Audience participation and discussion
Descending aorta
Chairing: Michel Makaroun, President SVS, Pittsburg, United States Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 13:30-13:35 Results of IFU versus non-IFU TEVAR procedures Dittmar Böckler, President DGG, Heidelberg, Germany 13:35-13:40 TEVAR outcome in real-life practice
Kevin Mani, Uppsala, Sweden
13:40-13:45 New TEVAR delivery system allows staged, predictable endograft deployment and in situ angulation control, while avoiding windsocking and bird-beaking Giovanni Torsello, Münster, Germany 13:45-13:50 Five-year experience with a low-profile thoracic endograft Eric Verhoeven, Nuremberg, Germany 13:50-14:00
Audience participation, discussion and polling
Dissections
Chairing: Gustavo Oderich, Rochester, United States Moderator: Martin Malina, London, United Kingdom 14:00-14:07 Outcomes of branched arch repair for post type A dissections Tilo Kölbel, Hamburg, Germany
2019
85
Thursday 18 April 2019
12:47-12:54 Case example of the clinical value of this new thoracic endograft Frank Arko, Charlotte, United States
Vascular & Endovascular Challenges Update 14:07-14:14 Management and results of acute dissection with arch tear Santi Trimarchi, San Donato Milanese, Italy 14:14-14:21 Limited and extended repair for acute type A dissection Heinz Jakob, Essen, Germany 14:21-14:30
Audience participation and discussion
14:30-14:37 TEVAR plus bare metal stent vs. TEVAR alone Stéphan Haulon, Le Plessis Robinson, France 14:37-14:44 Evidence for and risks of endovascular treatment of asymptomatic acute type B aortic dissection Rachel Clough, London, United Kingdom 14:44-14:51 Changing paradigms for treating acute type B aortic dissection William Jordan, Atlanta, United States 14:51-15:00
Audience participation and discussion
15:00-15:07 Evidence and compliance for best medical therapy for chronic type B aortic dissection Colin Bicknell, London, United Kingdom 15:07-15:14 Decision-making process and influencing factors for the treatment of uncomplicated type B aortic dissections Dittmar Böckler, President DGG, Heidelberg, Germany 15:14-15:21 Establishment and validation of 301 classification scheme for type B aortic dissection: Insights from ROBUST in China Wei Guo, Beijing, China 15:21-15:30
Audience participation and discussion
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
Spinal cord ischaemia
Chairing: Tara Mastracci, London, United Kingdom Moderator: Tilo Kölbel, Hamburg, Germany 16:00-16:08 Multistaged endovascular approach to thoracoabdominal pathology with fenestrated and branched endografts Luca Bertoglio, Milan, Italy 16:08-16:16 The influence of hyperglycaemia on spinal cord ischaemia Jade Hiramoto, San Francisco, United States 16:16-16:24 Neuromonitoring to guide temporary sac perfusion during endovascular TAAA repair Gustavo Oderich, Rochester, United States 16:24-16:32 Perioperative cerebrospinal fluid drainage for complex endovascular aneurysm repair cases Bijan Modarai, London, United Kingdom 16:32-16:42
Audience participation, discussion and polling
J uxtarenal, complex EVAR and challenging neck
16:42-16:50 Hospital workflow surrounding fenestrated and branch aortic repair: Nursing, anaesthesia, and critical care Gustavo Oderich, Rochester, United States
Thursday 18 April 2019
16:50-16:58 Results from the French multicentric study on chimney repair of pararenal aneurysms Raphael Coscas, Boulogne-Billancourt, France 16:58-17:06
Audience participation and discussion
17:06-17:16
CX Debate: FEVAR/BEVAR is preferred for juxtarenal reconstruction For the motion: 17:06-17:11 Gustavo Oderich, Rochester, United States Against the motion: 17:11-17:16 Konstantinos Donas, Munster, Germany
17:16-17:21
Audience participation, discussion and polling
17:21-17:29 Experience with new balloon-expandable endoprosthesis in FEVAR and BEVAR Giovanni Torsello, Münster, Germany 17:29-17:37 Fenestrated EVAR device cuff in the treatment of failed EVAR devices Michel Reijnen, Arnhem, Netherlands 17:37-17:45
Audience participation and discussion
17:45-17:55
CX Debate: Created-neck FEVAR beats chEVAR every time For the motion: 17:38-17:43 Eric Verhoeven, Nuremberg, Germany Against the motion: 17:43-17:48 Ralf Kolvenbach, Düsseldorf, Germany
17:55-18:00
Audience participation, discussion and polling
86 2019
Vascular & Endovascular Challenges Update
PERIPHERAL CRITICAL ISCHAEMIA CHALLENGES – PART 1
Lower Main Auditorium – 08:00-10:00 Interdisciplinary Leg Initiative
Chairing: Cliff Shearman, Southampton, United Kingdom Moderator: Robert Hinchliffe, Bristol, United Kingdom 08:00-08:08 Approaching critical limb ischemia from a population health point of view Barry Katzen, Miami, United States 08:08-08:16 The geriatric patient in the age of modern endovascular treatment options Marianne Brodmann, Graz, Austria 08:16-08:24 Management of critical limb ischaemia of the lower limbs: Guidelines according to international scientific experience Athanasios Giannoukas, Larissa, Greece 08:24-08:36 Audience participation, discussion and polling 08:36-08:44 Pilot assessment of the angiosome concept by intraoperative fluorescence angiography after tibial bypass surgery Ulrich Rother, Erlangen, Germany 08:44-08:52 GLobal Anatomical Staging System: Draft guidelines for chronic limb threatening ischaemia Michael Conte, San Francisco, United States 08:52-09:00 Combination approach in below-the-knee lesions Michael Lichtenberg, Arnsberg, Germany 09:00-09:12
Audience participation and discussion
09:12-09:20 How to reduce dissections below-the-knee: Techniques & devices Jos van den Berg, Lugano, Switzerland 09:20-09:28
TOBA II BTK update
09:28-09:36
Audience participation and discussion
Michael Lichtenberg, Arnsberg, Germany
09:36-09:44 Extended limb salvage operations for threatened ischaemic limbs Enrico Ascher, Brooklyn, United States 09:44-09:52 Determinants of long-term outcomes and costs in the management of critical limb ischaemia: A population-based cohort study Barry Katzen, Miami, United States 09:52-10:00
Audience participation and discussion
10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOPS
Coffee Symposium: Below the knee symposium
Chairing: Marc Bosiers, Dendermonde, Belgium
Amine Chouiter, Neuchatel, Switzerland
10:15-10:28 Multidisciplinary foot clinics, a pathway to limb salvage? Paul Moxey, London, United Kingdom
2019
87
Thursday 18 April 2019
10:03-10:13 The pedal access approach
Vascular & Endovascular Challenges Update
ERIPHERAL ARTERIAL P PODIUM 1ST SESSION Lower Main Auditorium –
10:30-12:30
Chairing: Gunnar Tepe, Rosenheim, Germany Moderator: Thomas Zeller, Bad Krozingen, Germany 10:30-10:38 Podium 1st: First results of the MUST trial and further updates on the use of microbubbles in thrombolysis Kak Khee Yeung, Amsterdam, Netherlands 10:38-10:46 Podium 1st: Angiography alone in the lower limb: First results comparing IVUS and angiography in the leg Konstantinos Stavroulakis, Münster, Germany 10:46-10:54 Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry Andrew Holden, Auckland, New Zealand 10:54-11:06
Audience participation and discussion
11:06-11:14 Podium 1st: The case for treating aortoiliac occlusive disease with a covered device: Early experience with new balloon-expandable endoprosthesis Michele Antonello, Padua, Italy 11:14-11:22 Podium 1st: DCB IDE below-the-knee six-month results with in-depth look at Rutherford 5 patients Patrick Geraghty, St Louis, United States 11:22-11:30 Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms Andrew Holden, Auckland, New Zealand 11:30-11:42
Audience participation and discussion
11:42-11:50 Podium 1st: Two-year data from the MIMICS-2 study Timothy Sullivan, Minneapolis, United States 11:50-11:58 Podium 1st: ZILVERPASS study – final 12-month and preliminary 24-month results Marc Bosiers, Dendermonde, Belgium 11:58-12:06
Audience participation and discussion
12:06-12:14 Podium 1st: Multivariate analysis of 2,400 patients using a drugeluting stent – patency data Michael Dake, Tucson, United States 12:14-12:22 Podium 1st: REPLACE study – heparin-bonded ePTFE graft vs. ePTFE graft Yann Goueffic, Nantes, France 12:22-12:30
Audience participation and discussion
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Thursday 18 April 2019
ERIPHERAL CRITICAL ISCHAEMIA P CHALLENGES – PART 2 Lower Main Auditorium – 13:30-18:00 M edical therapy and drug coating
Chairing: Michael Edmonds, London, United Kingdom Moderator: Keith Harding, Cardiff, United Kingdom 13:30-13:38 Survival after lower extremity revascularisation for critical limb ischaemia is better with high dose statins Marc Schermerhorn, Boston, United States 13:38-13:46 COMPASS and VOYAGER PAD are trying to answer our open questions for secondary prophylactic treatment in patients with peripheral arterial disease Marianne Brodmann, Graz, Austria 13:46-13:54 Will drug-coated balloons and stents significantly impact our treatment of critical limb ischaemia? Peter Schneider, Honolulu, United States 13:54-14:02
88 2019
Audience participation, discussion and polling
Vascular & Endovascular Challenges Update
14:02-14:10 Percutaneous transluminal lower limb angioplasty for ischaemic foot ulcers: Five-year experience Mohamed Cassim, Nawala, Sri Lanka 14:10-14:18 Patients awareness of peripheral arterial disease and the use of ankle-brachial Index measurement Jakob Sustersic, United Kingdom 14:18-14:26
Audience participation and discussion
14:26-14:34 Adequate wound care after successful endovascular treatment, a keystone for success Marianne Brodmann, Graz, Austria 14:34-14:42 Rutherford 6 wounds: The utility of multivessel revascularisation and inflow strategies Peter Schneider, Honolulu, United States 14:42-14:54
Audience participation and discussion
14:54-15:02 Footwear technology for diabetic foot ulcer patients Sjef van Baal, Almelo, Netherlands 15:02-15:10 Impact of hyperbaric oxygen on more advanced, Wagner grade 3 and 4 diabetic foot ulcers – matching therapy to specific wound conditions William Ennis, Oak Lawn, United States 15:10-15:18 Diabetes medications: Impact on inflammation and wound healing John Lantis, New York, United States 15:18-15:30
Audience participation and discussion
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
M ini-symposium on arterial disease below the ankle
Chairing: Gunnar Tepe, Rosenheim, Germany Moderator: Trevor Cleveland, President BSIR, Sheffield, United Kingdom
16:00-16:08 Indications and techniques for below-the-ankle angioplasty Roberto Ferraresi, Milan, Italy 16:08-16:16 The place for distal bypasses in below-the-ankle treatment Eric Ducasse, Bordeaux, France 16:16-16:24
Audience participation and discussion
M ini-symposium on the ischaemic renal foot and Charcot foot
16:24-16:32 Diabetic patients in renal failure high rates of morbidity and mortality Michael Edmonds, London, United Kingdom 16:32-16:40 Pathophysiology of lower limb and dialysis Robert Hinchliffe, Bristol, United Kingdom Audience participation and discussion
16:48-16:56 Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus Francis Game, Derby, United Kingdom 16:56-17:04 Chronic kidney disease as a predictor of outcome after revascularisation of the ulcerated diabetic foot Maarit Venermo, Helsinki, Finland 17:04-17:12 Understanding the ischaemic Charcot foot patient Michael Edmonds, London, United Kingdom 17:12-17:24
Audience participation and discussion
17:24-17:32 Surgical reconstruction of Charcot foot Venu Kavarthapu, London, United Kingdom 17:32-17:40 Bypass outcomes where no autologous vein available Robert Hinchliffe, Bristol, United Kingdom 17:40-17:48 Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): Results from a multicentre randomised controlled feasibility trial Graeme Ambler, Bristol, United Kingdom 17:48-18:00
Audience participation and discussion
2019
89
Thursday 18 April 2019
16:40-16:48
Vascular & Endovascular Challenges Update
Monday 15 April 2019
Tuesday 16 April 2019
Wednesday 17 April 2019
Thursday 18 April 2019
90 2019
Thursday 18 April 2019
Vascular & Endovascular Challenges Update
Thursday
Additional Events
2019
91
Vascular & Endovascular Challenges Update
CX Innovation Showcase llll Thursday 18 April – Pillar Hall Learning Centre
Innovation challenges
Chairing: Frans Moll, CX Advisory Board, Utrecht, Netherlands Moderator: Stephen Greenhalgh, London, United Kingdom 07:30-07:40 Confessions of a mad inventor
Lindsay Machan, Vancouver, Canada
07:40-07:50 Challenging the genius theory of innovation and discovery Frank Criado, Baltimore, United States 07:50-08:00 Supporting the physician inventor from prototype to commercialisation Derek Young, Dublin, Ireland 08:00-08:10 How do you exit your device well in the 21st century? Chas Taylor, Horsham, United Kingdom 08:10-08:20
Audience participation and discussion
Artificial intelligence
08:20-08:30 How artificial intelligence will change how we practise medicine Lindsay Machan, Vancouver, Canada 08:30-08:40 Artificial intelligence in vascular surgery Tom Carrell, Barrington, United Kingdom 08:40-08:50
Audience participation and discussion
Robotics
08:50-09:00 Endovascular robotics
Willem Wisselink, Amsterdam, Netherlands
09:00-09:10 Corindus Vascular Robotics CorPath GRX system Matt Lemay, New Mexico, United States 09:10-09:20
Audience participation and discussion
Peripheral innovation
Chairing: Stephen Greenhalgh, London, United Kingdom Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 09:20-09:30 Comparison of paclitaxel and sirolimus coated balloons Aloke Finn, Gaithersburg, United States 09:30-09:40 New Xtreme Touch sirolimus-eluting drug-coated balloon Edward Choke, Singapore
Thursday 18 April 2019
09:40-09:50 Temporary drug-coated Spur system to address the challenges of DCB technology Andrew Holden, Auckland, New Zealand 09:50-10:00
Audience participation and discussion
10:00-10:30
COFFEE AND VISIT TO HANDS-ON WORKSHOP
C3@CX
Chairing: Rajesh Dave, Memphis, United States Moderator: Michael Lichtenberg, Arnsberg, Germany
10:03-10:11 Lifting the curtain on aortoiliac CTO recanalisation techniques and choice of stent Rajesh Dave, Memphis, United States 10:11-10:19 Controversies in venous intervention Nilesh Balar, New York, United States 10:19-10:27 New wireless laser ablative technology: Mechanism and initial experience Charles Bailey, San Antonio, United States
Peripheral innovation (continued)
10:30-10:40 Initial experience with the MicroStent in below-the-knee arteries for critical limb ischaemia Robert Beasley, Miami, United States 10:40-10:50 B-Laser atherectomy system to treat peripheral artery disease Yoel Zabar, Rehovot, Israel
92 2019
Vascular & Endovascular Challenges Update 10:50-11:00 Smart stent to monitor blood flow and detect restenosis York Hsiang, Vancouver, Canada 11:00-11:10 CaveoVasc protection system to reduce bleeding complications during catheter directed thrombolysis – results from the first-in-man study Elias Noory, Bad Krozingen, Germany 11:10-11:20 Use of occlusion perfusion catheter in peripheral arterial disease (Copper BTK) Rex Teeslink, Augusta, United States 11:20-11:30 TAPAS catheter delivered paclitaxel Ronald Solar, San Diego, United States 11:30-11:40
Audience participation and discussion
Aortic innovation
Chairing: Bob Mitchell, Irvine, United States Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 11:40-11:50 Off-the-shelf Nexus endograft for arch aneurysms Mario Lachat, Hinteregg, Switzerland 11:50-12:00 Expandable modular branched graft thoracoabdominal and iliac branch Bao Bui, Sherbrooke, Canada 12:00-12:10 Total endovascular repair of zone 0 landing aortic arch aneurysms with Najuta Fenestrated Thoracic Stent Graft: A retrospective analysis of 492 cases Dai Yamanouchi, Madison, United States 12:10-12:20 Predicting AAA growth/rupture: Can 3D ultrasound help with AAA management and repair decisions Steven Rogers, Manchester, United Kingdom 12:20-12:30
Audience participation and discussion
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOP
L unch Symposium: Ramifications of the MDR from different perspectives
Chairing: Bob Mitchell, Irvine, United States Moderator: Stephen Greenhalgh, London, United Kingdom 12:30-12:40 The regulatory perspective
Daniel Shoukier, Zurich, Switzerland
12:40-12:50 The payer, provider and patient perspective Peter Gaines, Sheffield, United Kingdom 12:50-13:00
The large company perspective
Aine Smalley, United States
13:00-13:10
The small company perspective
Gido Karges, Wangs, Switzerland
13:10-13:20
The innovation perspective
13:20-13:30
Audience participation and discussion
Aortic innovation (continued)
13:30-13:40 In-house 3D printing for complex aortic endovascular procedures Jan Heyligers, Tilburg, Netherlands 13:40-13:50 Fluid dynamics in fenestrated arch endografts Santi Trimarchi, San Donato Milanese, Italy 13:50-14:00 Long term results of new lock stent device for vessel banding in a swine mode Carlo Setacci, Siena, Italy 14:00-14:10
Nellix: Failure or phoenix
14:10-14:20
Audience participation and discussion
Matt Thompson, Irvine, United States
Venous innovation
Chairing: Stephen Greenhalgh, London, United Kingdom Moderator: Bob Mitchell, Irvine, United States 14:20-14:30 Technique & preliminary results of HIFU for varicose veins Alfred Obermayer, Vienna, Austria
Vascular access innovation
14:30-14:40 New Pristine Access Technologies dialysis access catheter Michael Tal, Tel Aviv, Israel 14:40-14:50
Audience participation and discussion
2019
93
Thursday 18 April 2019
Jeffrey Jump, Mont-sur-Rolle, Switzerland
Vascular & Endovascular Challenges Update
Acute stroke innovation
14:50-15:00 Endovascular magneto-motive nano-robotic stroke therapy Sean Morris, United States Michael Tones, United States 15:00-15:10 Neuroprotection by endovascular selective cerebral hypothermia Ronald Solar, San Diego, United States
Wound care innovation
15:10-15:20
CSA: Next-generation wound care
15:20-15:30
Audience participation and discussion
Bob Mitchell, Irvine, United States
15:30-16:00 TEA AND VISIT TO HANDS-ON WORKSHOP
Diagnostic and imaging innovation
Chairing: Andrew Holden, Auckland, New Zealand Moderator: Stephen Greenhalgh, London, United Kingdom 16:00-16:10 The future of vector flow imaging is in 3D Lars Lönn, Copenhagen, Denmark 16:10-16:20 Update on holographic medical imaging to support operative procedures: The VPI Technology Jan Heyligers, Tilburg, Netherlands 16:20-16:30 Wearable technologies and telemonitoring for vascular disease to keep patients out of hospital Celia Riga, London, United Kingdom 16:30-16:40
Audience participation and discussion
Updates from previous Dragons’ Den winners
Chairing: Stephen Greenhalgh, London, United Kingdom Moderator: Frans Moll, CX Advisory Board, Utrecht, Netherlands 16:40-16:45 2018 Coramed antioxidant
Kieran Murphy, Toronto, Canada
16:45-16:50 2015 The Bullet Proof vascular access graft (InnAVasc) Shawn Gage, Raleigh, United States 16:50-16:55 2010 The HQS (Alseal) introducer
Claude Mialhe, Monaco, Monaco
Dragons’ Den
Panel: A ndrew Holden, Auckland, New Zealand Frans Moll, CX Advisory Board, Utrecht, Netherlands Bob Mitchell, Irvine, United States Peter Phillips, Didcot, United Kingdom Chas Taylor, Horsham, United Kingdom Jeffrey Jump, Mont-sur-Rolle, Switzerland Alan Edwards, Ruthin, United Kingdom
16:55-17:00 Introduction to Dragons’ Den Stephen Greenhalgh, London, United Kingdom
Thursday 18 April 2019
17:00-17:03 Phpc (phenox hydrophilic coating) for reduced thrombogenicity of stents Hans Henkes, Stuttgart, Germany 17:03-17:05
Questions from the Dragons
17:05-17:08 Nanoscale Medical Devices: A new frontier in the imaging and treatment of critical limb ischaemia Sean Morris, Missouri City, United States 17:08-17:10
Questions from the Dragons
17:10-17:13 Community Portable Infrared Thermography (C-PIT): Improving outcomes in patients with diabetic foot disease Colette Cook, Ellesmere Port, United Kingdom 17:13-17:15
Questions from the Dragons
17:15-17:18
Second-generation venous stent
17:18-17:20
Questions from the Dragons
Cees Wittens, Maastricht, Netherlands
17:20-17:23 Novel restorative vascular access graft technology Luke Burke, Eindhoven, The Netherlands 17:23-17:25
Questions from the Dragons
17:25-17:28 Butterfly iQ pocket-sized ultrasound John Martin, Annapolis, United States 17:28-17:30
Questions from the Dragons
17:30-17:33 HeadPeace radiation protection textile Petra Apell, Gothenburg, Sweden Fredrik Gellerstedt, Goteborg, Sweden 17:33-17:35
94 2019
Questions from the Dragons
Vascular & Endovascular Challenges Update 17:35-17:38
EVARPlanning’s platform
17:38-17:40
Questions from the Dragons
Paolo Spada, Buccinasco, Italy
17:40-17:43 Motilant AI technology to detect aortic ruptures Sandip Sarkar, London, United Kingdom 17:43-17:45
Questions from the Dragons
17:45-17:48
New cap for endovascular
17:48-17:50
Questions from the Dragons
17:50-17:53
SiteSeal: A new closure device
17:53-17:55
Questions from the Dragons
Claude Mialhe, Monaco Rex Teeslink, Augusta, United States
17:50-17:55 Voting by the Dragons and announcement of the winner followed by photograph with Dragons’ Den winner
CX Venous Techniques & Technologies (edited cases) – Day 2 l Venous City – 09:30-10:30 and 13:00-13:30
CX Venous edited cases – Morning Chairing: Manj Gohel, Cambridge, United Kingdom Moderator: Steve Elias, Englewood, United States 09:30-09:50 Mechanical thrombectomy in the treatment of acute venous occlusion Thomas Heller, Rostock, Germany 09:50-10:10
Abre venous stenting
10:10-10:30
Venous obstruction management
Stephen Black, London, United Kingdom Steven Dubenec, Sydney, Australia
CX Venous edited cases – Afternoon 13:00-13:20 JETi in a typical iliofemoral thrombosis 13:20-13:30 Interactive case vignettes
Bao Bui, Sherbrooke, Canada
CX Venous Workshop – Day 2 l Venous City – 09:30-15:30
Practical hands-on skills
Facilitators: T ristan Lane, London, United Kingdom Hayley Moore, London, United Kingdom
Cannulation
Roshan Bootun, London, United Kingdom
Device positioning
Gregory Fulton, Wilton, Ireland Saroj Das, Uxbridge, United Kingdom
Tumescent anaesthesia
Matthew Metcalfe, Stevenage, United Kingdom
D iagnostic venous ultrasound
Diagnostic venous ultrasound
Mary Ellis, London, United Kingdom Hema Rao, London, United Kingdom
2019
95
Thursday 18 April 2019
Manj Gohel, Cambridge, United Kingdom Stephen Black, London, United Kingdom
Vascular & Endovascular Challenges Update
Pelvic vein disorders
Pelvic vein embolisation
Jocelyn Brookes, London, United Kingdom
Transvaginal duplex scanning
Plethysmography
Air plethysmography
Yee Jia Ng, Singapore
Christopher Lattimer, London, United Kingdom Teresa Rola, London, United Kingdom
Strain gauge plethysmography
Oskar Nelzen, LinkĂśping, Sweden
Interventions for acute DVT
8F power aspiration with Indigo System Jasmin Al-Gaddooa, Germany, Belin Aspirex S – Rotational thrombectomy Thomas Heller, Rostock, Germany
Deep vein thrombosis
Bekim Hymeraj, RD Global, Ankara, Turkey Oguz Dinc, RD Global, Ankara, Turkey
EKOS Accoustic Pulse Thrombolysis treatment Mert Dumantepe, Istanbul, Turkey Houman Jalaie, Aachen, Germany JETi
David Look, Walk Vascular, Irvine, United States
Acute venous thrombosis
Investigation for occult malignancy after acute DVT Gerry Stansby, Newcastle-upon-Tyne, United Kingdom Superficial vein thrombosis Raghvinder Gambhir, Chessington, United Kingdom Thrombophilia assessment in acute DVT Adam Gwozdz, London, United Kingdom Acute DVT imaging and clot ageing Brahman Dharmarajah, London, United Kingdom Comparison of CT, MR and IVUS Chung Sim Lim, London, United Kingdom Cancer-related thrombosis
Francis Mattey, London, United Kingdom
Deep vein stenting ABRE venous stent
Optimed venous portfolio
Venovo venous stent
Erin Murphy, Charlotte, United States Steven Dubenec, Sydney, Australia
Zilver Vena case discussions and hands-on Marta Ramirez Ortega, Madrid, Spain
Thursday 18 April 2019
Vena cava filters
ALN vena cava filter
Alain Nigon, ALN, Bormes Les Mimosas, France
Cava filters
Valve reconstruction
SailValve and VenoValve
Prosthetic valve technologies
Nadeem Qazi, London, United Kingdom
Steve Elias, Englewood, United States Hayley Moore, London, United Kingdom
Additional stations
Vascular ultrasound training simulator Usman Jaffer, London, United Kingdom IVUS in deep venous stenting
David Greenstein, London, United Kingdom
Use of IVUS for upper limb and SVC interventions Sriram Narayanan, Singapore Paget-Schroetter syndrome Aero Wrap, Sun-Scientific
John Thompson, Exeter, United Kingdom Vikram Ravikumar, New York, United States
Endophlebectomy and open deep venous surgery Joseph Shalhoub, London, United Kingdom
96 2019
Vascular & Endovascular Challenges Update Venous therapies from acute to chronic solutions Domenico Baccellieri, Milan, Italy SVS/IVC stenting procedures PPG for dynamic assessment of venous function Mohammed Aslam, London, United Kingdom
CX Vascular Access Techniques & Technologies (edited cases) CX Vascular Access Workshop – 09:00-10:00
Chairing: N icholas Inston, Birmingham, United Kingdom Domenico Valenti, London, United Kingdom
09:00-09:20 The Ellipsys procedure for endo AVF Jeffrey Hull, North Chesterfield, United States 09:20-09:40
Using WavelinQ for fistula creation
Panagiotis Kitrou, Patras, Greece
09:40-10:00 Revision of cephalic arch stenosis with a covered endoprosthesis Daniel Patel, Daytona Beach, United States
CX Vascular Access Workshop CX Vascular Access Workshop – 09:00-16:00
Domenico Valenti, London, United Kingdom Kate Sommerville, London, United Kingdom Annette Quinn, London, United Kingdom Nicola Milburn, London, United Kingdom Emily Hillier, London, United Kingdom Nicholas Zakikhani, London, United Kingdom Phil Hickman, London, United Kingdom
Fist Assist for vein enhancement
Piur Tomographic ultrasound
Tej Singh, Los Altos Hills, United States Gurdeep Jandu, Bolton, United Kingdom
Techniques in vascular access
Ellipsys EndoAVF System
Alexandros Mallios, Paris, France
WavelinQ 4F Endo AVF
Panagiotis Kitrou, Patras, Greece Arne Beutler, Kalrsruhe, Germany
Management of AV fistula/graft stenosis with stent grafts David Kingsmore, Glasgow, United Kingdom Surgical techniques: Snuffbox fistula creation Giambattista Gagliardo, Palermo, Italy Surgical techniques: Radiocephalic AVF Teun Wilmink, Birmingham, United Kingdom Surgical techniques: Brachiocephalic AVF Hiren Mistry, London, United Kingdom Surgical techniques: Brachiobasilic AVF Melanie Field, Birmingham, United Kingdom Grafts – techniques for EC grafts Sapan Desai, Arlington Heights, United States
2019
97
Thursday 18 April 2019
Assessment of vascular access
USS stations with patients
Vascular & Endovascular Challenges Update Jaguar Support Catheter – micro cathether Murat Katitas, Ankara, Turkey
Complex access
HeRO
James Gilbert, Oxford, United Kingdom
Surfacer
Guerkan Sengoelge, Vienna, Austria
Advance Enforcer 35 – A scoring balloon for dialysis access Anders Bro, Bjaeverskov, Denmark Stents and stent grafts for vascular access Matteo Barattini, La Spezia, Italy
Dialysis made simple
Dialysis central venous catheters workshop Haimanot Wasse, Chicago, United States Fistula cannulation – It's not that easy! Karen Tullett, Birmingham, United Kingdom
USS-guided cannulation Aurangzaib Khawaja, Birmingham, United Kingdom
Plastic cannulas for diaslysis
Zoe Roberts, Sheffield, United Kingdom Amardeep Gill, Kempston, United Kingdom
Complications of access
Treatment strategies with prosthetic vascular access and future prospects Matteo Tozzi, Varese, Italy High flow and steal: Preserving the access Karl Illig, Tampa, United States Thrombosis, thrombolysis and thrombectomy Kate Steiner, Stevenage, United Kingdom Jason Wilkins, London, United Kingdom Robert Jones, Birmingham, United Kingdom CATD: Power aspiration with Indigo System Andrea Unger, Hamburg, Germany
USS guided angioplasty
CX Day 2
Olivier Pichot, Grenoble, France
Workshop –
CX iWound Workshop – 09:30-15:30 Thursday 18 April 2019
Facilitators: W illiam Ennis, Oak Lawn, United States Keith Harding, Cardiff, United Kingdom John Lantis, New York, United States Thomas O’Donnell, Boston, United States
Complex lower limb compression
Curettage wound debridement
Julie Stanton, United Kingdom David Gray, United Kingdom
Automatic ankle-brachial index system Anita Roberts, Cardiff, United Kingdom Debridement and compression solutions
Epifix/ReGen
Matjaz Span, Izola, Slovenia Jakob Susteric, United Kingdom
Bill Tettelbach, Marietta, United States Leanne Atkins, United Kingdom
Optical detection of bacteria
3C Patch autologous therapy
Oxygen therapy
Tomas Serena, Warren, United States Magnus Löndahl, Lund, Sweden Robert Frykberg, Phoenix, United States
Diabetic foot and infra-red tomography Susan Matthews, Oldham, United Kingdom Michael Edmonds, London, United Kingdom
Geko for leg ulcers
Mölnlycke Granulox
Dawn Smiles, Leeds, United Kingdom Andrew Costello, Milton Keynes, United Kingdom
Footwear technology for diabetic foot ulcer patients Sjef van Baal, Almelo, Netherlands
98 2019
Vascular & Endovascular Challenges Update
European Vascular Surgeons in Training – Prize Session Gallery Suite Learning Centre – 08:00-12:30
R eaching the limits of endo or open – when to change strategy Chairing: V assilios Zymvragoudakis, Dafni, Greece Florian Enzmann, Salzburg, Austria
08:00-08:30 Lower limb: Endovascular to open Baris Ata Ozdemir, Bristol, United Kingdom 08:30-09:00 Lower limb: Open to endovascular Konstantinos Katsanos, Patras, Greece 09:00-09:30
Aorta: Endovascular to open
Morad Sallam, London, United Kingdom
09:30-10:00 Vascular trauma to the neck: Open, endo or hybrid? Vincent Jongkind, Amsterdam, Netherlands 10:00-10:30
TEA AND VISIT TO HANDS-ON WORKSHOPS
EVST Abstract Prize Session Chairing: L ewis Meecham, United Kingdom Salome Weiss, Bern, Switzerland
10:31-10:37 Effect of centralisation on abdominal aortic aneurysm repair outcomes in Catalonia (Spain) Paolo Tripodi, Barcelona, Spain 10:37-10:38
Discussion
10:38-10:44 Long-term outcomes of endovascular treatment versus open surgical repair for abdominal aortic aneurysms Liliana Fidalgo Domingos, Valladolid, Spain 10:44-10:45
Discussion
10:45-10:51 Prediction of survival after 48 hours of intensive unit care following repair of ruptured abdominal aortic aneurysm – multicentric study for external validation of a new prediction score for 30-day mortality Andreia Coelho, Porto, Portugal 10:51-10:52
Discussion
10:52-10:58 Endovascular boundaries in complex thoracic aorta aneurysms treatment Ana Carolina Semiao, Porto, Portugal Discussion
10:59-11:05 Preliminary experience with the Covera Plus self-expandable covered stent as bridging stent in branched thoraco-abdominal endovascular aneurysm repairs with standard (off-the-shelf) endograft Nicola Leone, Baggiovara, Italy 11:05-11:06
Discussion
11:06-11:12 Aortic stump blowout in a hostile abdomen, a vascular challenge in emergency department Correia Ricardo, Lisbon, Portugal 11:12-11:13
Discussion
11:13-11:19 The CERAB technique in the treatment of an iatrogenic dissection of the abdominal aorta Ryan Melo, Lisbon, Portugal 11:19-11:20
Discussion
11:20-11:26 Treatment of superficial femoral and popliteal arteries long occlusions Leonid Magnitskiy, Russia 11:26-11:27
Discussion
11:27-11:33 Distal hybrids for long chronic total occlusion of superficial femoral artery with severely compromised runoff Pavel Kuryanov, Saint Petersburg, Russian Federation 11:33-11:34
Discussion
11:34-11:40 Hybrid revascularisation procedures in the management of multiple level peripheral vascular disease Muhammed Labeb Eldeeb, Egypt 11:40-11:41
Discussion
2019
99
Thursday 18 April 2019
10:58-10:59
Vascular & Endovascular Challenges Update 11:41-11:47 Patient and lesion characteristics of in-stent restenosis of the internal carotid artery Zsuzsanna Mihaly, Budapest, Hungary 11:47-11:48
Discussion
11:48-11:54 Outcomes of modified surgical approach to treat thoracic outlet compression syndrome: The Venetian blind technique Shanka Benaragama, Colchester, United Kingdom 11:54-11:55
Discussion
11:55-12:01 A single-centre experience using intravascular ultrasound as an adjunct in nutcracker syndrome Maria Pilar Lamarca Mendoza, Toledo, Spain 12:01-12:02
Discussion
12:02-12:08 Novel non-thermal versus thermal endovenous ablation in superficial venous incompetence: A systematic review and meta-analysis of comparative studies Thomas Aherne, Dublin, Ireland 12:08-12:09
Discussion
12:09-12:15 Immediate versus early endovenous ablation in venous ulcers Toni Pihlaja, Finland 12:15-12:16
Discussion
12:16-12:22 Endovenous laser ablation of great and small saphenous veins with 1470nm diode laser and radial slim fibres Hovsep Manjikian, Moscow, Russia 12:22-12:23
Discussion
12:23-12:30
Prize giving
CX Peripheral Arterial Abstract Presentations – Day 3 l Dark Room Learning Centre – 10:30-15:20
Peripheral Arterial Abstract Presentations Chairing: I an Chetter, Hull, United Kingdom Mark Portou, London, United Kingdom
Thursday 18 April 2019
10:30-10:35 First human experience with the Xtremetouch-Neo sirolimus-coated balloon in percutaneous peripheral arterial interventions George Dangas, New York, United States 10:35-10:40
Audience participation and discussion
10:40-10:45 Twenty four-month results of instent restenosis patients treated with a paclitaxel covered balloon in the real-world BIOLUX P-III all-comers’ registry Marianne Brodmann, Graz, Austria 10:45-10:50
Audience participation and discussion
10:50-10:55 Early and late outcome assessment of popliteal artery aneurysm open vs. endovascular repair Salvatore Turiano, Nicolosi, Italy 10:55-11:00
Audience participation and discussion
11:00-11:05 Outcomes of below-knee popliteal and tibial inflow venous bypass for critical limb ischaemia Goncalo Cabral, Sintra, Portugal 11:05-11:10
Audience participation and discussion
11:10-11:15 Rationale and design of a pivotal study for an autologous blood filter device for treatment of critical limb ischaemia Bijan Modarai, London, United Kingdom 11:15-11:20
Audience participation and discussion
11:20-11:25 Rotarex mechanical atherectomy with thrombectomy in chronic arterial de novo lesions: Single-centre experience with 671 patients Bruno Freitas, Leipzig, Germany
100 2019
Vascular & Endovascular Challenges Update 11:25-11:30
Audience participation and discussion
11:30-11:35 A comparative study of the patency of femoropopliteal bypass vs. long superficial femoral artery stenting Maher Hamish, Northampton, United Kingdom 11:35-11:40
Audience participation and discussion
11:40-11:45 Inverted T bypass: Redefining the concept of non-revascularisable critical limb ischaemia Goncalo Cabral, Sintra, Portugal 11:45-11:50
Audience participation and discussion
11:50-11:55 The qualitative and the quantitative malnutrition in patients with the critical limb ischaemia Piotr Ciostek, Warszawa, Poland 11:55-12:00
Audience participation and discussion
12:00-12:05 Strategies for limb salvage in patients with end-stage peripheral arterial disease and neuromoduation Beatrix Cucuruz, Nuremberg, Germany 12:05-12:10
Audience participation and discussion
12:10-12:15 “Via-pass”: A real alternative for the critical limb ischaemia after thrombosis of a vein bypass Javier Rio Gomez, Majadahonda, Spain 12:15-12:20
Audience participation and discussion
12:20-12:25 Endovascular graft bailout post reconstruction of popliteal artery injury. First case report Emad Eldeen Hussein, Heliopolis, Egypt 12:25-12:30
Audience participation and discussion
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Peripheral Arterial Abstract Presentations Chairing: B ijan Modarai, London, United Kingdom Sophie Renton, London, United Kingdom
13:30-13:35 Is amputation in the elderly CLI patients acceptable in the long term? Chloé Peters, Breda, Netherlands 13:35-13:40
Audience participation and discussion
13:40-13:45 Perioperative complications after revascularisation in diabetic and non-diabetic critical limb ischaemia patients and its relation with preoperative HBA1C Roshan Rodney Sengodan, Coimbatore, India 13:45-13:50
Audience participation and discussion
13:50-13:55 Quality of life and traditional outcome results at one year in elderly patients suffering from critical limb ischaemia and the role of conservative treatment Stijn Steunenberg, Breda, Netherlands 13:55-14:00
Audience participation and discussion
14:00-14:05 The prognostic value of the WIfI classification in patients with chronic limb-threatening ischemia: A systematic review and metaanalysis Nick van Reijen, Amsterdam, Netherlands Audience participation and discussion
14:10-14:15 Effect of abnormal lipid profile on wound healing in critical limb ischaemia patients with successful infrapopliteal angioplasty Roshan Rodney Sengodan, Coimbatore, India 14:15-14:20
Audience participation and discussion
14:20-14:25 Retrospective analysis of initial results of an atherectomy and thrombectomy device in patients with acute, subacute and chronic lower limb artery occlusion Christian Wissgott, Heide, Germany 14:25-14:30
Audience participation and discussion
14:30-14:35 The impact of a prior vascular procedure on the outcome of a future lower limb bypass for critical limb ischaemia Alice Camagni, Ferrara, Italy 14:35-14:40
Audience participation and discussion
14:40-14:45 Prospective evaluation of the CELT arterial closure device in an outpatient based catheterisation laboratory Syed Hussain, Peoria, United States 14:45-14:50
Audience participation and discussion
14:50-14:55 Retrograde use of the Outback re-entry catheter in complex infrainguinal arterial recanalisation Lorenzo Patrone, London, United Kingdom 14:55-15:00
Audience participation and discussion
15:00-15:05 Totally percutaneous fem-pop bypass: From first human case to a routine technique Pierre Sarradon, La Seynen Sur Mer, France
2019
101
Thursday 18 April 2019
14:05-14:10
Vascular & Endovascular Challenges Update 15:05-15:10
Audience participation and discussion
15:10-15:15 Creation and management of arteriovenous fistula during complex peripheral revascularisation Claudia Martinez, Dublin, Ireland 15:15-15:20
Audience participation and discussion
CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 2 l Dark Room Learning Centre
C X Venous Global Stars and Rising Stars (08:00-09:30) Chairing: A lun Davies, London, United Kingdom Johann Christoph Ragg, Berlin, Germany
08:00-08:05 Clinical and haemodynamic outcome of morbidly obese patients having severe chronic venou insufficiency with and without bariatric surgery: A comparative study Ahmed Naga, Alexandria, Egypt 08:05-08:10
Audience participation and discussion
08:10-08:15 A comparative analysis of the results of cyanoacrylate ablation and radiofrequency ablation in the treatment of venous insufficiency Fatih Islamoglu, Izmir, Turkey 08:15-08:20
Audience participation and discussion
08:20-08:25 Iliocaval stenting – diagnosis, technique and results Marta Ramirez Ortega, Madrid, Spain 08:25-08:30
Audience participation and discussion
08:30-08:35 Outcomes of left renal vein stenting in patients with nutcracker syndrome Rabih Chaer, Pittsburgh, United States 08:35-08:40
Audience participation and discussion
08:40-08:45 Great saphenous vein diameters in phlebological practice in France: A report of the diagraves study by the French Society of Phlebology Matthieu Josnin, La Roche Sur Yon, France 08:45-08:50
Audience participation and discussion
Thursday 18 April 2019
08:50-08:55 Vein valve defects and insufficiency in children Johann Christoph Ragg, Berlin, Germany 08:55-09:00
Audience participation and discussion
09:00-09:05 Foam versus liquid in sclerotherapy for telangiectasia of the lower limb: Study protocol for a randomised controlled trial; the Fovelite study Matthieu Josnin, La Roche Sur Yon, France 09:05-09:10
Audience participation and discussion
09:10-09:15 Treatment of iliac and femoral vein occlusive disease with the Venovo venous stent: Twelve-month results from the VERNACULAR trial Michael Dake, Stanford, United States 09:15-09:20
Audience participation and discussion
09:20-09:25 Reducing hyperpigmentation after sclerotherapy: Midterm results of a multicentre, randomised, controlled, clinical trial Alejandro Jose Gonzalez Ochoa, San Luis, Mexico 09:25-09:30
102 2019
Audience participation and discussion
Vascular & Endovascular Challenges Update
C X Venous Global Stars and Rising Stars (16:00-16:10) Chairing: M anj Gohel, Cambridge, United Kingdom Stephen Black, London, United Kingdom
16:00-16:05 Early and mid-term results of hybrid treatment approach for patients with acute iliofemoral deep vein thrombosis Ali Baran Budak, Ankara, Turkey 16:05-16:10
Audience participation and discussion
C X Venous Abstract Presentations (16:10-17:50)
16:10-16:15 Treatment of chronic deep vein thrombosis using ultrasound accelerated catheter-directed thrombolysis with sequential balloon angioplasty Mert Dumantepe, Istanbul, Turkey 16:15-16:20
Audience participation and discussion
16:20-16:25 Aspiration thrombectomy for acute deep vein thrombosis of the left lower extremity of a child after cardiac radiofrequency ablation Maria Antonella Ruffino, Turin, Italy 16:25-16:30
Audience participation and discussion
16:30-16:35 Novel compliant stent with specific design for truncular venous malformations: Results of a porcine model study Pierfrancesco Veroux, Catania, Italy 16:35-16:40
Audience participation and discussion
16:40-16:45 New method and instrument for improved phlebectomy Pierre Sarradon, La Seynen Sur Mer, France 16:45-16:50
Audience participation and discussion
16:50-16:55 The outcome of combined coiling and liquid sclerotherapy compared to coiling only on symptoms of pelvic congestion syndrome: A randomised controlled trial Mosaad Soliman, Mansoura, Egypt 16:55-17:00
Audience participation and discussion
17:00-17:05 Proper preoperative complex decongestive therapy and aggressive liposuction in combination with controlled compression: Paradigm shift in the management of lymphedema of lower limbs Yasser Elkiran, Mansoura, Egypt 17:05-17:10
Audience participation and discussion
17:10-17:15 Continuing on aspirin or half of the therapeutic dose of DOACs for one year reduces the risk of recurrent VTE Mosaad Soliman, Mansoura, Egypt 17:15-17:20
Audience participation and discussion
17:25-17:30
Audience participation and discussion
17:30-17:35 Thrombectomy devices in massive acute pulmonary embolism treatment: Initial single-centre experience with a novel technique using Aspirex through right jugular access Bruno Freitas, Leipzig, Germany 17:35-17:40
Audience participation and discussion
17:40-17:45 Patient radiation exposure from embolo-sclerotherapy of vascular malformations Leeying Giet, London, United Kingdom 17:45-17:50
Audience participation and discussion
2019
103
Thursday 18 April 2019
17:20-17:25 Why hydatic pressure compresses leg veins but stockings do not Christopher Lattimer, London, United Kingdom
Vascular & Endovascular Challenges Update
CX Abdominal Aortic Abstract Presentations – Day 2 l London Room Learning Centre – 08:00-18:00
Abdominal Aortic Abstract Presentations Chairing: F rank Criado, Baltimore, United States Anna Prent, London, United Kingdom
08:00-08:05 Major complications patients want to be informed about prior to abdominal aortic aneurysm surgery: A best-worst scaling study Sylvana de Mik, Amsterdam, Netherlands 08:05-08:10
Audience participation and discussion
08:10-08:15 Impact of common iliac artery’s anatomy on the risk of endograft limb occlusion after EVAR Liborio Ferrante, Palmero, Italy 08:15-08:20
Audience participation and discussion
08:20-08:25 Are NHS vascular surgeons adequately prepared to meet the demands of the newly proposed NICE guidelines on AAA management? Simon Glasgow, London, United Kingdom 08:25-08:30
Audience participation and discussion
08:30-08:35 Evolution of EVAR stent graft design provides opportunity to reduce perioperative radiation exposure Paul Hayes, Cambridge, United Kingdom 08:35-08:40
Audience participation and discussion
08:40-08:45 Localised aortic primary stenting for focal aortic stenosis; a review of nine patients with short-term outcomes Mohamed Ismail, Cairo, Egypt 08:45-08:50
Audience participation and discussion
08:50-08:55 The role of sarcopenia in survival of patients with abdominal aortic aneurysm: A prognostic factor review and meta-analysis of time-toevent data Maciej Juszczak, Birmingham, United Kingdom 08:55-09:00
Audience participation and discussion
09:00-09:05 Insight in national numbers of secondary reintervention procedures after primary abdominal aortic aneurysm surgery Eleonora Karthaus, Amsterdam, Netherlands 09:05-09:10
Audience participation and discussion
09:10-09:15 Symptoms of depression and risk of abdominal aortic aneurysm. A population-based prospective study in Norway (the HUNT study) Linn Aldstedt Nyronning, Trondheim, Norway
Thursday 18 April 2019
09:15-09:20
Audience participation and discussion
09:20-09:25 Screening cardiovascular patients for aortic aneurysms – high prevalence of AAA in coronary heart disease requiring intervention Benedikt Reutersberg, London, United Kingdom 09:25-09:30
Audience participation and discussion
09:30-09:35 An automatised algorithm to evaluate the patent aortic lumen in noncontrast computed tomographies Gioele Simonte, Perugia, Italy 09:35-09:40
Audience participation and discussion
09:40-09:45 Treatment of calcified iliac stenosis using intravascular lithotripsy to facilitate percutaneous aortic intervention Mazin Foteh, Austin, United States 09:45-09:50
Audience participation and discussion
09:50-09:55 Augmented reality in vascular surgery – 3D holographic imaging during endovascular aortic repair Natalia Wrzesinska, Nieporet, Poland 09:55-10:00
Audience participation and discussion
10:00-10:30 COFFEE AND VISIT TO HANDS-ON WORKSHOPS
104 2019
Vascular & Endovascular Challenges Update
Abdominal Aortic Abstract Presentations Chairing: M eryl Davis, London, United Kingdom Kevin Mani, Uppsala, Sweden
10:30-10:35 Retroperitoneal versus endovascular approach for the treatment of asymptomatic infrarenal aortic aneurysms – a single-centre experience Gladiol Zenunaj, Ferrara, Italy 10:35-10:40
Audience participation and discussion
10:40-10:45 Analysis of aortic neck dilatation after endovascular aortic repair Simone Hofer, Chur, Switzerland 10:45-10:50
Audience participation and discussion
10:50-10:55 Endovascular treatment of short and severe abdominal aortic lesions Teodora Mares, Bucharest, Romania 10:55-11:00
Audience participation and discussion
11:00-11:05 Endovascular aortoiliac grafting in patients with juxtarenal aortoiliac occlusive disease Piotr Ciostek, Warszawa, Poland 11:05-11:10
Audience participation and discussion
11:10-11:15 Percutaneous revascularisation as a feasible option for complex aortoiliac occlusive disease with fair one-year outcome Ahmed Allam, Benha, Egypt 11:15-11:20
Audience participation and discussion
11:20-11:25 3D aortic models for the urgent endovascular treatment of paravisceral penetrating aortic ulcers using physician-modified stent grafts Daniela Branzan, Leipzig, Germany 11:25-11:30
Audience participation and discussion
11:30-11:35 Endovascular treatment of terminal aorta occlusion Mikhail Chernyavskiy, St Petersburg, Russia 11:35-11:40
Audience participation and discussion
11:40-11:45 Neck morphologic changes and clinical consequences of enlarged necks requiring 34–36mm devices Jose Pedro Pinto, Porto, Portugal 11:45-11:50
Audience participation and discussion
11:50-11:55 Quantitative description of aortic rigid and non-rigid deformation during endovascular aneurysm repair Salma El Batti, London, United Kingdom 11:55-12:00
Audience participation and discussion
12:00-12:05 Long-term follow-up post surgical treatment of infected aortofemoral vascular graft: Limited, sequential vs. total graft replacement Grzegorz Gorski, Warszawa, Poland 12:05-12:10
Audience participation and discussion
12:10-12:15 Endovascular treatment of aortoiliac disease using in situ fenestration Jeremie Jayet, Boulogne-Billancourt, France Audience participation and discussion
12:20-12:25 New off-the-shelf branched EVAR technique for thoracoabdominal aneurysms Marco Lourenco, Curitiba, Brazil 12:25-12:30
Audience participation and discussion
12:30-13:30
LUNCH AND VISIT TO HANDS-ON WORKSHOPS
Abdominal Aortic Abstract Presentations Chairing: P aul Hayes, Cambridge, United Kingdom Emma Wilton, Beaconsfield, United Kingdom
13:30-13:35 One-year outcomes of BeGraft stent grafts used as chimney grafts in conjunction with the Endurant device for the treatment of complex abdominal diseases Konstantinos Donas, Münster, Germany 13:35-13:40
Audience participation and discussion
13:40-13:45 Early outcomes of native and graft related abdominal aortic infection managed with orthotopic xenopericardial grafts Baris Ata Ozdemir, Bristol, United Kingdom 13:45-13:50
Audience participation and discussion
13:50-13:55 Mid-term results following 295 endovascular aneurysm sealing cases with the nellix stent-graft system: A single-centre experience Kate Stenson, London, United Kingdom 13:55-14:00
Audience participation and discussion
2019
105
Thursday 18 April 2019
12:15-12:20
Vascular & Endovascular Challenges Update 14:00-14:05 Patient-specific computational analysis of the impact of fenestrated and chimney endovascular aortic repair on haemodynamics in renal arteries Sabrina Ben Ahmed, Clermont Ferrand, France 14:05-14:10
Audience participation and discussion
14:10-14:15 Two-year outcomes of endovascular aneurysm sealing and chimney EVAS in abdominal aortic aneurysms based on calculated neck length: A single-centre study Patrick Berg, Kevelaer, Germany 14:15-14:20
Audience participation and discussion
14:20-14:25 Endovascular treatment of isolated common iliac artery aneurysms using iliac branch stent grafts without aortic component: A national multicentre registry Alessia Giaquinta, Catania, Italy 14:25-14:30
Audience participation and discussion
14:30-14:35 Long-term results of the chimney technique by use of a standardised combination of devices in the treatment of 211 patients with pararenal pathologies Konstantinos Donas, MĂźnster, Germany 14:35-14:40
Audience participation and discussion
14:40-14:45 Rupture after endovascular abdominal aortic aneurysm repair: A late challenge Nelson Camacho, Lisbon, Portugal 14:45-14:50
Audience participation and discussion
14:50-14:55 Cerebrovascular and cardiovascular complications in the survivors of ruptured abdominal aortic aneurysm Terri-Ann Russell, Northamptonshire, United Kingdom 14:55-15:00
Audience participation and discussion
15:00-15:05 A comparison of survival after endovascular and open repairs of unruptured elective infrarenal abdominal aortic aneurysms in octogenarians Kane Treadwell, United Kingdom 15:05-15:10
Audience participation and discussion
15:10-15:15 Factors associated with elimination of endoleak type II during the first year post EVAR Konstantinos Spanos, Larissa, Greece 15:15-15:20
Audience participation and discussion
15:20-15:25 Emergency EVAR for complex abdominal aortic aneurysms Maciej Juszczak, Birmingham, United Kingdom 15:25-15:30
Audience participation and discussion
15:30-16:00
TEA AND VISIT TO HANDS-ON WORKSHOPS
Abdominal Aortic Abstract Presentations Chairing: C olin Bicknell, London, United Kingdom Celia Riga, London, United Kingdom
16:00-16:05 Post-implantation syndrome and asymptomatic myocardial injury after EVAR Joel Sousa, Oporto, Portugal 16:05-16:10
Audience participation and discussion
Thursday 18 April 2019
16:10-16:15 Patient preferences and attitudes towards surveillance post EVAR Bilal Azhar, London, United Kingdom 16:15-16:20
Audience participation and discussion
16:20-16:25 Long-term outcomes of surgical, endovascular and hybrid treatment of aortoiliac occlusive disease in patients younger than 60 years old Swati Chaparala, Rochester, United States 16:25-16:30
Audience participation and discussion
16:30-16:35 Outcomes after contemporary elective EVAR: Five-year experience of a single NHS trust Lola Eid-Arimoku, Frimley, United Kingdom 16:35-16:40
Audience participation and discussion
16:40-16:45 Redefining the volume outcome relationship for endovascular aneurysm repair Jens Eldrup-Jorgensen, Portland, United States 16:45-16:50
Audience participation and discussion
16:50-16:55 Observing a decade of yearly standardised surveillance in EVAR – patients with ultrasound or CT scan: Results from a single centre Anna Geraedts, Amsterdam, Netherlands 16:55-17:00
Audience participation and discussion
17:00-17:05 Long-term outcomes of endovascular aortic repair in patients with abdominal aortic aneurysm and ectatic iliac arteries Lorenzo Gibello, Turin, Italy
106 2019
Vascular & Endovascular Challenges Update 17:05-17:10
Audience participation and discussion
17:10-17:15 Multicentre post-EVAR surveillance evaluation study (EVARSCREEN) Matthew Joe Grima, London, United Kingdom 17:15-17:20
Audience participation and discussion
17:20-17:25 Iliac branch endoprosthesis conformability is associated with freedom from adverse iliac events Donald Harris, Monona, United States 17:25-17:30
Audience participation and discussion
17:30-17:35 Post-EVAR aneurysm sac shrinkage is prognostically favourable but does not justify withholding follow-up Jasper Langenberg, Breda, Netherlands 17:35-17:40
Audience participation and discussion
17:40-17:45 Secondary complication in an asymptomatic retroperitoneal lymphocele after an open abdominal aortic surgery: Management of a prosthetic vascular graft infection Cristina Lozano Ruiz, Albacete, Spain 17:45-17:50
Audience participation and discussion
17:50-17:55 Fusion image laser fenestration in situ for endovascular repair of type Ia endoleak Marek Majewski, CRÉTEIL, France 17:55-18:00
Audience participation and discussion
CX Aortic Selected Posters Presentations l Poster Gallery – 12:30-13:30 Aortic Poster Presentations
Chairing: Emma Wilton, Beaconsfield, United Kingdom Moderator: Celia Riga, London, United Kingdom 12:30-12:33 Device conformability after thoracic endovascular aortic repair: A single-centre experience Jose Antonio del Castro Madrazo, Oviedo, Spain 12:33-12:35 Audience participation and discussion 12:35-12:38 Strategies to minimise risk of spinal cord injury during complex endovascular aortic repair Luis Mariano Ferreira, Buenos Aires, Argentina 12:38-12:40
Audience participation and discussion
12:40-12:43 Aortic remodelling effect of Zenith dissection endovascular system on acute type B aortic dissection with patent false lumen Kenichi Hashizume, Shinagawa, Japan Audience participation and discussion
12:45-12:48 Geometric and haemodynamic analysis of abdominal branches after complex endovascular aneurysm repair Enrique María San Norberto García, Valladolid, Spain 12:48-12:50
Audience participation and discussion
12:50-12:53 Short-stay EVAR: Which patients are suitable? Ryan Preece, London, United Kingdom 12:53-12:55
Audience participation and discussion
12:55-12:58 Impact of baseline renal function on the five-year mortality in octogenarians undergoing EVAR followed up with CT angiogram Simran Parmar, Newcastle-under-Lyme, United Kingdom 12:58-13:00
Audience participation and discussion
13:00-13:03 Factors associated with increased incidence of rupture in large (>80mm) AAA Petroula Nana, Larissa, Greece 13:03-13:05
Audience participation and discussion
13:05-13:08 Percutaneous groin access for EVAR in ruptured abdominal aortic aneurysm: The experience in Burapha University Hospital Trakarn Chaivanit, Chonburi, Thailand 13:08-13:10
Audience participation and discussion
2019
107
Thursday 18 April 2019
12:43-12:45
Vascular & Endovascular Challenges Update 13:10-13:13 A new approach to endovascular aneurysm repair surveillance with contrast-enhanced ultrasound Claudio Castagno, Biella, Italy 13:13-13:15
Audience participation and discussion
13:15-13:18 Clinical and cost-effectiveness of open vs. endovascular repair for ruptured abdominal aortic aneurysm: 10-year single-centre experience of Japan Yukio Umeda, Gifu, Japan 13:18-13:20
Audience participation and discussion
13:20-13:23 Majority of elective small aneurysm repairs still fall within current SVS guidelines Thomas Heafner, Rochester, United States 13:23-13:25
Audience participation and discussion
13:25-13:28 Superior mesenteric artery open surgical revascularisation: A singlecentre experience Sandeep Mahapatra, Hyderabad, India 13:28-13:30
Audience participation and discussion
An Introduction to Vascular Surgery An Introduction to Vascular Surgery, Exhibition Hall – 09:00-15:30 The Vascular Society of Great Britain & Ireland, Rouleaux Club and CX Symposium are running An Introduction to Vascular Surgery for medical students, foundation doctors and core surgical trainees considering a career in Vascular Surgery.
Chairing: Sophie Renton, Secretary General VSGBI, London, United Kingdom
09:00-09:30
Registration
09:30-10:15
elcome and introduction to the Course W What is Vascular Surgery? A career in Vascular Surgery – a junior’s perspective
10:15-12:15 Groups A and B: Hands-on training in vascular anastomosis Groups C and D: Visit CX Venous Workshop (venous duplex and US-guided cannulation) Visit to workshops
Thursday 18 April 2019
12:15-13:00
LUNCH
13:00-13:30
ow to prepare your portfolio H How to apply for training in Vascular Surgery Why choose Vascular Surgery?
13:30-15:30
roups C and D: Hands-on training in vascular anastomosis G Groups A and B: Visit CX Venous Workshop (venous duplex and US-guided cannulation) Visit to workshops
15.30
Feedback and close
108 2019
Vascular & Endovascular
Challenges Update
B O O K AVA I L A B L E N O W !
Edited by Roger M Greenhalgh Published April 2019 Available for purchase during CX 2019 (until 18 April) at the Registration Desk – Launch price Hardback £65 After 18 April, please visit www.cxsymposium.com/cx-books Hardback £85 Digital £42
www.cxsymposium.com
Tuesday 16 April 2019
Tuesday
Sponsored Events
Sponsored Events
Sponsored Satellite RD Global Sponsored Satellite (COFFEE) Lower Main Auditorium 10:00-10:30
Arterial and venous insufficiency treatment with RD Global innovative medical devices
Speaker: Raşit Dinç, Ankara, Turkey
10:00-10:05 Thermal ablation for varicose insufficiency with ThermoBlock RF technology
Tuesday 16 April 2019
10:05-10:10 Glue ablation innovative technology for varicose insufficiency with Venablock, VeinOff and Internal Compresion Therapy (ICT) 10:10-10:15 Deep vein thrombosis management with Mantis, Dovi Aspiration, Viper and Inca Filter 10:15-10:20 Peripheral artery disease treatment with Temren Atherectomy device and Drug Eluting Balloon 10:20-10:25 Vascular access with RD Global Technology: Jaguar Support Catheter, Microcatheter and Guide Catheter 10:20-10:25 Panel discussion This session will be presented in Turkish with simultaneous translation into English. To listen to the translation please download the Interprefy app on your phone, enter the code “cxsymposium” and click “Connect”. You can hold the phone to your ear as you would when making a phone call, or use headphones if you have them. Alternatively, use of the headsets provided.
Refreshments will be served in the Lower Main Auditorium.
Booth and pavilion activities Bentley Refreshing beer @ Bentley booth Booth 419 From 17:00 Enjoy a freshly draught Bavarian beer on Tuesday and Wednesday from 17:00 after a long congress day! We look forward to seeing you there.
Corindus Vascular Robotics Hands-on demonstrations of CorPath GRX System Booth 400 CorPath GRX is the only robotic system cleared for percutaneous coronary and vascular procedures. Hands-on demonstrations in the system’s interventional cockpit will be available during all exhibit hours.
Cryolife Hands-on workshop on a simulator for AAA and iliac branch devices Booth 440 14:00-16:00 Minimal invasive treatment of aortoiliac aneurysms represents a well-established procedure. The aim of the workshop is to develop the technical skills of the participants, in order to achieve a successful endovascular treatment for the aortoiliac aneurysmatic pathology with a preservation of the internal iliac artery through the implantation of a branched stent graft.
112 2019
Sponsored Events
Firstkind Booth 131 A practical demonstration of the innovative geko device – what it is and how it works – in addressing the significant and growing burden of slow to heal wounds.
Getinge
09:00-11:00
Open AAA (bifurcated graft)
14:00-16:00 Open AAA (bifurcated graft)
Merit Medical Meet the Experts Booth 470 15:00-17:00 Innovative solutions for vascular challenges: Discuss ClariVein tips and tricks with Leith Williams and discuss the Surfacer System with Guerkan Sengoelge. Refreshments will be provided
Ra Medical Hands-on with Dabra Atherectomy System Booth 509 08:00-18:00 Learn and practise wireless, non-thermal laser atherectomy techniques.
Siemens First demonstration of Artis icono Booth 150 From 13:00
Experience procedural intelligence for EVAR
Straub Medical Booth 418 15:00 Arterial Workshop – Meet the Expert: Miroslav Bulvas, Prague, Czech Republic
Terumo Aortic Booth 240 During exhibition hours each day
Individualised Solutions
Meet our engineers, clinical planners and specialists to learn more about the processes used in the planning and design of individualised devices; tailored solutions are available for treatment across the thoracic and abdominal aortic regions incorporating technologies from the Anaconda, Relay and TREO platforms. Learn about the unique Case Rehearsal Service offered with Fenestrated Anaconda that provides a prototype device alongside an accurate 3D printed model of your patient’s anatomy.
Sewing Operators
Our sewing operators will be demonstrating the intricate sewing techniques used in the manufacturing of a wide range of our products.
2019
113
Tuesday 16 April 2019
Vascular and Endovascular Masterclasses Booth 170 Getinge is again showing its commitment to vascular and endovascular training. Participants will have the possibility to learn, in closely supervised modules, the latest techniques from experts on life like simulators. Onsite registration is possible depending on availability.
Wednesday 17 April 2019
Wednesday
Sponsored Events
Sponsored Events
Booth and pavilion activities Bentley Refreshing beer @ Bentley booth Booth 419 From 17:00 Enjoy a freshly draught Bavarian beer on Tuesday and Wednesday from 17:00 after a long congress day! We look forward to seeing you there.
Corindus Vascular Robotics Hands-on demonstrations of CorPath GRX System Booth 400 CorPath GRX is the only robotic system cleared for percutaneous coronary and vascular procedures. Hands-on demonstrations in the system’s interventional cockpit will be available during all exhibit hours.
Cryolife Hands-on workshop on a simulator for AAA and iliac branch devices Wednesday 17 April 2019
Booth 440 14:00-16:00 Minimal invasive treatment of aortoiliac aneurysms represents a well-established procedure. The aim of the workshop is to develop the technical skills of the participants, in order to achieve a successful endovascular treatment for the aortoiliac aneurysmatic pathology with a preservation of the internal iliac artery through the implantation of a branched stent graft.
Endologix Join Endologix for a reception to acknowledge early innovators and the ongoing dedication to evidence driven solutions. Pillar Hall Learning Centre Reception at 17:45 Panel discussion at 18:15 Honourees:
Roger Greenhalgh, London, United Kingdom Andrew Holden, Auckland, New Zealand Marc Schermerhorn, Boston, United States Hence Verhagen, Rotterdam, Netharlands
Please register at endologix.com/cx2019 Firstkind Booth 131 A practical demonstration of the innovative geko device – what it is and how it works – in addressing the significant and growing burden of slow to heal wounds.
116 2019
Sponsored Events
Getinge Vascular and Endovascular Masterclasses Booth 170 Getinge is again showing its commitment to vascular and endovascular training. Participants will have the possibility to learn, in closely supervised modules, the latest techniques from experts on life like simulators. Onsite registration is possible depending on availability. 09:00-11:00
Renal stenting in complex aortic cases
12:00-14:00 Renal stenting in complex aortic cases 15:00-17:00
Renal stenting in complex aortic cases
Ra Medical Hands-on with Dabra Atherectomy System Booth 509 08:00-18:00 Learn and practice wireless, non-thermal laser atherectomy techniques.
Siemens Booth 150
Experience procedural intelligence for EVAR
Straub Medical Booth 418 10:00 Arterial Workshop – Meet the Expert: Miroslav Bulvas, Prague, Czech Republic 15:00 Venous Workshop – Meet the Expert:
Thomas Heller, Rostock, Germany
Terumo Aortic Booth 240 During exhibition hours each day
Individualised Solutions
Meet our engineers, clinical planners and specialists to learn more about the processes used in the planning and design of individualised devices; tailored solutions are available for treatment across the thoracic and abdominal aortic regions incorporating technologies from the Anaconda, Relay and TREO platforms. Learn about the unique Case Rehearsal Service offered with Fenestrated Anaconda that provides a prototype device alongside an accurate 3D printed model of your patient’s anatomy.
Sewing Operators
Our sewing operators will be demonstrating the intricate sewing techniques used in the manufacturing of a wide range of our products.
2019
117
Wednesday 17 April 2019
First demonstration of Artis icono
Sponsored Events
Thursday 18 April 2019
Thursday
Sponsored Events
Booth and pavilion activities Corindus Vascular Robotics Hands-on demonstrations of CorPath GRX System Booth 400 CorPath GRX is the only robotic system cleared for percutaneous coronary and vascular procedures. Hands-on demonstrations in the system’s interventional cockpit will be available during all exhibit hours.
Cryolife Hands-on workshop on a simulator for AAA and iliac branch devices Booth 440 09:00-11:00 and 14:00-16:00 Minimal invasive treatment of aortoiliac aneurysms represents a well-established procedure. The aim of the workshop is to develop the technical skills of the participants, in order to achieve a successful endovascular treatment for the aortoiliac aneurysmatic pathology with a preservation of the internal iliac artery through the implantation of a branched stent graft.
Firstkind Booth 131 A practical demonstration of the innovative geko device – what it is and how it works – in addressing the significant and growing burden of slow to heal wounds.
Getinge Vascular and Endovascular Masterclasses Booth 170 Getinge is again showing its commitment to vascular and endovascular training. Participants will have the possibility to learn, in closely supervised modules, the latest techniques from experts on life like simulators. Onsite registration is possible depending on availability.
Thursday 18 April 2019
09:00-11:00
Endovascular treatment of complex aortoiliac cases: Kissing stent
12:00-14:00
Endovascular treatment of complex aortoiliac cases: Kissing stent
Ra Medical Hands-on with Dabra Atherectomy System Booth 509 08:00-18:00 Learn and practice wireless, non-thermal laser atherectomy techniques.
Siemens First demonstration of Artis icono Booth 150
Experience procedural intelligence for EVAR
Straub Medical Booth 418 09:30 Venous Workshop – Meet the Expert:
120 2019
Thomas Heller, Rostock, Germany
Vascular & Endovascular Challenges Update
The Charing Cross Symposium would like to thank all the Pavilion Sponsors and Major Sponsors.
Pavilion Sponsors
Major Sponsors
The Charing Cross Symposium programme is supported by educational grants from: Abbott Vascular Avenu Medical BD/Bard Bentley Biotronik Boston Scientific Cook Medical Cydar Medical Endologix GE Healthcare Getinge Gore HammerMed Intact Vascular
122 2019
Jotec/Cryolife Kaster Lifetech Scientific Mediplast Fenno Oy Medtronic Philips Healthcare Ra Medical Reapplix Secord Medical Shockwave Medical Straub Medical Terumo Aortic Vivasure
Vascular & Endovascular Challenges Update
CX 2019 CME Credits The Charing Cross Symposium 2019, London, United Kingdom, 15/04/2019-18/04/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 28 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.amaassn.org/education/earn-credit-participation-international-activities. Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
EACCME credits Each participant can only receive the number of credits he/she is entitled to according to his/her actual participation at the event once he/she has completed the feedback form. Cf. criteria 9 and 23 of UEMS 2016.20.
Certificate of attendance and CME credits collection We send Certificates of Attendance following completion of our survey submitted at the end of the event. We ask you to complete an electronic CME questionnaire. Please visit cx2019app.com to view and fill out the CX 2019 CME questionnaire. It will be available from Tuesday lunchtime. Your certificate will be emailed to the address you provided with your registration. fter the event – You can access the Certificate of attendance A and CME credits questionnaire online at www.cxsymposium. com/cme. Your certificate will be emailed to the address you provided with your registration.
2019
123
Vascular & Endovascular Challenges Update
CX Pick Up Point Delegate bags
Book & Bag Stand
CX Book pick up point Book & Bag Stand
CX Programme – Slim Jim Book & Bag Stand
Pavilion Sponsors Cook Medical
140
Gore
Endologix
155
Medtronic
250/260 450
Getinge
170
Terumo Aortic
240
BD
428
Merit Medical
470
Bentley
419
Philips
444
Boston Scientific
228
RD GLOBAL
238
Cydar Medical
229
Siemens Healthineers
150
JOTEC - CryoLife
440
Straub Medical
418
Lombard Medical
432
Major Sponsors
Exhibitors 3D Systems Simbionix
315
Legs Matter
136
Abbott Vascular
232
Lifetech Scientific
523
Advanced Oxygen Therapy Inc
138
LimFlow
714
ALN Implants Chirurgicaux
122
LINC
648
AndraTec
712
LSO Medical
220
Aortic Association
710
Medi
217
Avenu Medical
734
Micro Medical solutions
738
BALTON SP. Z.O.O.
304
Mölnlycke
134
BIBA Medtech Insights
110
Nanjing ECO Microwave
208
Biotronik
402
optimed
404
BTG
212
Orbus Neich
505
C3 interventional Academy
501
Penumbra
412
CACVS / i-MEET /DIVINE ID
118
Pie Medical Imaging
538
Cardionovum
716
Piur Imaging
215
CIRSE
644
R&D Surgical
720
Clinlogix
736
Ra Medical Systems
509
Concept Medical
401
Regen Medical
124
Corindus
400
Scanlan International
211
Edinburgh Surgery Online
135
Shockwave Medical
424
Edizioni Minerva Medica
646
SITE
501
Edwards Lifesciences
137
Therenva
533
ESVS
114
Vascular News
110
Evarplanning
132
EVC
213
Vascular Society and Circulation Foundation 207
EVF
117
EVT
119
F Care Systems
116
Firstkind
131
Fist Assist Devices
718
GE Healthcare
311
H&R Healthcare
308
Huntleigh
209
Intact Vascular
408
Laminate Medical
409
124 2019
Venclose
112
Venous News
110
VentureMed
732
Veryan Medical
438
Vivasure Medical
317
Walk Vascular
113
Wisepress Medical Bookshop
725
Ziehm Imaging
223
Vascular & Endovascular Challenges Update
New exhibitors at CX 2019 Advanced Oxygen Therapy Inc
Booth 138
Advanced Oxygen Therapy Inc. (AOTI) offers a wide range of its patented Topical Wound Oxygen (TWO2) systems allowing this unique multi-modality therapy to be delivered effortlessly across the continuum of care, all the way to the patient’s home. Leading clinical trials have shown TWO2 to heal chronic DFU, VLU and PU at an unprecedented rate with far lower recurrence. TWO2 is also effective in healing post-surgical and burn wounds. Over 1,500,000 TWO2 treatments have be delivered to patients to date. www.aotinc.net Clinlogix
Booth 736
Clinlogix is a Global Clinical Research Organisation working to improve human quality of life by supporting and accelerating innovation in the life science industry. Its full suite of clinical research services supports the regulatory and clinical development pathway of medical devices, biotechnologies and pharmaceuticals from bench to bedside. www.clinologix.com Concept Medical
Booth 401
Concept Medical is an India based research division of CMI founded in 2008, which is dedicated for research and development of drug delivering medical devices in various medicinal applications including cardiovascular and peripheral medical devices. Concept Medical believe in bringing innovations which inspires not only the industry but others to innovate and create something revolutionary, our products have been the leaders and not followers in the market. Philosophy: Converting Concepts into reality. www.conceptmedicals.com Corindus Vascular Robotics
Booth 400
Corindus is a global technology leader in robotic-assisted vascular interventions. The company’s CorPath platform is the first FDAcleared and CE-marked medical device to bring robotic precision to percutaneous coronary and vascular procedures. Corindus is focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialised and timely medical care to patients around the world. www.corindus.com Evarplanning
Booth 132
EVARplanning is a software company founded by Paolo Spada, Vascular Surgeon in Milan, Italy. Well known for its free web-app for the endograft configuration, EVARplanning has now expanded its team and expertise, to provide a comprehensive preoperative system, based on advanced algorithms and cutting-edge sharing technologies. www.evarplanning.com Firstkind
Booth 131
Firstkind Ltd, a UK-based medical devices company, is the manufacturer of a ground-breaking platform technology, OnPulse, embedded in its wearable geko device, designed increase blood flow by combination of proprietary nerve and muscle stimulation, resulting in increased venous, arterial and microcirculatory blood flow – creating conditions favourable to wound healing. www.gekodevices.com
2019
125
Vascular & Endovascular Challenges Update Fist Assist Devices
Booth 718
Fist Assist Devices, LLC is a company based in Silicon Valley, CA USA. We have developed a patented, external wearable (Fist Assist) designed for arm vein enhancement and vein dilation before and after AV fistula surgery for renal failure patients and venipuncture procedures. The company is completing the FACT trial at The University of Chicago and all regulatory requirements before sales launch in Europe and the USA. www.fistassistdevices.com H&R Healthcare Ltd
Booth 308
H&R Healthcare Ltd is a UK based distributor with over 12 years’ experience supplying innovative and cost-effective medical products to the NHS. Our innovative products include: FlowOx, a novel system for the treatment of PAD-related problems such as pain, reduced walking distance and chronic ulcers. It is a non-invasive, gentle and easy-to-use device that works by generating pulsating negative pressure, perfusing the lower limb, thus improving the blood flow and oxygenation; Accel-Heal, using electroceutical energy that stimulates healing and reduces pain in leg ulcers. hrhealthcare.co.uk Huntleigh
Booth 209
A proud member of the Arjo family, Huntleigh has been committed to supporting healthcare professionals in improving outcomes and enhancing patient wellbeing since 1979. We do this through our proven solutions for Vascular Assessment & Treatment and Fetal & Patient Monitoring. With innovation and customer satisfaction as our guiding principles, we strive for clinical excellence and improved performance, for life. www.huntleigh-diagnostics. co.uk Intact Vascular
Booth 408
Intact Vascular is committed to developing safe, efficacious and easyto-use products for patients with vascular disease and the physicians who treat them. Founded in 2011, our core technology, the Tack Endovascular System is a first-of-its-kind dissection repair device that is purpose-built and designed to provide precision treatment of peripheral arterial dissections following balloon angioplasty, in either above- or below-the-knee therapeutic interventions. www.intactvascular.com LimFlow
Booth 714
LimFlow is a private, venture-backed medical device company transforming the treatment of critical limb ischaemia with a novel technology solution to perform percutaneous deep vein arterialisation. www.limflow.com medi
Booth 217
Global leaders in venous healthcare. Visit the stand to see Medi’s wound care therapy chain. Assess with the world’s fastest ABPI device – MESI ABPI MD – an accurate reading in one minute, with no need for prior resting before testing. Clean and debride with UCS pre-moistened debridement cloth – soft loop technology helps to catch wound debris and slough. Can be used both sides. Sterile and ready to use. Heal venous leg ulcers with juxtalite the only adjustable Velcro device with measurable compression. Eight sizes and two lengths for all stages of venous disease. www.mediuk.co.uk
126 2019
Vascular & Endovascular Challenges Update Micro Medical Solutions
Booth 738
Micro Medical Solutions is an innovative, US-based medical device company committed to the advancement of the least invasive technology for the treatment of patients suffering from CLI. MMS’ lead product, MicroStent, is a uniquely designed self-expanding stent for the treatment of BTK peripheral artery disease. MMS’ mission is to improve patient quality of life and clinical outcomes, reduce amputation associated with CLI, and lessen the healthcare economic burden. www.micromedicalsolutions.net Mölnlycke
Booth 134
Mölnlycke is a world-leading medical solutions company. We are here to advance performance in healthcare across the world, and we aspire to equip everybody in healthcare with solutions to achieve the best outcomes. www.molnlycke.co.uk Nanjing ECO Microwave System CO, LTD
Booth 208
Established in 2000, ECO is a leading manufacturer of medical instruments in China, which covers microwave, high frequency and laser systems. With the vision “To be no.1 in China and first-class in the world”, and mission to help employees realise their self-worth and contribute to human health, ECO is trying every effort to deliver advanced technology and provide product solutions to healthcare industry at home and abroad. www.ecomicrowave.com Orbus Neich
Booth 505
OrbusNeich is a global pioneer in the provision of life-changing vascular solutions. Portfolio includes peripheral devices; JADE, Sapphire II Pro PTA, Scoreflex PTA balloons & Teleport/ Teleport Control microcatheters together with coronary stents, balloons and microcatheters. OrbusNeich is the exclusive distributor of the Stealth 360 Peripheral Orbital Atherectomy System from Cardiovascular Systems, Inc. outside of the USA and Japan. www.orbusneich.com Regen Medical
Booth 124
Part of the Joint Operations family, Regen Medical is a leading distributor in the fields of burns and woundcare. Regen Medical prides itself on introducing new, innovate and ground-breaking products to the regenerative space within the UK. These include Epifix from MiMedx, a dehydrated Human Amnion/ Chorion Membrane (dHACM) Allograft. www.regenmedical.com Venclose
Booth 112
Venclose is a privately held, commercial-stage Silicon Valley medical technology company developing next-generation solutions for the treatment of venous reflux disease, also known as chronic venous insufficiency (CVI). CVI is a progressive medical condition affecting more than 40 million adults in the USA alone. The VENCLOSE RF Ablation System offers physicians more versatility than earlier generation endovenous radiofrequency ablation technologies and is commercially available in the USA and Europe. www.venclose.com
2019
127
Vascular & Endovascular Challenges Update
Product launches 2019 ARTIS pheno and ARTIS icono, Siemens
See minimally invasive treatment in a new light: Siemens’ new imaging systems ARTIS pheno and ARTIS icono with procedural intelligence allow you to optimise clinical operations in the Hybrid OR and achieve consistency across workflows with ease – regardless of procedural complexity.
Carnelian Support Catheter, Biotronik
Carnelian Support catheter is indicated to support guidewire in peripheral vascular procedures evolving the PVI product portfolio towards complex disease. Biotronik offers five different versions to allow physicians to choose the right tool suitable for challenging lesions. The multisegment shaft is optimally balanced providing additional strength, trackability and pushability.
Fortress Line Extension, Biotronik The Fortress introducer sheath is reinforced with a resilient and flexible stainless steel coil that provides a maximum degree of flexibility and stability to introduce devices to treat diseased arteries. To further strengthen Fortress’ success Biotronik has added 65cm and 90cm lengths in 4F, 5F, 6F, to its portfolio providing physicians more opportunities during peripheral interventions.
Legacy Needle Holders and Forceps with the revolutionary Scan-II handle, Scanlan Scanlan International presents the new Legacy Needle Holders and Forceps with the revolutionary Scan-II handle. The unique ScanII handle combines flat surfaces for control with round sides for manoeuvrability. Scanlan titanium Legacy instruments are designed for optimal weight and balance. Surgeons say “it’s like an extension of my hands”.
Microwave Therapeutic System for varicose vein, Nanjing ECO Microwave System CO, LTD
The Microwave Endovenous ablation therapy, with 80oC ablation, coagulating protein of veins. It provides inside-out heat to the vein wall, with fewer complications (less ecchymosis, less edema, less pain) and a lower recurrence rate.
PerQseal, Vivasure Medical
Vivasure Medical has developed PerQseal, a fully absorbable patch-based closure device for large-bore arteriotomies up to 24F. PerQseal is simple and intuitive to use, sealing and healing the artery from the inside, without the need for sutures, collagen or metal clips. The implant is completely absorbable, leaving nothing behind.
Pulsar-18 T3, Biotronik
Pulsar-18 T3 SES designed for effective lesion treatment in the
128 2019
Vascular & Endovascular Challenges Update SFA, popliteal and infrapopliteal arteries up to 200mm. A unique combination for an improved implantation procedure: The 4F low profile decreases the risk of access site complications, while the triaxial shaft design facilitates accurate implantation of the proven Pulsar stent.
Stealth 360 Peripheral Orbital Atherectomy System, distributed by OrbusNeich, manufactured by Cardiovascular System, Inc
The Stealth 360 Peripheral Orbital Atherectomy System is a minimally invasive catheter-based system used to treat patients who suffer from peripheral arterial disease. It is designed to contact 360 degrees of the vessel wall with differential sanding that treats hard plaque while minimising damage to the media.
Valiant Navion stent graft system, Medtronic
Medtronic is introducing the Valiant Navion stent graft system, featuring a low 18F OD profile system for expanded access. Valiant Navion is broadly indicated to treat all pathologies of the descending thoracic aorta, and leverages the proven design of the Valiant and Endurant stent graft system platforms.
Satellite Sessions The following Satellite Sessions have been supported by educational grants from industry partners:
Tuesday 16 April
• Coffee Symposium: The paclitaxel safety controversy - from patient-level data to big data: What the newest clinical evidence is telling us (Medtronic) • Coffee Symposium: Arterial and venous insufficiency treatment with RD Global innovative medical devices (RD Global) • Coffee symposium: Innovative solutions for the treatment of visceral arteries in complex aortic procedures (Gore) • Lunch Symposium: Optimising DCB results for long-term success (Philips) • Tea Symposium: Aortoiliac obstructive disease: Endoluminal solutions (Gore)
Wednesday 17 April
• Coffee Symposium: Expanding aortic treatment indications (Gore) • Coffee Symposium: The rationale and evidence for focal dissection repair (Intact Vascular) • Lunch Symposium: Over 15 years of experience with a reliable, proven, trusted balloon-expandable covered stent (Getinge) • Lunch Symposium: New technologies and multi-disciplinary approach: How I treat failing access in my ESRD patients (BD) • Tea Symposium: From infrarenal AAA to complex TAAA repair: Endovascular outcomes and future hybrid innovations (Terumo Aortic) • Tea Symposium: Data update on a safe and efficient DCB in lower limb (BD)
Thursday 18 April
• Coffee Symposium: A roundtable on global trends and outcomes in aortic arch repair (Terumo Aortic) • Coffee Symposium: Below the knee symposium (Cook Medical) • Lunch Symposium: The freedom to do more with a new conformable and low-profile thoracic endograft (Medtronic)
2019
129
Vascular & Endovascular Challenges Update
Dorsett Shepherds Bush
Hilton London Kensington K West Hotel & Spa
Novotel London West
Co
Hilton London Olympia
Grand Hall Olympia
K+K Hotel George
130 2019
Vascular & Endovascular Challenges Update
Travel connections and hotels Airports
Public transport
Gatwick Gatwick is easily accessed via the Southern service to Clapham Junction. From Clapham Junction, change onto the London Overground which will take you direct to Kensington (Olympia). Approximate journey time 45 minutes.
Nearest station: Kensington (Olympia) Turn left out of the exit of the station onto Olympia Way and follow signs for Olympia Grand.
Heathrow Heathrow is easily accessed via the Heathrow–Paddington, ‘Heathrow Express’, link. When you arrive at Paddington, take the District Line to West Brompton, then one stop to Kensington (Olympia) via the London Overground. Approximate journey time 40–50 minutes. Delegates are advised not to bring their cars as parking is restricted.
London Overground Direct services run from West Brompton, Clapham Junction, Balham, East Croydon, Shepherd’s Bush, Watford Junction, Milton Keynes Central, Willesden Junction, West Hampstead and Stratford. The entrance to Olympia Grand is opposite the station exit in Olympia Way. London Underground The District Line trains to Olympia operate during weekends only. London Buses Bus routes 9, 27, 28 and 391 all stop directly outside Olympia National Hall on Hammersmith Road.
opthorne Tara Hotel
Holiday Inn High Street
The Rembrandt Hotel
The Baileys Hotel London Millennium Gloucester Hotel
DoubleTree by Hilton
2019
131
Vascular & Endovascular Challenges Update
Notes
2019
133
Vascular & Endovascular Challenges Update
Notes
134 2019
Vascular & Endovascular Challenges Update
Notes
2019
135
Vascular & Endovascular Challenges Update
Monday 15 April
07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 0
Pillar Hall Learning Centre Tuesday 16 April Upper Main Auditorium Lower Main Auditorium Pillar Hall Learning Centre London Room Learning Centre Gallery Suite Learning Centre Dark Room Learning Centre
07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 0 Peripheral Proximal Arterial Ischaemia Challenges – p22 Venous & Lymphatic Challenges – p25
● CX Aortic Techniques & Technologies (edited cases) – p3
● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 1 – p37 ● CX Thoracic Aortic Global Stars and Rising Stars and Abs Presentations – Day 1 – p40 ● CX Acute Stroke Abstract Presentations – p36
CX Peripheral Workshop CX Aortic Workshop Poster Gallery Wednesday 17 April Upper Main Auditorium Lower Main Auditorium Pillar Hall Learning Centre London Room Learning Centre Gallery Suite Learning Centre Dark Room Learning Centre CX Venous City
07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 0 Aortic Podium 1st Session – p52
● Periphe T&T – p
● LINC@CX – p58 ● CX Vascular Access Masterclass – p62 iWounds – p64
● CX Peripheral Arterial Global Stars and Rising Stars and Abstract Presentations – Day 2 – p70 ● CX Venous Global Stars and Rising Stars and Abstract Presentations – Day 1 – p73 ● Venous Day 1 – p6
CX Peripheral Workshop CX Aortic Workshop CX iWounds Workshop Poster Gallery Thursday 18 April Upper Main Auditorium Lower Main Auditorium Pillar Hall Learning Centre London Room Learning Centre Gallery Suite Learning Centre Dark Room Learning Centre CX Venous City CX Vascular Access Workshop CX iWounds Workshop Poster Gallery
136 2019
07:30 07:45 08:00 08:15 08:30 08:45 09:00 09:15 09:30 0 Thoracic Aortic Challenges – p84 Peripheral Critical Ischaemia Challenges – p87 ● ● ● ● CX Innovation Showcase – p92 ● CX Abdominal Aortic Abstract Presentations – p104
European Vascular Surgeons in Training – Prize Session – p ● CX Venous Global Stars and Rising Stars and Abstract Presentations – p102
● Venous Day 2 – p9 CX iWoun
● CX Vasc. Acces (edited cases) –